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ISTRODUCTION AND LITERAIDRE REVIEW 
Historical Points 
Rabies is considered one of the first diseases that brought 
lawmakers in the earliest civilization on earth to institute a public 
health protection act. The Premosaic Eshnunna Code of Babylon, which 
predates the Code of Hummurabi of the 23rd century B.C., states: "If a 
dog is mad and the authorities have brought the fact to the knowledge 
of its owner; if he does not keep it in, and it bites a man and causes 
his death, then the owner shall pay two-thirds of a mina (40 shekels) 
of silver. If it bites a slave and causes his death, he shall pay 15 
shekels of silver" (Sellers, 1954). The code mentioned above clearly 
indicated that the disease originated in the dog, was transmissible to 
man by the bite of a rabid dog, and caused the death of the bitten 
person. Thus, rabies was recognized since that time as an 
anthropozoonotic disease that by direct transmission was accompanied by 
a high mortality rate. It was also recognized that isolation and/or 
control of rabid animals was an effective public health protective 
measure. 
Rabies was also recognized and noted by early Greek philosophers, 
including Democritus (470 B.C.) and Aristotle (4th century B.C.). 
Aristotle wrote in The Natural History of Animals, "Dogs suffer from 
madness. This causes them to become very irritable and all animals 
they bite become diseased" (Steele, 1975). The role of wild animals in 
transmitting the disease was recognized by Celsus in 100 A.D. (Steele, 
1975). Many detailed descriptions were written about hydrophobia in 
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man or rabies in animals, and many preventive or postexposure cura­
tive measures were proposed during the centuries after that (Sellers, 
1954; Steele, 1975; Beran, 1981; Wiktor, 1985). In the tenth 
century, the Arab physician Rhazes in Iraq described dog to human 
transmission and hydrophobia in human paients (Figure 1) (Sellers, 
1954). In the eleventh century, the Arab physician, Avicena, also 
described hydrophobia and recommended that the wound be kept open for 
40 days by the placing of ordinary blistering chemicals on it (Steele, 
1975; Wiktor, 1985). In 1026, Howel the Good of Wales described an 
outbreak of rabies in dogs and people (Steele, 1975). Countless 
remedies which were used as postexposure curative measures have been 
described since 500 B.C. Such remedies included cutting the frenulum 
attaching the tongue in order to excise the tongue worm, the supposed 
cause of the disease; washing the wound with or without antiseptic 
compounds; and cauterization with a hot iron, treatment with caustic 
alkali, strong acids or corrosive substances, and the use of ordinary 
blistering agents (Sellers, 1954; Sorts and Top 1972; Steele, 1975; 
Beran, 1981; Baer, 1985c; Wiktor, 1985). It was not until 1885, when 
Pasteur developed and used the first vaccine to prevent rabies, a 
milestone in medicine, that a vaccine was used for post-exposure treat­
ment (Sorts and Top, 1972; Steele, 1975; Beran, 1981; Wiktor, 1985). 
Although the causative agent was not known to Pasteur, rabbit-origin 
attenuated rabies virus vaccine was developed by him and his collabor­
ators, Rous, Chamberland, and Thuillier (Steele, 1975; Wiktor, 1985). 
Rabies virus was maintained by intracerebral inoculation into rabbits 
"And chey make music, and some of them run away from the light 
while others enjoy it. Others howl like dogs and bite whomever 
approaches them, who in turn get afflicted also. Some people 
mentioned that they saw one or two men bitten and loose, and that 
Odimus and Hemson were affected by the disease and that one of 
them succumbed to the disease after being bitten and then 
expired; the other, however, was staying with a friend and 
manifested fear of water and ra." (Translation, courtesy of Mr. 
A. E. Najjar) 
Figure I. Iraqi painting: A.D. 1224 (Rajab 621 H. ) Baghdad 
School. Written by Abdallah ibn al-Fadl. Outdoor 
scene with mad dog biting man (Courtesy of the Freer 
Gallery of Art, Smithsonian Institution, Washington, 
D.C. 20560. Reproduced with permission) 
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for 90 consecutive passages (Wiktor, 1985). The original incubation 
period of 18 days became shorter with the number of passages and 
remained fixed at 7 days after 50 passages. Spinal cords were 
removed from rabbits showing signs of paralysis 7 days after 
inoculation. When such cords were suspended in dry air at room 
temperature, their virulence decreased rapidly, and they were 
completely avirulent after 15 days of desiccation (Steele, 1975; 
Beran, 1981; Wiktor, 1985). Thus, by varying the period of 
desiccation from 1-15 days, virus with variable levels of virulence 
would be obtained. Vaccination was started with a nonvirulent 
suspension of cord dried for 15 days and concluded with a final dose 
of fully virulent unattenuated cord. Twelve successive inoculations 
of infected spinal cord preparations of increasing virulence were 
given to Joseph Meister, the first boy protected by this vaccine 
(Sellers, 1954; Steele, 1975; Wiktor, 1985). In 1908, Fermi reported 
the development of a phenolized vaccine that was more stable than 
dried spinal cord preparations (Wiktor, 1985), and in 1911, Semple 
modified Fermi's vaccine by complete inactivation with phenol. These 
vaccines were used widely even though in some patients they caused 
demyelinating neuroparalytic accidents (Steele, 1975; Beran, 1981; 
Wiktor, 1985). In 1955, Fuenzalida and Palacios reported on a UV or 
B-propiolactone inactivated suckling-mouse-brain tissue vaccine 
(Steele, 1975; Wiktor, 1985). This vaccine was used for both human 
beings and animals. Other vaccines have since been developed from 
cell culture cultivated virus. These vaccines will be discussed 
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under "vaccines" in the section on control measures* 
Definition and Clinical Signs 
Rabies is an acute viral encephalomyelitis of all warm blooded 
animals, including human beings and bats (Beran, 1981; Humphrey and 
Constantine, 1983; Benenson, 1985; Paterson, 1986; Postic and Wiktor, 
1986b). 
Human beings 
The incubation period is variable depending on the site of 
infection, usually extending from 2-8 weeks, but it may be as short as 
10 days or so long that the time of exposure is forgotten by the 
patient (up to one year or more) (Acha and Szyfres, 1980; Benenson, 
1985; Bernard and Hattwick, 1985; Paterson, 1986; Postic and Wiktor, 
1986b). The clinical symptoms are first evident in the prodromal phase 
of 2-10 days duration with malaise, anorexia, fatigue, headache, and 
fever which are not specific except for pain or paresthesia occurring 
at the site of exposure (Paterson, 1986; Postic and Wiktor, 1986b). 
This is followed by a 2-7 day period of acute neurologic symptoms, with 
anxiety, agitation, depression, disorientation, incoordination, paresis 
or paralysis, pharangeal spasm, spasms of muscles of deglutition on 
attempts to swallow, leading to fear of water (hydrophobia), and maybe 
other signs of central nervous system involvements (Acha and Szyfres, 
1980; Benenson, 1985; Paterson, 1986; Postic and Wiktor, 1986b). The 
terminal phase of coma and increasing cardiopulmonary dysfunction 
commonly terminates in death in 1-2 weeks due to cardio-pulmonary 
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arrest (Benenson, 1985; Paterson, 1986; Postic and Wiktor, 1986b). A 
stage of recovery has rarely occurred during this usually terminal 
phase, (Kaplan, 1985; Postic and Wiktor, 1986a,b). 
Animals 
The incubation period is highly variable within and among species. 
Generally, it runs between 2-8 weeks but may be less or more than that 
(10 days to 8 months or more) (Acha and Szyfres, 1980; Beran, 1981; 
Constantine, 1966a,b,c; Constantine and Woodall, 1966; Greene et al., 
1984; Kaplan, 1985). The phases of the disease in animals are 
comparable in progress to those in human patients, with variability 
among species in susceptibility to infection (Beran, 1981; Greene et 
al., 1984; Kaplan and Koprowski, 1980; Kaplan, 19a5). Hydrophobia is 
not a characteristic of the disease in animals (Beran, 1981; Cran, 
1986; Greene et al., 1984). Generally, the prodromal phase lasts for 
2-3 days and is characterized by behavioral changes, apprehension, 
anxiety, and temperament change (Beran, 1981; Cran, 1986; Greene et 
al., 1984). A furious or aggressive phase follows, usually lasting for 
1-7 days with restlessness, irritability, muscular incoordination and 
disorientation. Dogs may eat unusual objects, especially wood, which 
may be observed at necropsy as gastrointestinal foreign bodies (Acha 
and Szyfres, 1980; Beran, 1981; Greene et al., 1984; Kaplan, 1985). 
The furious phase in dogs may be unnoticed or be very short and 
progress rapidly to the paralytic phase (Beran, 1981; Greene et al., 
1984; Kaplan, 1985; Trimachi et al., 1986). The dumb, or paralytic, 
phase usually develops within 4 days after the appearance of clinical 
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signs in dogs (Beran, 1981; Greene et al., 1984; Kaplan, 1985; Kaplan 
and Koprowski, 1980). Paralysis may start in the the area of first 
exposure and progress toward the central nervous system or may develop 
first in the posterior extremities and/or the lower jaw (Baer, 1975b; 
Cran, 1986; Kaplan, 1985; Kaplan and Koprowski, 1980; Murphy, 1985; 
Trimachi et al., 1986). The disease in other animals follows the same 
sequence of categories described in the dog with some differences among 
species (Constantine, 1966a,b,c; Cran, 1986). Cats more consistently 
develop a furious phase. Foxes and coyotes are considered the most 
highly susceptible species to rabies followed by skunks, raccoons, 
cats, cattle, sheep, goats, swine, and horses. Dogs are of moderate 
susceptibility, and opossums are the least susceptible to rabies 
(Baer, 1975a,b; Beran, 1985a; Kaplan, 1985; Kaplan and Koprowski, 1980; 
Constantine, 1966a,b,c; Constantine and Woodall, 1966; Trimachi et al., 
1986). 
Pathogenicity and Lesions 
Following the deposition of rabies virus in the tissues by a rabid 
animal or on the nasal mucosa from aerosol inhalation, the first stage 
of infection of a susceptible host begins. In striated muscle cells, 
where the virus first enters, it may be recovered for a variable period 
of time (Beran, 1981; Baer, 1935c; Carski et al., 1962; Fekadu et al., 
1982; Humphrey and Constantine, 1983; Koprowski, 1984). Experi­
mentally, the course of the infection may be interrupted or aborted by 
removal of an inoculated limb or cutting the ascending nerves 
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anterior to the site of infection within a limited period of time, 
usually within the first 24 hours (Baer, 1985c; Beran, 1981; Koprowski, 
1984; Murphy, 1985; Wiktor et al., 1985). Commonly, there is no 
viremia (Murphy, 1985} unless it follows a high inoculum dose in an 
experimental «nimai 1q which it may represent a spill-over of virus 
(Beran, 1981). 
From the striated muscle cells, rabies virus invades the exposed 
peripheral unmyelinated nerve endings in their motor endplates, 
neuromuscular junctions (NMJ) or neurotendinal spindles (Dietzschold et 
al., 1985b; Koprowski, 1984; Lodmell and Ewalt, 1985; Murphy, 1985; 
Spriggs, 1985). Rabies virus accumulation around the NMJ and infection 
of the nerve endings is dose—dependent and variable being detectable 
from 1-6 hours after experimental intramuscular inoculation to days., 
weeks, and even months following natural exposure (Beran, 1981; Baer, 
1985c; Murphy, 1985; Smith et al., 1984a; Spriggs, 1985). 
Rabies virus utilization of acetylcholine receptors (AChR) for 
invasion of the nervous system has been studied by some investigators 
(Smith et al., 1984a). By co-localization of rabies virus antigen and 
AChR, and inhibition of virus localization in the presence of 
acetylcholine-binding inhibitors, they concluded that rabies virus 
employs this tract for the invasion of the nervous system. However, 
due to the observation that rabies virus infects a wide variety of 
cells in—vivo and in—vitro, and from studies using different cell lines 
by another group of investigators (Reagan and Wunner, 1984, 1985); it 
was concluded that rabies virus interaction with cell surface was by 
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utilization of a rhabdovirus-common receptor that is independent of 
AChR (Reagan and Wunner, 1984, 1985; Murphy, 1985; Spriggs, 1985). The 
attachment of rabies virus to chicken-embryo-related (CER) cells was 
shown to be inhibited by pretreatment of the cells with neuraminidase 
(Superti et al., 1984). Ammonium chloride and chloroquine were shown 
to inhibit the early steps of the infection of CER cells; and the virus 
entry into these cells, which is probably through adsorptive 
endocytosis, does not require the Involvement of cellular energy 
processes (Reagan and Wunner, 1984; Superti et al., 1984). 
By aerosol transmission, rabies virus may be deposited in the 
olfactory end organs in the nares where the neuroepithelial cells are in 
direct contact with the body surface and extend without interruption 
into the olfactory bulb of the brain (Murphy, 1985). The olfactory 
neuroepithelium is easily infected and probably the key to the rare 
aerosol transmission of rabies virus in bat caves (Constantine, 1966a; 
Martin and Sednick, 1983; Murphy, 1985). 
Rabies virus entry into nerve endings begins the infection phase 
in which centripetal passive movement of viral genomes within axons at 
a rate of 2-5 mm/hr leads to infection of the dorsal root ganglia, 
where the virus replication takes place (Greene et al., 1984; Martin and 
Sednick, 1983; Murphy, 1985; Postic and Wiktor, 1986a,b). From the 
dorsal root ganglia, the virus progresses via the spinal cord to the 
ultimate target organ the brain (Beran, 1981; Koprowski, 1984; Murphy, 
1985; Postic and Wiktor, 1986a,b). After this initial invasion of the 
central nervous system (CNS), the virus disseminates in a rapid and 
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selective manner to the neuronal cells of the brain stem, the 
hippocampus, the subcortical nuclei, the limbic cortex, and the 
Purkinje cells in the cerebellum (Beran, 1981; Fekadu et al., 1982; 
Murphy, 1985; Postic and Wiktor, 1986a,b). By centrifugal 
dissemination the virus invades, via the peripheral nerves, other 
tissues such as the eyes, salivary glands, nerve bundles of hair roots, 
particularly vibrissae and nuchal hairs, the tongue, skin, lungs, 
heart, pancreas, thymus, kidneys, ovaries, uterus, adrenal glands, 
liver, spleen, intestines, and skeletal and smooth muscle (Baer, 
1985c; Beran, 1981; Bernard and Hattwick, 1985; Greene et al., 1984; 
Murphy, 1985; Postic and Wiktor, 1986a,b). 
It is apparent that only limited lesions have been noted given 
the severity of the symptoms observed. Basically, the changes noted 
include encephalomyelitis characterized by diffuse and perivascular 
cuffing, neuronophagia and neural degeneration, proliferation of the 
capsular cells surrounding ganglionic neurons and the neuronal 
intracytoplasmic inclusion bodies (Negri bodies) (Atanasiu, 1975; 
Beran, 1981; Koprowski, 1984; Murphy, 1985; Paterson, 1986; Postic and 
Wiktor, 1986a,b). These Negri bodies are 2-10 pm in size and are found 
most abundantly in the central pyramidal layer of Âmmon's horn of the 
hippocampus, but also in the Purkinje cells of the cerebellum, and less 
frequently, in the motor areas of the cerebral cortex and medullary 
nuclei (Atanasiu, 1975; Beran, 1981; Koprowski, 1984; Murphy, 1985; 
Paterson, 1986; Postic and Wiktor, 1986b). Negri bodies consist of 
rabies virus ribonucleoprotein and are observed as mostly acidophilic 
Inclusions with basophilic granules which may be demonstrated by the 
use of Seller's stain containing basic fuchsin and methylene blue 
(Atanasiu, 1975; Beran, 1981; Koprowski, 1984; Paterson, 1986). 
The pathological changes vary with the stage of infection, the 
part of the brain or spinal cord affected, the immune response, the 
ecotype of virus that caused the disease, and to a lesser extent, in 
the species affected (Âtanasiu, 1975; Baer, 1975b, 1985c; Greene et al., 
1984; Koprowski, 1984; Martin and Sednick, 1983). It has been reported 
that the immune system has a double role in street rabies virus 
infection (Baer, 1985c). Experimental animals immunosuppressed with 
cyclophosphamide have had virus leave the site of inoculation earlier 
and have had significantly higher mortality rates, while at the same 
time the immuno-suppression delayed the onset of disease signs and of 
death for 1 to 2 weeks (Lodmell and Ewalt, 1985; Smith et al., 1982). 
Wild ecotypes or street rabies virus (not attenuated) have arginine in 
position 333 of the amino acid sequence of the viral glycoprotein 
which, in lethal Infections with rabies virus results in suppression of 
cytotoxic T-lympho cyte s (CTTL); however, attenuated ecotypes, ERA or 
HEP-Flury, which have arginine substituted by isoleucine or glutamine 
in position 333 have induced high levels of CTTL (Koprowski, 1984; 
Gerber et al., 1985; MacFarlan et al., 1984; Murphy, 1985; WHO, 1984b). 
This difference may determine the failure of host defenses (cell-
mediated immune responses) which occur in natural infections, but not 
under experimental conditions .using fixed or attenuated ecotypes of 
rabies virus (Hill, 1974; Macfarlan et al., 1984; Koprowski, 1984; 
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Koprowski et al., 1985; Murphy, 1985; Gerber et al., 1985). 
Centrifugal dissemination of rabies virus from the brain to other 
tissues is important to complete the natural cycle. In the nervous 
system, nearly all virions are formed upon membranes within cells that 
are not actually destroyed by the infection. In such locations, the 
virus may be hidden from the immune and inflammatory systems of the 
hosts (Murphy, 1985). However, in the salivary glands, nearly all 
virus is formed on plasma membranes of mucus-producing cells and is, 
therefore, immediately delivered into saliva by normal secretory flow. 
Virus is readily transmitted to new host with infective saliva through 
bites (Beran, 1981; Baer, 1985c; Koprowski, 1984; Murphy, 1985). 
Rabies virus or antigens have been demonstrated frequently in 
intestines but fecal transmission has not been considered to be of 
importance. Virus has also been recovered from kidneys, urinary 
bladder or other urinary tract tissues and aerosolized urine 
transmission may play a possible role in the epidemiology of rabies in 
foxes and bats (Beran, 1981; Kaplan and Koprowski, 1980). Rabies virus 
or antigens have been isolated from, or demonstrated in the mammary 
glands and milk of infected cattle, bats, skunks, and sheep (Baer, 
1975a,b; Beran, 1981; Zaragoza, 1984) The presence of rabies virus in 
the milk of cattle and sheep is not considered to be of public health 
importance as human beings are resistant to oral exposure, the virus 
would be inactivated by pasteurization, the number of excreted virions 
would be diluted out, and infected animals would stop milking in a very . 
short period of time (Beran, 1981). 
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Diagnosis 
Primary diagnosis of rabies may depend on Che clinical signs but 
must be confirmed by laboratory tests. Animal Inoculation and 
isolation of rabies virus are highly specific diagnostic methods but 
they take a long time to perform and are successful only using fresh 
specimens because the virus dies soon after animals start to decompose 
(Àtanasiu, 1975; Beran, 1981; Bernard and Hattwick, 1985; Greene et al., 
1984; Johnson and Emmons, 1985). Observation of stained Negri bodies 
is also highly specific, but this method has limited sensitivity due to 
the fact that the Negri bodies usually arise late in the clinical 
course of the disease and many strains, especially those of high 
viirulence, are weak producers of inclusion bodies (Acha and Szyfres, 
1980; Atanasiu, 1975; Beran, 1981; Sorts and Top, 1972; Johnson and 
Emmons, 1985; Sikes, 1975). Fluorescent antibody (FA) staining has 
been widely adopted following the report of Goldwasser and Kissling in 
1958 (Dean and Abelseth, 1973). It provides rapid and specific 
diagnosis, with sensitivity greater than 98% in the hands of 
experienced laboratory personnel (Baer, 1985c; Beran, 1981; Beran and 
Crowley, 1983; Beran, 1985b; Bogel and Kuwert, 1985). The FA test is 
performed for the detection of rabies virus antigens in the brain or 
salivary gland tissues of animals suspected to have died of rabies 
(WHO, 1984b; Baer, 1985c; Beran, 1985b; Bogel and Kuwert; 1985). The 
test has also been employed for the detection of rabid animals 2-3 days 
before and during clinical symptoms, to evaluate the rabies status of a 
biting dog or cat through examination of biopsies of hair follicle-rich 
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skin of the postero-lateral neck or impression smears of the anterior 
surface of the cornea (Schneider, 1969; Blenden et al., 1983; Greene et 
al., 1984; Ginsberg, 1980b; Paterson, 1986). Impression smears or 
tissues biopsy stained with fluorescein isothiocyanate conjugated 
specific antibodies permit detection of rabies antigen in such 
preparations within 6 hours or less after receiving them (Blenden et 
al., 1983; Johnson and Emmons, 1985; Kaplan and Koprowski, 1980; Fostic 
and Wiktor, 1986a,b). 
The virus neutralization test, which historically was conducted in 
mice, may be performed in cell cultures, using FA techniques. The 
fluorescent focus inhibition test (FFIT), or a modification, the rapid 
fluorescent focus inhibition test (RFFIT) are now approved as standard 
and dependable methods for assay of sera for rabies virus antibodies 
(Baer, 1985c; Beran, 1985b; Brown et al., 1984; Johnson and Emmons, 
1985; WHO, 1984b). 
Other diagnostic serological tests include the complement fixation 
(CF) test which depends on the N protein which is shared with rabies-
related viruses (Mokola and lagos-bat viruses), and the 
hemagglutination inhibition (HI) test with goose enythoocytes which 
depends on the glycoprotein (G) specific antigen. The G antigen has a 
lower sensitivity for rabies-related viruses (Beran, 1981; Humphrey and 
Constantine, 1983; Johnson and Emmons, 1985; Kaplan, 1985; Kaplan and 
Koprowski, 1980; Koprowski et al., 1985). The presence of non-specific 
inhibitors (low-density lipoproteins) in sera from, human beings and 
various species of animais requires treatment of these sera with kaolin 
16 
and/or colloidal silicic acid to remove these inhibitors (Mannen et 
al., 1984). Low levels of antibodies in sera from immunized human 
subjects have been detected with higher sensitivity by combining 
colloidal silicic acid treatment of sera with the use of bromelin-
treated goose erythrocytes in the HI test (Mannen et al., 1984). 
Etiology 
Rabies is caused by rabies virus, the prototype for the genus 
Lyssavirus of the family Rhabdoviridae (Fenner et al., 1974; Ginsberg, 
1980b; Postic and Wiktor, 1986a; Melnick, 1986). The other rabies-
related members of this genus that are morphologically similar to 
rabies virus include: Mokola, Duvenhage, Lagos bat, Obodhiang, and 
Kotonkan viruses. Duvenhage and Mokola may be associated with human 
infections (Ginsberg, 1980b; Kaplan and Koprowski, 1980; Koprowski et 
al., 1985; Melnick, 1986). Nigerian horse virus has also been reported 
to have serological and morphological relatedness to rabies (Kaplan, 
1985). 
Characteristics 
Rabies virus has a negative, non-segmented, single stranded RNÂ 
genome, and an elongated cylindrical bullet-shape (with one rounded end 
and one planar or concave-planar end). The virion is 100-300 x 65-75 nm 
and enveloped with a lipid bilayer (Fenner et al., 1974; Ginsberg, 
1980a,b; Melnick, 1986; Postic and Wiktor, 1986a). Six to eight nm 
glycoprotein (G) spikes protrude through the glycoprotein membrane (M) 
and the lipid envelope and cover all the virus surface except the 
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planar end; they also carry the virus specific antigenic determinant 
and the virus hemagglutinin (Baer, 1985c; Dietzschold et al., 1985; 
Ginsberg, 1980a,b; Joklik, 1984; Postlc and Wiktor, 1986a). The 
nucleoprotein (N) is enclosed in the membrane, carries the genus shared 
antigen, is important in identifying the virus by CF and FA techniques, 
and its inner surface interacts with helices 30-35 of the RNA genome to 
form the ribonucleoprotein (RNP) (Dietzschold et al., 1985; Ginsberg, 
1980b; Dulbecco, 1980). The RNA genome has an elongated cylindrical 
shape of about 50 nm diameter, is approximately 160 nm long, is 3.6-4.6 
X 10^  Daltons (Da) molecular weight, and is not infectious (Borts and 
Top, 1972; Ginsberg, 1980a,b; Postlc and Wiktor, 1986a; Crick, 1985). 
Rabies virus has a CsCL bouyant density of 1.20 gm/cm^  (Fenner et 
al., 1974). The purified rabies virus contains 1% RNA, 4% 
carbohydrate, 21% lipid and 74% protein (Fenner et al., 1974; Ginsberg, 
1980b; Postlc and Wiktor, 1986a). With SDS-gel electrophoresis, five 
proteins have been identified in rabies virus including: L(large 190 
KDa) is the virus transcriptase (polymerase); G(Glycoprotein 69 KDa); 
N(nucleoprotein 50 KDa); and and (Matrix proteins of 40 KDa and 
29 KDa, respectively). There is no nucleocapsld (NS) protein in rabies 
virus (Baer, 1985c; Crick, 1985; Ginsberg, 1980b; Joklik, 1984; 
Koprowski, 1984; Melnick, 1986; WHO, 1984b). 
Rabies virus, an enveloped virus, is destroyed by various 
concentrations of formalin, ether, phenol, halogens, mercurials, 
mineral acids and other disinfectants (Bernard and Uattwick, 1985; 
Ginsberg, 1980b). The virus is unstable at pH ^  3 or pH 11, is 
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rapidly inactivated by desiccation, ultraviolet and x-irradiation, 
sunlight, trypsin, B-propiolactone, ether, and detergents (Ginsberg, 
1980b; Bernard and Hattwick, 1985; Crick, 1985). Glycerol preserves the 
Infectlvity of rabies infected tissues; thus, brain and other tissues 
for laboratory examination may be mailed or preserved in 50% neutral 
glycerol-saline solution (Ginsberg, 1980a,b; Greene et al., 1984). Virus 
suspended in 0.1% bovine serum albumin at neutral pH is inactivated 
with a half life of about 24 hours at 4* C, 4 hours at 40" C, 30 
minutes at 54° C and 35 seconds at 60" G (Bernard and Hattwick, 1985). 
Rabies virus is stable for many years when frozen at -60* C to -80" G 
(Bernard and Hattwick, 1985; Ginsberg, 1980b). Rabies virus was found 
to survive in skunk carrion for 22 days at 10" C, but its titer was 
greatly diminished at 24" C, although still viable, after 2 weeks 
(Schaefer, 1983). 
Antigenic relationships between rabies and rabies-related viruses 
Monoclonal antibodies (MGAb) with different specificities have 
been used (Wiktor and Koprowski, 1978) in the analysis of several 
ecotypes (strains) of fixed (ERA, PM, CVS, and Flury HEP) and street 
rabies virus by virus neutralization procedures. These studies have 
demonstrated differences in the antigenic composition between fixed 
ecotypes, and crossreactions between street rabies virus ecotypes. 
Other studies using MCAbs directed against the N or G proteins of 
different ecotypes of rabies and rabies-related viruses have detected 
antigenic differences among isolates from different regions around the 
world (Flamand et al., 1980a,b). Fused mouse myeloma cells with 
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splenocytes of BALB/c mice immunized wich either rabies virus or Mokola 
virus, have secreted monoclonal antibodies specific for the 
nucleocapsids of the inducer virus. Twenty-one hybridoma cultures have 
been reported, displaying different specificities for the nucleocapsids 
of rabies and rabies-related viruses; these have been classified into 
eight groups which corresponded to different antigenic determinants on 
the nucleocapsids. Four strains of fixed rabies virus (CVS, ERA, 
Flury-LEP and Kelev) could not be differentiated by the nucleocapsld-
specific MCÂb. The Flury-HEP virus and the rabies-related viruses 
Mokola, Lagos bat and Duvenhage, have shown marked differences in their 
reactivities with MCAbs to N. Three of these hybridomas have produced 
antibodies which may be used for rapid differential diagnosis among all 
members of the Lyssavirus group. Monoclonal antibodies directed . 
against specific G proteins of rabies or rabies-related viruses have 
been prepared by twenty-five hybridoma cultures. These MCAbs have been 
used to differentiate the G proteins of rabies and rabies-related 
viruses into fourteen antigenic groups which probably correspond to 
different antigenic determinants. These MCABs when used in either 
radiolmmunoassy (RIA) or in neutralization tests have allowed 
differentiation of laboratory strains of rabies virus from each other 
as well as from street rabies strains and from rabies-related viruses. 
Strains from the same geographical area and host species origin have 
displayed similar patterns of reactivity, suggesting antigenic 
specificities related to both animal species and areas. A panel of 20 
MCAbs specific for N antigens of rabies and rabies-related viruses have 
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been used In the FA procedure (Sureau et al., 1983) to study 204 
Isolates of street rabies virus originating from Europe, Africa and 
Asia. Definite pattern of reactivity were observed with ecotypes of 
the same geographic origin with the exception of ecotypes originating 
from Madagascar, Thailand, and Iran which were more diversified. The 
epizootic of raccoon rabies in the U.S. has been studied (Smith et al., 
1984b) with a panel of 23 MCAbs to N proteins of rabies virus, and 
compared with isolates of rabies virus collected from areas of major 
reservoir endemnicity (skunk rabies in the midwestern states, fox 
rabies in the northeastern states, and raccoon rabies in the 
southeastern states). This study as well as another study of antigenic 
ecotypes of rabies virus using MCAbs using isolates from eastern, 
.central and northern Canada (Webster et al., 1985b) have shown definite 
patterns of reactivity among isolates from different species in the 
same geographic area. 
The results of studies using MCAbs led the WHO Expert Committee on 
rabies (WHO, 1984) to the following classification of the rabies group 
of Rhabdoviridae. genus Lyssavirus: 
Serotype 1: Prototype strain — Challenge Virus Standard (CVS) 224; 
includes the majority of field viruses and laboratory 
strains from different parts of the world and the newly 
recognized rodent isolates from Central Europe. 
Serotype 2: Protype strain — Lagos bat virus; first isolated from 
pooled brains of bats in Nigeria, then from a bat in 
Central African Republic. 
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Serotype 3: Prototype strain — Mokola virus; first isolated from 
shrews in Nigeria, and then from a human patient, and from 
wild and domestic animals in several African countries. 
Serotype 4: Prototype strain — Duvenhage virus; first isolated from a 
human patient in South Africa, and then from bats in South 
Africa and Central Europe. 
Serotypes 2, 3, and 4 are commonly referred as rabies-related viruses. 
Monoclonal antibodies have been used to select neutralization-
resistant ecotype viruses which have been used to construct operational 
antigenic maps of the rabies glycoproteins. Three functionally 
independent antigenic sites in CVS-11 and five functionally distinct 
antigenic sites in ERA were defined (Wunner et al., 1984; Wunner et 
al., 1985a,b; WHO, 1984b). Also five spacially distinct antigenic 
sites on ERA nucleoprotein have been detected (Lafon and Wiktor, 1985). 
These antigenic variants have been identified and their locations 
defined using DNA sequencing techniques (WHO, 1984b). Analysis of the 
G-gene for CVS-11 has revealed two types of G proteins, G1 and Gil, 
differentiated by the utilization at the glycosylation sites qf Asn-204 
and Asn-319 in Gl, while only Asn-319 was utilized in Gil (Dietzschold 
et al., 1984; Wunner et al., 1985a,b). 
Epidemiology 
Special characteristics of rabies virus that contribute to its 
survival and transmission have been maintained since the Eshnunna and 
Babylon era, namely, the maintenance in dogs and transmission by dog 
bites (Beran and Crowley, 1983; Beran, 1985; Kaplan, 1985; Kaplan and 
Koprowski, 1980; Sellers, 1954). In developing countries, these two 
determinants continue to be active and the dog is the principal 
reservoir and disseminater of the disease to other domestic animals and 
human beings (Acha and Hubbard, 1975; Acha and Arambulo, 1985; Beran, 
1985; Femandes and Arambulo, 1985). Wild animals in these countries 
may be infected by dogs and disseminate the disease, but they play only 
a minor role in the rabies cycle in developing countries (Acha and 
Hubbard, 1975; Acha and Arambulo, 1985; Femandes and Arambulo, 1985). 
In developed countries, vaccination of owned dogs and cats, and the 
absence of free roaming (stray) dogs have broken transmission cycles of 
rabies in these domestic animals (Acha and Arambulo, 1985; Anderson and 
May, 1979; Kaplan, 1985; Kaplan and Koprowski, 1980). Wildlife species 
of the Canidae family and many species of bats continue to maintain the 
rabies infection cycle in Europe and North America (Acha and Szyfres, 
1980; Acha and Arambulo, 1985; Beran, 1981; Fernandes and Arambulo, 
1985; Kaplan, 1985; Pacer et al., 1985). Domestic animal and human 
infections in developed countries have originated mainly from wildlife 
species; dogs and cats may play a role as transmitting hosts to human 
victims after being attacked by wildlife species (Beran, 1981; Beran 
and Crowley, 1983; Kaplan, 1985). Thus, rabies has been maintained in 
developing countries by the urban cycle in dogs, and in developed 
countries by the sylvatic cycle in wild animals (Acha and Arambulo, 
1985; Beran and Crowley, 1983; Kaplan, 1985; Steele, 1985). 
In both of these two cycles, there are main or principle reservoir 
species of the cycle and other species playing minor or transmitting 
23 
roles. These reservoir species differ in different geographical 
locations (Anderson and May, 1979; Baer, 1985b; Fischman, 1984; Kaplan, 
1985; Carey, 1985; Jackson and Schneider, 1984). 
In the U.S., wildlife species most involved in the rabies cycle 
include striped and spotted skunks (Mephitis mephitis and Spilogal 
putorius), raccoon (Procyon lotor), red and grey foxes (Vulpes fulva 
and Urocyon cineroargenteus) and many species of bats (CDC, 1985b; 
Pacer et al., 1985). In Europe, red and grey foxes (%. fulva and IJ. 
cineroargenteus) are the principal hosts of rabies. In Africa, Asia 
and Latin America, dogs have played a major role as the reservoir of 
rabies which has claimed the lives of tens of thousands of human beings 
each year (Beran and Crowley, 1983; Beran, 1981; Fernandes and 
Arumbulo, 1985; Kaplan, 1985; Kaplan and Koprowski, 1980). Figure 2 
shows the principal animals which maintain the rabies cycle in the 
endemic areas of the world. 
Rabies in the U.S. 
A total of 5,630 cases of rabies were reported by the Centers for 
Disease Control (CDC) in 1984 (CDC, 1985b). Of these, 5,174 (91.95%) 
cases were in wild animals, 453 (8%) cases were in domestic animals and 3 
(0.05%) cases were human (CDC, 1985b). Of the total reported wild 
animal cases, skunks represented 2,082 (40%) cases, raccoons 1,820 
(35%) cases, bats 1,038 (20%) cases and foxes 139 (3%) cases (CDC, 
1985b). These records, except for those of human cases, were based on 
voluntary reports of rabies cases by the states. A passive 
surveillance system such as this undoubtedly underestimates the number 
Fig. 2. Principal animal vectors of rabies are indicated for the major 
regions in which the disease appears. Australia, the British 
Isles and much of Scandinavia are free of rabies (Kaplan and 
Koprowski, 1980, ® 1979 by Scientific American, Inc., All 
rights reserved. Reprinted with permission) 
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of cases (Pacer et al., 1985). It has been estimated that the reported 
number of wildlife cases of rabies may represent 1 to 10% of the actual 
number (Beran, 1981). 
In 1970, the number of reported cases in skunks was 1,235. This 
increased in 1972 to 2,095 cases, declined to 1,226 cases in 1975, 
increased to 4,480 cases in 1981 and declined gradually to the number 
of cases reported for 1984. Reported cases in skunks were mainly from 
midwestem states and extended north to south along the Ohio and 
Mississippi River basins to the southern states and westward to the 
Rocky Mountains with a focus in California (Beran, 1981; CDC, 1985b; 
Pacer et al., 1985). See Figure 3. The reported number of cases in 
raccoons, 181 in 1970 was maintained at approximately that number until 
1976 when 277 cases were reported (CDC, 1983; CDC, 1985a). The number 
of reported rabies cases in raccoons then continued to climb until 1983 
when 1,906 cases were reported. There was a slight decline to 1,820 
cases in 1984 (CDC, 1985b). Reported cases of raccoon rabies have been 
mainly from southeastern and mid Atlantic States. See Figure 4. 
Reported cases of rabies in bats showed a continuous increase from 1970 
(296 reported cases) through 1984 when 1,038 cases of rabies were 
reported (CDC, 1985b). Many species of bats have been found to be 
infected with rabies and their distribution covers most of the 
continental U.S. See Figure 5. Rabies cases in foxes (red and grey 
foxes) were in continuous decline from 771 cases in 1970 to 139 cases 
in 1984. Other than sporadic isolated cases, rabies cases in foxes 
were mainly in the eastern and northeastern. New England states. 
Figure 3. Reported rabies cases In wild and domestic animals In the 
United States, by year, 1953-1984 (CDC, 1985b) 
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Figure 4. Counties reporting cases of skunk rabies in the U.S. in 1984 
(CDC, 1985b) 
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See Figure 6. 
Studies on rabies in the U.S. have demonstrated species-
geographical associations in skunk, raccoon, and fox rabies cases and 
the area of endemnicity (Beran, 1981; Carey, 1985; Hubbard, 1985; 
Sargeant et al., 1982; Storm and Verts, 1966; Verts and Storm, 1966). 
Â recent epidemiological study using MCAbs to differentiate 
nucleocapsid proteins of rabies virus isolates has demonstrated an 
ecotype-species-geographical association (Smith et al., 1984b) and has 
shown that different species of animals including domestic animals in 
the same areas were infected with the same ecotype (Smith et al., 1984b). 
The number of cases of rabies reported in domestic animals in the U.S. 
has generally declined since 1970, with two periods during which 
increases in the number of rabies cases were recorded. These increases 
correlated with the two peaks in skunk rabies cases in the years 1971-
72 and 1980-81. See Table 1 and Figure 2. Dog, cat, and cattle cases 
of rabies were reported mainly from skunk rabies reservoir areas. See 
Figures 7-9. Dogs and farm animals other than cats showed a continuous 
decline in the number of reported cases of rabies since 1970. See 
Table 1. Cats, on the other hand, maintained the same level of 
reported cases of rabies. Although no domestic animals continue to 
serve as reservoir hosts of rabies in the U.S., sporadic outbreaks 
occur mainly in unvaccinated dogs or other farm animals exposed to wild 
animal ecotypes of rabies virus (Baer, 1975a,b; Beran, 1981; Carey, 
1985; Kaplan and Koprowski, 1980; Pacer et al., 1985). 
A total of 29 cases of rabies in human beings were reported in the 
Table 1. Rabies in the United States by type of animals for the years 
1968-1984* (CDC, 1984b) 
Year Dogs Cats 
Farm 
Animals Foxes Skunks 
1968 296 157 457 801 1,400 
1969 256 165 428 888 1,156 
1970 185 135 399 771 1,235 
1971 235 222 484 677 2,018 
1972 232 184 547 645 2,095 
1973 180 139 448 477 1,851 
1974 232 121 303 302 1,421 
1975 129 104 200 276 1,226 
1976 116 106 198 187 1,468 
1977 120 108 217 122 1,631 
1978 119 96 254 148 1,657 
1979 196 156 284 145 3,031 
1980 247 214 499 213 4,096 
1981 216 285 581 196 4,480 
1982 153 209 381 222 3,088 
1983 132 168 . 284 111 2,285 
1984 97 140 216 139 2,082 
I^ncludes Guam, Puerto Rico, and Virgin Islands. 
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Other 
Bats Raccoons Animals Humans Total 
291 153 57 1 3,613 
321 255 52 1 3,522 
296 181 71 3 3,276 
465 190 99 2 4,392 
504 162 56 2 4,427 
432 114 56 1 3,698 
537 176 63 0 3,155 
514 192 31 3 2,675 
737 277 55 2 3,146 
637 281 65 1 3,182 
567 404 49 4 3,298 
756 543 34 5 5,150 
726 394 92 0 6,481 
858 481 111 2 7,210 
975 1,156 94 0 6,278 
910 1,906 82 2 5,880 
1,038 1,820 95 3 5,630 
Figure 6. Counties reporting cases of bat rabies In the U.S. In 1984 
(CDC, 1985b) 
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Figure 8. Counties reporting cases of cat rabies in the U.S. in 1984 
(CDC, 1985b) 
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U.S. from 1970 through 1984; 35% of those cases were the result of 
unknown e^ gosure outside the U.S. and 65% resulted from direct or 
indirect exposure by wild animals in rural areas, laboratory e:q>osure 
and one nosocomial infection through corneal transplant (Anderson et 
al., 1984; Beran, 1981; CDC, 1985b). Approximately 30,000 people 
receive poste3q>osure prophylactic vaccine each year in the U.S. (Beran, 
1981). 
Reservoir hosts and transmission in the U.S. 
The 1984 report of rabies by CDC (CDC, 1985b) indicated that 
skunks (mainly M. mephitis) and raccoons (^ . lotor) constituted 75% of 
the cases in wild animals. Epidemiological and ecological observations 
on these two species follow. 
1. Skunks. Striped skunks (Mephitis mephitis), are by far the 
most common of these mustelid animals, in the U.S. and since 1961 have 
also been the species most commonly reported rabid, followed with less 
frequency by spotted skunks (Spilogale putorius) (Parker, 1975). 
Hooded skunks (Mephitis macroura) and hog-nosed skunks (Conepatus 
leuconotus) are found in limited areas of the U.S., but they are seldom 
reported as rabid (Parker, 1975; Pacer et al., 1985). Skunks generally 
live in relatively close contact with human beings on farm premises in 
such places as post piles, under out-buildings or even under dwellings. 
It was reported (Sargeant et al., 1982) that most striped skunks 
occupied communal dens during winter. Communal denning by adults 
occurred rarely in spring after whelping began, and when it was 
observed, resulted in the intraspecific conflict. Evidence of • 
intraspecific strife when adult males visited rearing dens, and 
interspecific strife between adults were reported to result in kit and 
some adult mortality (Parker, 1975; Sargeant et al., 1982). It was 
reported that adult females remained in the same areas for extended 
periods but that long distance dispersal by adult male was not uncommon 
(Sargeant et al., 1982). Dispersal by juveniles apparently was common, 
but more females than males remained near their places of birth 
(Sargeant et al., 1982; Parker, 1975). 
This intraspecific and interspecific strife as well as dispersal 
conflict may make convenient channels for rabies transmission. Rabies 
infected skunks have been reported to move long distances (Storm and 
Verts, 1966; Sargeant et al., 1982). Dispersal of adult males during 
the spring when incidence of rabies is high (Verts and Storm, 1966; 
Parker, 1975), and the intersexual fighting which may occur at dens, 
have been suggested as possible methods of rabies transmission among 
skunks in widely separated locations (Sargeant et al., 1982; Storm and 
Verts, 1966). Oral transmission of rabies in a skunk population has 
been reported (Parker, 1975). Skunks have been reported to be more 
resistant to rabies than foxes although they show comparable incubation 
periods (Sikes, 1975; Parker, 1975). The incubation period in skunks 
has been reported from 14 days in experimental inoculation, to 88, 105, 
137 or even 177 days in natural infections (Sikes, 1975; Parker, 1975). 
Sables virus has been found in high titers in the submandibular, 
moderate in the parotid and low to moderate in the zygomatic, molar, 
and sublingual salivary glands (Charlton et al., 1984). The nasal 
mucosa (glands and epithelium) has contained virus at low to moderate 
titers, occasionally equal to titers in brain (Charlton et al., 1984). 
It has been reported (Parker, 1975; Sikes, 1975) that skunks are 
capable of excreting virus in their saliva for as long as 9-18 days 
before death and at least 8 days before clinical signs of rabies were 
observed. Rabies virus inhibiting substance (RIS) has been reported 
(Wilsnack and Parker, 1966; Parker, 1975) to be present in skunk 
salivary glands and brain experimentally rendering the virus non—lethal 
for mouse inoculation. 
Thirty-four states reported (2,082 cases) skunk rabies in 1984 
(CDC, 1985b). However, it has been estimated that the actual number of 
cases in skunks may be more than 10 times the reported number (Parker, 
1975; Beran, 1981). Verts and Storm (1966) reported that 9.1% of the 
skunks they trapped (30/329) in Illinois from 1958-1964 were rabid; 
however, only two skunks in that area were reported as rabid through 
normal reporting channels. Parker (1975) found 8% of trapped striped 
skunks and 4% of spotted skunks to be rabid. (See Figure 3 for states 
reporting skunk rabies.) Since 1981, when the total number of reported 
cases of rabies in the skunk population was 4,480 cases, the annual 
number of reported cases has shown a continuous annual decline of 9-30% 
(CDC, 1985b). However, the 1981 peak had been preceded nine years 
earlier, in 1972, by a lower peak of 2,095 cases of skunk rabies (see 
Table 1). This has been described as part of the cyclical waves which 
characterize the disease in the skunk population (Beran, 1981). 
2. Raccoons. The natural habitat of raccoons has been reported 
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to lie between 9' and 50' N latitude, or from southern Canada to 
Panama, including all contiguous areas of the U.S. except the high 
mountains and deserts of the western states (McLean, 1975; Hubbard, 
1985). Raccoons have been described as the most omnivorous of North 
American mammals, highly intelligent and adaptable. They have become 
sufficiently semidomesticated to thrive on human garbage in many 
industrialized areas of the U.S. (McLean, 1975; Kaplan, 1985). 
Environmental and ecological factors such as the amount of rainfall, 
habitat conditions, and human population density have been reported to 
have a direct effect on movement of raccoons from one area to another 
(Hubbard, 1985). Reduction of favorable habitats due to reduced 
rainfall and influx of displaced raccoons into other areas may lead to 
physiological stress in the form of increased intra-specific 
competition, hormonal and neurological changes. These stress factors 
may subsequently result in lower resistance to introduced disease such 
as rabies (Anderson and May, 1974; Hubbard, 1985). Habitat destruction 
has appeared to be related to the rabies epizootic which occurred in 
raccoons in Florida in 1969 (Hubbard, 1985); this has been suggested by 
McLean (1975) to have been a stress-related epizootic. 
Studies have been conducted during different time periods in 7 
states on state-wide bases for the assessment the occurrence of rabies 
in the raccoon population. These studies have been summarized by 
McLean (1975). In four states that reported sporadic cases of raccoon 
rabies, trapped raccoons were found to be infected at rates of 0.0% in 
Kansas, 1.1% in Indiana, 1.3% in California, and 3.6% in Iowa. Two 
states that reported epizootic rabies had rates of 36.6% in Georgia, 
45% in Manatee county Florida and 80% in Island (LBK), Florida. This 
survey was conducted prior to the current extensive outbreak, the 
positive rate in New York was 11.8% In the 1975 report. À recent study 
during an outbreak in Loudoun County, Virginia showed a positive rate 
of 75% (Hubbard, 1985). 
Recently, rabies virus Isolates from different animal species in 
eastern states have been studied (Smith et al., 1984b) with MCAbs to 
the N antigens of rabies virus. All of the Isolates were recognized as 
the raccoon ecotype of rabies virus. 
Since 1970, when 181 cases of raccoon rabies were reported in the 
U.S., the number of cases reported each year has steadily increased and 
reached 1,906 cases in 1983 (Table 1). In 1984, 17 states reported a 
total of 1,820 cases of rabies in raccoons (CDC, 1985b). In Figure 5, 
two foci of infection in the eastern U.S. are shown. 
Control Measures 
Babies has been maintained throughout the endemic areas of the 
world due to the presence of reservoir animals (Beran and Crowley, 
1983; Kaplan and Koprowski, 1980; Bogel et al., 1982). These animals 
have maintained survival and propagation of the rabies virus and have 
spread the disease to other reservoir animals and susceptible hosts 
(Schwabe, 1984; Sedmak and Martin, 1984; Kaplan, 1985). These 
reservoir animals are dogs in developing countries and wild animals in 
developed countries (Beran and Crowley, 1983; Bogel et al., 1982; Âcha 
and Àrambul'o, 1985; Fernandes and Arambulo, 1985). Dog rabies is the 
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major threat to public health even in areas where the disease is also 
established in wildlife (Kaplan and Koprowski, 1980; Bogel et al., 
1982; Beran and Crowley, 1983). Rabies virus has been isolated for an 
extended period of time (up to 10 months) from the saliva of dogs 
experimentally infected with strains of rabies virus from Ethiopia 
which had recovered from symptomatic rabies (Fekadu et al., 1983; 
Fekadu et al., 1982; Fedaku et al., 1981; Fekadu and Baer, 1980). The 
significance of these findings for wider geographical areas is 
uncertain. Latent infections of rabies in raccoons has been suggested 
(McLean, 1975) with virus transmission occurring under stressful 
conditions. Also, the virus has been isolated from raccoon saliva 
(Hubbard, 1985; Winkler et al., 1985; McLean, 1975) and bites by such 
animals may help to maintain the transmission cycle of the disease. 
An effective control measure involves breaking the cycle of 
transmission in dogs and wild animals. The rabies transmission cycles 
are dependent on the density of the susceptible hosts (Beran and 
Crowley, 1983; Beran, 1981; Anderson and May, 1974). 
Rabies status and control measures 
Countries around the world may be classified in one of three 
categories depending on the ecological factors, on the control measures 
they employed for the control of rabies, and their rabies status. 
These categories are (a) dog-rabies dominant; (b) wild animals-rabies 
dominant, and (c) rabies-free countries (Fernandes and Arambulo, 1985; 
Beran and Crowley, 1983; Acha and Hubbard, 1975). 
In countries where the urban cycle is responsible for maintaining 
rabies, e.g., in developing countries, the dog population plays the 
major role as reservoir of the disease and maintains the transmission 
cycle to human beings and other domestic animals (Acha and Arumbulo, 
1985; Beran, 1985; Beran and Crowley, 1983; Kaplan and Koprowskl, 
1980). Tens of thousands of human cases of rabies are reported 
annually and there may be billions of dollars in economic losses due to 
the disease in livestock and postexposure prophylactic treatments for 
human beings in these countries (Acha and Arumbulo, 1985; Fernandes and 
Arambulo, 1985; Kaplan, 1985; Nawathe and Lamorde, 1982; Wiktor and 
Koprowskl, 1982). The presence of susceptible dogs, in the form of 
owned dogs, community dogs, and stray dogs has maintained the disease 
in most tropical and subtropical areas of the endemic countries (Beran 
and Crowley, 1983; Bogel et al., 1982). 
In developed nations such as Canada, the U.S. and many European 
countries, terrestrial wild animals have maintained the rabies cycle 
with a continuous threat to human beings and domestic animals (Acha and 
Arambulo, 1985; Fernandes and Arambulo, 1985; Kaplan, 1985; Beran, 
1981). The major reservoir species of wild animals for rabies are in 
the U.S.: skunks, raccoons, foxes, and bats; in Canada: skunks and 
foxes; and in Europe: red and grey foxes (Kaplan, 1985; Beran, 1981). 
Dogs and other domestic animal species usually become infected with 
rabies after being exposed to wild animals (Fernandes and Arambulo, 
1985; Kaplan, 1985; Kaplan and Koprowskl, 1980). 
In rabies-free countries, such as Australia, the British Isles, 
Spain, Portugal, and the Scandinavian countries, they are either 
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historically free or they eliminated rabies from their territories and 
became free (Femandes and Axambtilo, 1985; Kaplan, 1985; Beran, 1981). 
This free state has been maintained by strict quarantine measures on 
all imported animals, especially those suspected of being reservoir 
hosts of rabies virus, for up to 6 months (Kaplan, 1985; Beran, 1981; 
Kaplan and Koprowski, 1980). In spite of such procedures, two dogs 
were reported to have developed clinical rabies; one showing clinical 
signs 10 days and the other 3 months after the six month quarantine 
periods (Schwabe, 1984; Beran, 1981). Some of these countries have 
natural barriers that have helped in controlling the entrance of 
rabies; animals being able to enter the country only through seaports 
or airports (Schwabe, 1984; Beran, 1981; Kaplan and Koprowski, 1980; 
Acha and Hubbard, 1975). 
Control of canine rabies 
1. Applied ecology and sociology. An understanding of the 
ecology of the reservoir am'mal population is basic to the development 
of a rabies control program (Beran, 1985a; Narayan, 1985; Schwabe, 
1984; Beran and Crowley, 1983). Any control program to be initiated 
should start by obtaining complete data on patterns of dog ownership, 
relationship of animals to human society, population density, age 
structure and turnover, habitat, and relationship of dogs to other 
reservoir species (Schwabe, 1984; WHO, 1984b; Beran and Crowley, 1983). 
Dog populations in developing countries may be classified into three 
broad categories as (a) owned dogs; (b) community dogs; and (c) stray 
dogs (Beran, 1985a; Beran and Crowley, 1983). Collecting data on the 
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dog population size and distribution and on accessibility of dogs to 
other animals is essential in planning a program for rabies control in 
dogs (Schwabe, 1984; WHO, 19%b). 
2. Epidemiological investigation. Surveillance must be an 
essential component of any program for rabies control (Schwabe, 1984). 
An intensive follow-up of animal bites and the collection, collation, 
evaluation, and rapid dissemination of diagnostic data are needed not 
only for treatment of people exposed to rabies but also are basic for 
planning, organizing, and implementing rabies control programs (WHO, 
1984b; Femandes et al., 1983; Bogel et al., 1982). Surveillance 
information is needed in the analysis of the disease situation and in 
the planning of appropriate control procedures (WHO, 1984b; Beran and 
Crowley, 1983; Femandes et al., 1983). Appropriate information may 
also be passed Co authorities in other countries (WHO, 1984b). 
International collaboration in surveillance is particularly important, 
especially for the investigation of rabies episodes on regional bases 
and in view of increased travel and international transfer of animals 
(WHO, 1984b; Griffiths, 1983). 
3. Community education and participation. Realization and 
recognition of the importance of disease control by the community is 
vital for any disease control program including rabies control to be 
successfully achieved (Beran and Crowley, 1983). Sociologically 
acceptable methods of control encourage the participation of the 
community residents in the implementation of rabies control methods 
(WHO, 1984b). Mobilization of local societies for animal protection. 
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civic, educational, cultural and/or religious organizations is an 
important step in disease control (Beran, 1985a; WHO, 1984b; Femandes 
et al., 1983). 
4. Dog registration and control. Dog ownership identification in 
the community may be considered a basis for dog population control as 
well as for mass immunization (WHO, 1984b,c). Dog control measures serve 
to reduce contacts among dogs and to enforce compliance with 
vaccination requirements. Quarantine, movement restriction, habitat 
reduction, and reproduction control are the methods reported (WHO, 
1984b; Beran and Crowley, 1983)/ 
5. Mass immunization. Resistant hosts are capable of breaking 
the disease transmission cycles and the goal of mass immunization is to 
break rabies transmission cycles by immunizing at least 80% of the dogs 
in each cpnmunity (Schwabe, 1984; WHO, 1984b; Beran and Crowley, 1983). 
Vaccination at veterinary clinics, through local campaign centers or 
frequently most effectively in developing countries, through house-to-
house visits have been used by communities (Beran, 1985a; WHO, 1984b; 
Beran and Crowley, 1983). Vaccination of all dogs 3 months of age and 
older with a booster dose one year later is recommended by a WHO 
Committee (WHO, 1984b). The use of colored tags or colored plastic 
collars has proven very useful in identifying vaccinated dogs and has 
contributed considerably to the success of vaccination campaigns (WHO, 
1984b; Beran and Crowley, 1983; Fernandes et al., 1983). 
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Control of wildlife rabies 
Many wild animal species have continued to maintain rabies 
in a sylvatlc cycle in developed countries after the elimination of dog 
rabies (Acha and Arambulo, 1985; Femandes and Arambulo, 1985; Kaplan, 
1985). The majority of rabies cases in domestic animals in developed 
countries now result from e^ osure to rabid wild animals. Both the 
risk of exposure and the number of tables cases in the domestic animal 
population increase with the increasing incidence in wild animals 
species (Kaplan, 1985; Schwabe, 1984; Umoh and Blenden, 1981; Kaplan 
and Koprowskl, 1980). Different techniques have been employed to 
decrease the animal population density below a certain threshold in 
order to decrease the opportunity for infected and susceptible animals 
to interact (Baer, 1985b; Schwabe, 1984; Sedmak and Martin, 1984; WHO, 
1984b). Trapping, hunting with or without bounties, poison baits, and 
den gassing have been reported (Schwabe, 1984; WHO, 1984b), but these 
techniques have yielded limited success (Jackson and Schneider, 1984; 
WHO, 1984c). A successful rabies control program in wild animals may 
be dependent on: 
1. Epidemiology and ecology of wildlife rabies. Within a given 
ecosystem there are apparently only one or two species responsible for 
the perpetuation of rabies endemnlcity or a rabies epidemic, e.g., 
foxes (2« fulvu and U^ . clneroargenteus) in Europe, raccoons (2» lotor) 
' in eastern U.S. and skunks (11. mephitis mostly) in mid-western states 
(Kaplan, 1985; Schwabe, 1984; Beran, 1981). Understanding population 
density, age structure and turnover, habitat, movements and the effects 
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of different environmental conditions on the population are important 
elements in the control program in wild animals as in the dog 
population (Jackson and Schneider, 1984; Schwabe, 1984; WHO, 1984b). 
The epidemiology of the disease in wild animals including 
susceptibility, incubation period, movement of infected animals, latent 
infection and the effects of stress factors are also important elements 
in disease control program (Beran, 1985a; Jackson and Schneider, 1984; 
WHO, 1984b). 
2. Mass immunization. Experiments on the oral vaccination of the 
fox population using baited chicken heads have proven to be successful 
in halting rabies in this species (Crick et al., 1985; Jackson and 
Schneider, 1984; WHO, 1984a,c). Vaccines reconmended for wildlife 
immunization have to be highly immunogenic, completely safe, easily 
identifiable, and distinguishable from field virus, by characterization 
with monoclonal antibodies or other suitable techniques (Crick et al., 
1985; WHO, 1984b,c). 
Vaccination 
Rabies vaccine was developed by Pasteur in 1885, was improved by 
Fermi in 1911, and later by Semple's procedure which was based on 
partial and complete inactivation with phenol (Wiktor, 1985; Steele, 
1975). Many types of vaccines have been produced since that time from 
nerve tissues of adult or neonatal animal origin; due to the combined 
side effects of these vaccines, all except suckling mouse brain origin 
vaccines were used mostly in postexposure prophylaxia -(Wiktor, 1985; 
Steele, 1975). For a quarter of a century beginning in the 1950s, 
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vaccines of avian embryo origin were very Important (Roprowski and 
Black, 1952; Peck et al., 1955). Vaccinés of cell culture origin 
developed In the last two decades for human and animal immunization are 
very safe, pure, and potent (Wiktor, 1985; WHO, 1984c). Vaccine 
potency may be ascertained by several laboratory procedures including 
the Habel and the guinea pig potency test. Recently a single radial 
diffusion (SRD) technique has been recommended (WHO, 1984a). 
1. Vaccines for human immunization. The types of vaccines 
recommended by WHO Expert Committee on rabies (WHO, 1984b) for human 
immunization include: 
a. Vaccines derived from nerve tissues of adult animals (e.g., 
sheep, goats, and rabbits) or newborn animals (rabbits, rats, and 
mice). Vaccines derivied from adult brain tissues may cause a 
demyelinating disease or other neuroparalytic injury (Wiktor, 1985; 
WHO, 1984b; Steele, 1975). The use of this type of vaccine in people 
has been suspended in developed countries. It is still used, however, 
for people exposed to rabies in many developing countries where 
suckling mouse or cell culture technologies for rabies vaccine 
production have not been introduced (WHO, 1985b; WHO, 1984b). 
b. Cell culture vaccines. Many types of cell culture vaccines 
have been produced in different countries. The Pasteur strain of 
rabies virus has been grown in a human diploid cell (HDC) strain and 
inactivated with B-propiolactone ; it has been produced in France and 
Germany (WHO, 1984b). In the U.S. the same vaccine which has been 
disrupted with trl-n-butyl phosphate and inactivated with B-
proplolactone has been used (WHO, 1984b). Another vaccine involving 
fetal bovine kidney cells and the Pasteur strain of rabies virus has 
been developed in France (Earth et al., 1985). In Japan, an HEP-Flury 
strain grown in chick-embryo cell culture has been used in an 
inactivated vaccine (WHO, 1984a,b). Cell culture vaccines have appeared 
to combine safety with high antigenic content (Wiktor, 1985; WHO, 
1984b). Many studies on the tolerance, serological effectiveness and 
safety of human diploid cell (HDC) vaccine have proven its safety and 
high antigenicity with no serious side effects in children or in 
pregnant women for either pre and postexposure applications (Aijan et 
al., 1985; Burridge et al., 1984; WHO, 1984b; Vamer et al., 1982; 
Bahmanyar et al., 1976). However, symptoms of immune complex-like 
diseases such as urticaria, macular rash, angio-oedema and arthralgia 
with an onset from 3-13 days postvaccination and lasting from 1-5 days 
have been reported (Dreesen et al., 1986). One case of neuroparalytic 
illness in an 11-year old boy after completing his post-exposure 
prophylactic treatment with HDC vaccine has been reported (Bernard et 
al., 1982). Human diploid cell vaccine is now approved for both pre­
exposure prevention and post-exposure prophylactic treatment (WHO, 
1984b). An effective economical intradermal regimen of HDC vaccine for 
postexposure prophylaxis using 4 to 5 intradermal injections of 0.1 ml 
on days 0, followed by 3 injections on day 3, 2 on day 7 and one on 
each of days 28, and 91, was reported as very effective if administered 
with rabies Immune globulin (RIG) (Warrell et al., 1985; Ubol and 
Phanuphak, 1986). One case involving fatal encephalitis in a woman who 
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had received HDC vaccine but not human rabies immune globulin (URIG) 
has been reported (Devriendt et al., 1982). HRIG has been reported to 
be safe, potent, and to cause minimal interference with vaccine-induced 
antibody production when used at 20 I.U. Kg ^  body weight (BW)(Helmlck 
et al., 1982). Â WHO Expert Conmittee recommended 20 I.U. Kg ^  BW of 
HRIG or 40 I.U. Kg BW of heterologous species antlsera (WHO, 1984b). 
Primary hamster kidney cell culture has been used to produce a vaccine 
reported to be as effective as HDCV and less expensive (Fangtao et al., 
1983). A new vaccine produced in a rhesus diploid cell culture strain 
has been reported (Burgoyne et al., 1985) to be similar to HDCV in 
potency and to produce fewer side effects. Neither is as yet licensed. 
As advancements in molecular biology and molecular genetics have 
contributed to the production of safer and more potent vaccines they 
have also improved understanding of the events in rabies pathogenesis 
(Eisenstein and Engleberg, 1986; Fields and Greene, 1982). 
Experimental development is in progress for production of vaccines by 
isolation of the glycoprotein (G) gene of rabies virus (Wunner et al., 
1983), construction of a plasmid that carries the G gene, and 
production of the glycoprotein by coll (Yelverton et al., 1983); by 
the use of a vaccinia virus recombinant containing rabies G gene 
(Wiktor et al., 1984); and by the production of synthetic vaccines 
(Lemer, 1985) which depend on short chains of amino acids assembled in 
the laboratory to mimic sites on the surface of viral proteins. Of 
these procedures only the vaccinia virus recombinant has shown 
promising immunological effectivity so far (WHO, 1984b). 
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Technical advancement in vaccine production as well as in 
laboratory techniques for diagnosis and surveillance studies are being 
developed in laboratories in several countries. Very important are 
international cooperation and the assessment of techniques for control 
of other infectious diseases to rabies control (Beran, 1985b; Bôgel and 
Kuwert, 1985; Griffiths, 1983; WHO, 1985b; Acha and Hubbard, 1975). A 
recent guide for rabies postexposure treatment for human beings 
recommended by the WHO Expert Committee on rabies is provided in the 
Committee's Seventh Report (WHO, 1984b) and is enclosed as Appendix 1. 
2. Vaccines for animal immunization. Rabies occurrences in animals 
has historically been reduced significantly in many countries by the 
use of inactivated nerve-tissue vaccines prepared from fixed viruses in 
the brains of adult sheep and goats (WHO, 1984b). Modified live-virus 
(MLV) vaccines prepared from low egg passage (LEP), high egg passage 
(HEP), Street-Alabama-Dufferin (SAD), Challenge Virus Standard (CVS), 
Gaynor-Rokitniki-Abelseth (ERA) and other strains of rabies virus 
adapted to grow in cell cultures or propagated in the brains of 
neonatal animals have achieved widespread acceptance. These vaccines 
have had reduced side effects as compared to adult brain tissue 
vaccines (Baer, 1985a; Prosperi et al., 1984; Schwabe, 1984; Beran, 
1981). Inactivated vaccines are generally preferred in areas where the 
disease is under control for immunizing dogs and other domestic animals 
(Baer, 1985a; WHO, 1984b). Potency, purity, and safety are recommended 
criteria for vaccines to elicit long duration immunity (Baer, 1985a; 
Derbyshire and Mathews, 1984; WHO, 1984b; Beran, 1981; Umoh and 
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Blenden, 1981). The Compendium of Animal Rabies Vaccines licensed for 
use in the U.S. prepared by the National Association of State Public 
Health Veterinarian, Inc., 1986 is enclosed as Appendix 2. 
Antiviral Drugs 
History 
The search for antiviral drugs began at the time when 
antimicrobial substances were first being shown to be effective as 
prophylactic and therapeutic agents in bacterial diseases (Bauer, 1985; 
Gifford, 1982). Several effective antibacterial drugs were known as 
early as the late 1930s, but the discovery of antiviral compounds did 
not come until the 1950s and it was not until 1960 that two compounds 
came into clinical use, namely, idoxuridine for the treatment of 
herepetic keratitis and methisazone for prophylaxis of small pox in 
contact persons and the treatment of infectious complications of small 
pox vaccination (Bauer, 1985). In 1963, amantadine hydrochloride (1-
adamantanamine hydrochloride, aminoadamantane hydrochloride) was shown 
to influence the course of influenza A2 infections in human patients 
(Gifford, 1982). In 1964, amantadine hydrochloride was reported to 
inhibit the multiplication of rubella virus and to be effective 
experimentally in inhibiting infections with influenza A, Al, and A2 in 
cell cultures, and in mice (Bauer, 1985; Gifford, 1982). In 1966, the 
U.S. Food and Drug Administration (FDA) licensed the use of amantadine 
hydrochloride in the prevention of respiratory illness due to influenza 
A (Gifford, 1982). Amantadine hydrochloride was reported (WHO, 1983) 
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to be particularly effective in the prevention of influenza and had 
therapeutic use in shortening the duration of influenza A-induced 
fever, malaise, and virus shedding (Bauer, 1985; WHO, 1985a). Other 
antiviral agents including cytarabine, trifluorothymidine, vidarabine, 
and acyclovir have been studied in the search for therapeutic drugs 
against herpesviruses (Bauer, 1985). Ribavirin activity against a 
number of DNÂ and BNA viruses in vitro was reported recently (WHO, 
1983; Allen, 1980; Sidwell, 1980). In 1974, rifamycin was reported to 
inhibit the reverse transcriptase of RNA tumor viruses (Smith and 
Gallo, 1974). However, Antosz reported (Antosz, 1982) that the 
antiviral activity of ansama crolides (rifamycin group) was actually due 
to inhibition of the assembly of virus particles. 
Areas of application 
Antiviral chemotherapy has been reported (Oxford, 1985; Webster et 
al., 1985a; WHO, 1985a; Douglas Jr., 1984; Flynn and Hoeprich, 1983; 
Gifford, 1982) to be medically useful in the following instances: 
1. Control of diseases caused by viruses which show antigenic 
changes (antigenic shift and antigenic drift) like influenza 
viruses. 
2. Control of diseases caused by viruses which are antigenically 
stable but with more than one hundred different antigenic 
types as the rhinoviruses. 
3. Control of viral diseases which occur even in the presence of 
circulating antibodies such as Herpes simplex virus infections. 
Vaccines which stimulate humoral immunity may not be 
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effective unless cell-mediated immunity is also stimulated. 
4. Control of viral diseases in individuals with 
immunodeficiency disorders, such as hypogamma-globullnemla 
and Wlskott-Aldroch Syndrome, and in those Individuals who 
are immunologically compromised by immunosuppressants 
following organ transplantations. 
Chemotherapy also has the advantage of immediate action against 
infectious agents while vaccines take days or weeks to induce immunity. 
The inmediate employment of chemotherapeutlcs as population protection 
measures could halt epidemics when vaccines are not available (Oxford, 
1985; Webster et al., 1985a; Flynn and Hoeprich, 1983). 
Chemotherapeutlc Agents 
Three chemotherapeutlc drugs were chosen to evaluate their 
activity against rabies virus. These were amantadine hydrochloride, 
ribavirin and rifamycin. See Figure 11. 
Amantadine hydro^^hi orlde 
1-adamantanamlne hydrochloride, aminoadamantane hydrochloride, 
Symmetrel® (DuPont Pharmaceuticals, E.I. duFont de Nemours & Company, 
Inc., Wilmington, Delaware 19898) is a synthetic antiviral agent, 
Cj^ O^ lT^ 'HCl. It is a stable, crystalline, water-soluble, tricyclic 
amine, of unusual structure unrelated to any of the other antimicrobial 
agents (Hayden et al., 1986; WHO, 1985a; Hayden and Douglas Jr., 1983). 
See Figure 11a. Amantadine hydrochloride is completely absorbed from 
the gastrointestinal tract, 90% of which wil be excreted in the urine 
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(50% within 20 hours) in unchanged form; the drug is not metabolized in 
the body (Hayden et al., 1986; WHO, 1985a; Gifford, 1982) 
1. Mechanism of action. The mechanism of action of amantadine has 
not been exactly defined, but it appears to inhibit an early stage in 
viral replication, possibly the uncoating of the viral genome. It has 
been found that viral attachment and penetration were normal in the 
presence of amantadine hydrochloride (Hayden et al., 1986; WHO, 1985a) 
and no direct effect on virus-associated RNÀ dependent SNA polymerase 
activity was found (Braude, 1986; Hayden et al., 1986; Gifford, 1982). 
2. In vitro antiviral activity. Amantadine hydrochloride in a 
subtoxic concentration has inhibited (2 99% of the replication of all 
influenza A subtype viruses tested in cell cultures (H^ N^ , H^ N^ , and 
HgNg) (Chou and Merigan, 1985; WHO, 1985a; Gifford, 1982). Amantadine 
hydrochloride was also reported (Chou and Merigan, 1985; Dulbecco, 
1980b) to have in vitro activity against influenza C, Sendal, 
pseudorabies, fowl plague, dengue, and rubella viruses. Influenza B, 
parinfluenza types 1-3 and respiratory syncytial viruses were reported 
to be resistant to its action (Bauer, 1985; Chou and Merigan, 1985; 
WHO, 1985a; Scholtissek and Faulkner, 1979; Skehel et al., 1977). 
3. In vivo antiviral activity. Amantadine hydrochloride markedly 
reduced infection rates, pneumonia and mortality in mice given the drug 
and then challenged with influenza A virus (Chou and Merigan, 1985). 
Amantadine hydrochloride has, in addition to Its protective effect 
against influenza A infections in human beings, also has shown an 
antiviral effect against equine influenza virus in horses and against 
Figure 11. Chemical structure of (A) Amantadine, (B) Ribavirin, and 
(C) Rtfamycln 
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avian influenza A strain in quails and turkeys (Douglas Jr., 1986; 
Galbraith, 1985; Webster et al., 1985a; Douglas Jr., 1984; Gifford, 
1982; Dulbecco, 1980b). 
4. Clinical applications. Several natural and experimental double-
blind placebo-controlled challenge studies with influenza A 
and viruses, have demonstrated the prophylactic efficacy of 
amantadine hydrochloride in reducing infection rates in human beings by 
about 50% as measured by seroconversions or symptoms (Chou and Merigan, 
1985; Galbraith, 1985; Douglas Jr., 1984; Hayden and Douglas Jr., 1983). 
The protective efficacy demonstrated in clinical trials has ranged from 
70-90% (Douglas Jr., 1986; Grande, 1986; WHO, 1985a). 
5. Dosage. Amantadine hydrochloride in recommended daily human 
dosages of 200 mg (2.5 mg/Kg), given In two equal parts, will give a 
blood concentration peak of 0.6-0.8 ug/ml, and 300 mg/day will give a 
peak of 1.0 yg/ml, but with slightly increased side effects (Galbraith, 
1985; WHO, 19b5a; Dolin, 1984; Douglas, Jr., 1983). 
6. Toxicity and side-effects.. Orally administered amantadine 
hydrochloride is generally well-tolerated and no serious renal, 
hepatic, or hematopoetic toxicities have been documented (Hayden and 
Douglas Jr., 1983). Mild dose-related side-effects involving the 
central nervous system have occurred in a small proportion of subjects 
(WHO, 1985a; Hayden and Douglas Jr., 1983; Gifford, 1982), the most 
frequently observed being nervousness, light-headedness, difficulty in 
concentrating, insomnia, depression, confusion, hallucination, 
drowsiness, and fatigue (WHO, 1985a; Gifford, 1982). However, other 
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criais have failed Co show imporcanc side-effects involving the nervous 
system, and up to four years of administration to patients with 
Parkinson's disease has failed to produce serious effects attributable 
to the drug (WHO, 1985a). 
Ribavirin 
Ribavirin (1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide, 
Virazole® (ICN Pharmaceuticals, Inc., 3300 Hyland Avenue, Costa Mesa, 
California 92626) is a guanosine analogue in which the purine ring is 
open. See Figure lib. It is a colorless crystalline compound that is 
readily soluble in water and has a molecular weight of 244.21 Da (Chou 
and Merigan, 1985; Hayden and Douglas Jr., 1983). The ribavirin 
triazole-carboximide moiety and the D-ribose sugar are necessary for 
its wide spectrum antiviral action against both RNA- and DNA-containing 
viruses (Chou and Merigan, 1985; Galbraith, 1985; Hayden and Douglas 
Jr., 1983; Sidwell, 1980). 
1. Mechanism of action. Ribavirin is phosphorylated in the host 
cells to mono-, di- and triphosphate derivatives (Hayden and Douglas 
Jr., 1983) and may exert antiviral action the following mechanisms. 
a. Ribavirin monophosphate has been shown to competitively 
inhibit inosine-5'-phosphate dehydrogenase and interferes 
with the synthesis of guanosine nucleotides thus inhibiting 
nucleic acid synthesis (Galbraith, 1985; Dawson and Lozaya-
Saldana, 1984; Hayden and Douglas Jr., 1983; Smith, 1980). 
b. Ribavirin triphosphate has been shown to inhibit messenger 
RNÀ (mRNA) guanyltransferases and so to prevent the initial 
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step in the capping of the 5' end of n&NA (Dawson and Lozoya-
Saldana, 1984; Hayden and Douglas Jr., 1983) and to 
specifically inhibit the virion SNA polymerase of influenza 
A viruses (Galbraith, 1985; Becker and Uadar, 1980). 
c. Ribavirin at concentrations of 5-10 g/ml has also been 
reported (Douglas Jr., 1986; Galbraith, 1985; Douglas Jr., 
1984; Hayden and Douglas, 1983) to reduce significantly the 
production of hemagglutinin and neuraminidase of influenza A 
viruses. 
Ribavirin does not induce interferon and it is not virucidal 
(Smith, 1980). 
2. In vitro antiviral activity. Ribavirin is inhibitory in cell 
culture systems to a variety of different RNA and DNA viruses, 
including myxo-, paramyxo-, arena-, bunya-, RNA-tumor, herpes-, adeno-, 
and pox viruses, but not to single stranded RNA genomes that act 
directly as mRNA such as in entero- and rhinoviruses (Chou and Merigan, 
1985; Galbraith, 1985; Hayden and Douglas Jr., 1983; Gifford, 1982; 
Dulbecco, 1980b; Sidwell, 1980). 
3. In vivo antiviral activity. Ribavirin has shown an antiviral 
action against several different RNA and DNA viruses including herpes-, 
myxo-, paramyxo-, adeno-, arena-, bunya-, RNA tumor, rhabdo-, and pox 
viruses (Douglas Jr., 1986; Huggins et al., 1986; Galbraith, 1985; 
Johnson, 1985; Hall, 1984; Hayden and Douglas Jr., 1983; Allen, 1980; 
Becker and Hadar, 1980). Species difference between animal models were 
reported (Allen, 1980). 
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4. Clinical applications. Ribavirin aerosols were found to be 
effective against respiratory syncytial virus (RSV) infectious in human 
patients in a placebo-controlled, double blind study in which it 
reduced fever and systemic symptoms (Hayden and Douglas Jr., 1983). In 
a study among college students during an outbreak of Influenza A 
(H^ N^ ), ribavirin administered by aerosol to patients suffering from 
the infection produced a highly significant reduction in height and 
duration of fever, a reduction in systemic illness and more rapid 
disappearance of influenza virus from respiratory secretions (Douglas 
Jr., 1986; Chou and Merigan, 1985; Galbraith, 1985; Knight, 1984). 
5. Dose. Ribavirin is well-tolerated and may be given to adults 
at 600-1000 mg/day orally (Hayden and Douglas Jr., 1983). Ribavirin 
adfflinstered orally at 3 mg/Kg was excreted in urine at a rate of 33% in 
24 hours and 52% in 72 hours, with peak plasma levels of 1-2 p.g/ml 
occurring at 1-1.5 hour. The drug decayed in a complex manner (Douglas 
Jr., 1986; Hayden and Douglas Jr., 1983). 
6. Toxicity and side-effects. Ribavirin at 15 mg/Kg decreased the 
half life of erythrocytes without affecting their osmotic fragility or 
deformability (Canonico et al., 1984b). At a higher dosage of 60 
mg/Kg, ribavirin inhibited the release of erythrocytes from the bone 
marrow, but termination of treatment was quickly followed by their 
release (Canonico et al., 1984b). Rhesus monkeys given intramuscular 
injections of ribavarin for 10 days in doses of either 30 or 100 
mg/Kg/day developed normochromic, normocytic anemia that was mild in 
the low drug dose group and severe in the higher drug dose group 
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(Canonlco et al., 1984a). Â transient elevation of serum bilirubin was 
reported (Hayden and Douglas Jr., 1983). 
Rlfagycln 
Rlfamycln is an antibiotic from the family ansamacrolides that are 
characterized by an aliphatic ansa bridge that connects two nonadjacent 
positions of an aromatic nucleus (Antosz, 1982). Five rlfamycins, À-E 
are recognized. They have been Isolated from fermentation broth of 
Nocardia mediterranei (Antosz, 1982). The rlfamycins are biologically 
active against gram-positive microorganisms and nycobacteria, 
particularly M. tuberculosis. and also show antiviral activity in 
inhibiting reverse transcriptase (Farr and Mandell, 1983; Antosz, 1982; 
Smith and Gallo, 1974). The most therapeutically useful derivative is 
the N-amino-N'-methyIpiperazine hydrazone of rifaldehyde known as 
Rifampin® in the U.S. and Rifamplcln® elsewhere. Rifampin has a 
chemical composition of 4^3^ 53^ 4^ 12* an orange-yellow 
crystalline solid with melting point at 183-188° C (Antosz, 1982; Smith 
and Gallo, 1974). For the chemical structure see Figure 11c. 
1. Mechanism of action. Rifampin has been shown to inhibit bacterial 
growth by interfering in RNA synthesis (Farr and Mandell, 1983; Follett 
and Pennington, 1973). This is accomplished by forming a tight complex 
with the B-unit of DNA-dependent RNA polymerase, thus inhibiting the 
initiation step of RNA synthesis (Farr and Mondell, 1983; Antosz, 1982; 
Smith and Gallo, 1974). This complex does not prevent the formation of 
the first phosphodiester bond but inhibits formation of the second 
phosphodiester bond (Antosz, 1982; Smith and Galo, 1974). The 
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antiviral activity of rifampin has been reported (Farr and Mandell, 
1983; Antosz, 1982) as not due to inhibition of BNÀ polymerase but due 
to the inhibition of the assembly of virus particles. 
2. Antiviral activity* Rifamycin derivatives have been reported 
(Hayden and Douglas Jr., 1985; Farr and Mandell, 1983) to be effective 
inhibitors of viral reverse transcriptase of murine leukemia virus and 
to inhibit replication of this virus in mouse embryo cells in culture. 
Inhibition of replication of several pox viruses and of vaccinia virus 
in mammalian cell culture systems has been reported also (Hayden and 
Douglas Jr., 1983; Antosz, 1982). 
3. Clinical application. Rifamycin derivatives are mainly 
antimicrobial agents utilized against gram-positives bacteria and >i. 
tuberculosis (Carruthers, 1986; Farr and Mandell, 1983; Smith and 
Gallo, 1974). 
4. Toxicity and side-effects. Ko toxicity has been reported, 
however, side effects such as gastrointestinal complaints, asymptomatic 
elevation of serum enzymes, eoslnophllla. Interstitial nephritis, 
thrombocytopenia, hemolytic anemia and possible immunosuppression have 
been reported (Carruthers, 1986; Farr and Mandell, 1983). 
Papers Presented in this Dissertation 
The experimental research work presented in the following four 
papers deals mainly with two topics. The epidemiology of rabies in 
Iowa is investigated in the first three sections, with a retrospective 
epidemiological study followed by epidemiological investigation of the 
disease in wild animals. In these sections, an attempt was made to 
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elucidate the mechanisms of transmission of rabies in Iowa. In the 
fourth paper, an evaluation of the activity of three chemotherapeutics 
against rabies is presented. 
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SECTION 1. RABIES IN IOWA: 1. A RETROSPECTIVE EPIDEMIOLOGICAL STUDY 
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Summary 
A retrospective epidemiological investigation of the data on 
reported cases of rabies in domestic and wild animals in Iowa has shown 
that skunks (mainly Mephitis mephitis) are the principal reservoir 
hosts of rabies and the source of exposure to domestic and wild animals 
in the state. In skunks, the number of rabies cases was found to 
increase during each spring and summer. The increase was considered to 
be related to transmission which occurred during winter communal 
denning and during the breeding season in early spring. 
Introduction 
Rabies in Iowa has been maintained by its sylvatic cycle of 
transmission with wild animals serving as the reservoir hosts for the 
virus (Pacer et al., 1985; Beran, 1981). People and their domestic 
animals can develop clinical rabies after being attacked and bitten by 
a rabid wild animal (Beran, 1981). Many species of wild animals are 
incriminated in the cycles of sylvatic rabies in the U.S., including 
skunks (M. mephitis and to a a lesser extent Spilogale putorius), 
raccoons (Procyon lotor), red and grey foxes (Vulpes fulva and Urocyon 
cineroargenteus). and many species of bats (CDC, 1985a,b; Pacer et al., 
1985; Smith et al., 1984; Beran, 1981). In Iowa, rabies is diagnosed 
in many species of wild animals each year (CDC, 1985b); skunks, 
however, dominate the number of reported cases and have represented 
more than 95% of the total confirmed cases in wild animals in the last 
few years (CDC, 1985a,b). Other wild species have included bats. 
foxes, and raccoons (CDC, 1983). The date rabies was first recognized 
in skunks in Iowa is not exactly known. Sporadic cases of rabies in 
skunk were reported in the central U.S. in the 1930s and early 1940s 
(Parker, 1975). The present epizootic seems to have began in the late 
1940s (Parker, 1975). There were 200 and 179 cases, respectively, of 
rabies in skunks reported in 1961 and 1962 (CDC, 1961; 1962). During 
four winter trapping seasons, in the central U.S. between 1964 and 
1968, 8% of striped skunks (M. mephitis) and 4% of spotted skunks (S^ . 
putorius) were detected as seropositive (Parker, 1975). The first 
reported cases of rabies in raccoons in Iowa were in 1948 (McLean, 
1975). From 1958 through 1965, 913 raccoons were laboratory examined 
in Iowa. The positive rate was found to be 3.6% (McLean, 1975). There 
were no recorded cases of rabies in raccoons in Iowa in 1961, and only 
2 cases in 1962 (CDC, 1962; 1961). Bats with rabies were reported for 
the first time in the U. S. in the early 1950s (Beran, 1981). 
Since the early 1960s, Iowa has been among the highest 10 states 
in the continental U.S. in the number of reported cases of rabies (CDC, 
1985b; 1983; 1977). In this study, a retrospective epidemiological 
analysis was designed to investigate the nature of the disease in Iowa 
over the last 23 years to elucidate the main reservoir and .transmission 
cycles, and the monthly or seasonal prevalence of the disease in wild 
and domestic animals. 
Materials 
The data for this study were collected from the following: 
1. Annual Rabies Surveillance Reports for the years 1961-1965, 
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published by Communicable Disease Center (CDC, 1966; 1965; 1963; 1962; 
1961). 
2. Zoonoses Surveillance: Annual Rabies Summaries for the years 
1966-1968, published by National Comnunlcable Disease Center (NCDC, 
1968; 1967a,b). 
3* Zoonoses Surveillance: Annual Summaries: Rabies for the 
years 1969-1971, published by the Center for Disease Control (CDC, 
1972a; 1969-1971). 
4. Rabies; Zoonoses Surveillance; Annual Summaries: Rabies, for 
the years 1972-1977, published by the Center for Disease Control (CDC, 
1978; 1977; 1976a,b; 1974; 1972b). 
5. Rabies Surveillance: Annual Summaries: Rabies for the years 
1978-1984, published by the Centers for Disease Control (CDC, 1985a,b; 
1983; 1981a,b). 
Methods 
Tables and graphs havae been used to Interpret the behavior of the 
disease in major species of wild and domestic animals that have been 
reported to have rabies in Iowa in the period 1963-1985. The positive 
rate equals the number of samples which are laboratory confirmed as 
positive for rabies divided by the total number of samples submitted to 
the two official diagnostic laboratories in the state. 
Results 
In the 23 years since 1963 until the end of 1985, there were 5645 
cases of rabies reported In Iowa. A total of 3583 (63.5%) of the cases 
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were reported In wild animals (Table 1) and 2062 (36.5%) of the cases 
were reported in domestic animals (Table 2). See also Figure 1. 
Among the four wild animal species considered to be hosts of 
rabies in the U.S., skunks have appeared to be the principal reservoir 
hosts of rabies in Iowa, representing more than 93% of the total 
reported cases in wild animals (Table 1). Other species, including 
bats, foxes, and raccoons have appeared to play minor roles in the 
epidemiology of rabies, representing only 4%, 1.22%, and 0.92%, 
respectively, of the reported cases during the 23 year period. The 
number of reported cases in skunks during this period displayed three • 
peaks in the years 1964, 1972, and 1981. See Figure 2. An increase in 
the number of reported cases in other wild animals for the same period 
occurred during the same years (Table 1). 
Of the domestic animals, cattle have had the highest number of 
cases of rabies (1195 cases). For the 23 year period, this constituted 
58% of the total cases recorded in domestic animals and 21% of the 
total number of reported cases in Iowa during that period. An increase 
in the number of reported cases of rabies in cattle could be seen 
during the peak periods of skunk rabies (Table 2). Reported cases of 
rabies in cats in the last 23 years have totaled 484, representing 
23.5% of the cases in domestic animals and also reflecting an increase 
in cases during peaks in skunk rabies (Table 2). The number of cases 
of rabies in dogs totaled only 228 representing 11% of the total 
domestic animal cases. Although the peak of 1981 showed an increase in 
the number of dog rabies cases, the previous peaks of rabies in skunks 
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Table 1. Reported cases of rabies in wild animals in Iowa for the 
years 1963-1985 
Years Skunks Bobcats Coyotes Foxes Raccoons Bats Other 
Animals 
Total 
Year 
1963 192 6 4 3 3 208 
1964 305 — — 7 4 — 1 317 
1965 118 — — 1 3 6 1 129 
1966 94 — — — 1 3 98 
1967 77 — — 1 — 7 85 
1968 72 — — 2 — 4 1 79 
1969 47 — — 2 — 8 57 
1970 72 — — 3 1 5 81 
1971 135 — — 3 3 8 3 152 
1972 217 — — 1 1 5 225 
1973 121 — — 1 — 3 125 
1974 67 — — • 1 — — 1 71 
1975 52 — — 1 7 60 
1976 84 — — — 1 2 87 
1977 79 — — — 1 2 82 
1978 80 — — 3 1 2 1 87 
1979 126 — — 1 2 8 137 
1980 353 — — 3 3 7 1 367 
1981 533 — 1 4 6 25 5 574 
1982 227 — 1 2 2 7 2 241 
1983 120 — — — 5 125 
1984 91 — — 1 — 8 100 
1985 82 — — 1 — 16 99 
Total for 
each 3344 00 2 44 33 141 19 3583 
species 
% for 
each 
species 93.30 0.06 1.22 0.92 4.00 0.50 100.0 
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Table 2. Reported cases of rabies in domestic animals in Iowa for the 
years 1963-1985 
Years Dogs Cats Cattle Horses Sheep Swine Total/ 
& Mules & Goats Year 
1963 13 21 89 5 — 7 135 
1964 17 26 100 3 — — 146 
1965 11 28 56 4 1 3 103 
1966 6 22 42 — — — 70 
1967 1 16 31 3 — — 51 
1968 2 9 34 1 — 1 47 
1969 — 12 32 2 — — 46 
1970 3 9 43 — — — 55 
1971 11 22 52 1 1 1 88 
1972 7 20 87 7 2 2 125 
1973 3 18 60 6 1 1 89 
1974 6 15 35 3 — — 59 
1975 10 12 17 1 — 2 42 
1976 3 7 26 2 — — 38 
1977 5 12 32 1 — 2 52 
1978 10 16 31 4 2 — 63 
1979 7 13 39 5 4 1 69 
1980 22 44 95 10 7 — 178 
1981 49 87 140 21 7 3 307 
1982 10 38 77 9 2 — 136 
1983 14 18 34 6 3 — 75 
1984 12 11 23 3 2 1 52 
1985 6 8 20 2 — — 36 
Total for 
each 228 484 1195 99 32 24 2062 
species 
% for 
each 
Species 11.0 23.5 58.0 5.0 1.5 1.0 100.0 
Figure 1. Percentage of rabies cases reported during the years 1963-
1985 in Iowa. (A) In domestic (Dora) and wild species, (B) In 
different species of domestic animals, and (C) In different 
species of wild animals 
S 
Dom Wild Dog Cat Cattle Horse Sheep Swine Skunk Bats Fox Raccoon Other 
& & animals 
Mule Goat 
(A) Total animals (B) Domestic animals (C) Wild animals 
Figure 2. Trends of correlation between rabies in skunks and rabies in 
domestic animals 
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in 1964 and 1972 were not reflected in an increase in the number of 
cases of dog rabies (Table 2). Horses and mules contributed 99 cases, 
sheep and goats 32 cases and swine 24 cases of rabies during the same 
period representing 1.5%, and 1.0%, respectively, of the rabies 
cases in domestic animals (Table 2). The prevalence in all domestic 
animal species reflected increase in number of cases of rabies during 
the peaks of skunk rabies (Figure 2). 
During the period 1980-84, skunks showed a mean positive rate of 
67% of the specimens submitted to the laboratories (Table 3). The 
positive rate in skunks during the peak of 1981 was 75%, the rate 
decreased to 54% in 1984. The mean positive rate in all domestic 
animal carcasses submitted in the same period was 6.4%. The positive 
rate was highest at 10% in 1981 and has been decreasing gradually since 
to 3% in 1984 (Table 4). The positive rate in cattle was consistently 
higher than in other domestic animals with a mean of 16% during the 
same period, from a high of 23% during 1981 to 8% in 1984 (Table 5). 
The mean positive rates for dogs and cats were 3.6% each, with highs 
during 1981 of 6.3% for dogs and 5.6% for cats (Tables 6 and 7). 
Based on the five-year period of 1980-84 (Table 8), the cumulative 
monthly tabulated data of laboratory confirmed cases of rabies in 
skunks showed a gradual increase in the number of reported cases of 
rabies started in February each year and continues through March and 
April. The number of cases then remained at approximately the same 
level with small differences through July and August. The number of 
reported cases then decreased each September and October, and then 
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Table 3. Positive rate for rabies In skunks in Iowa in the 
years 1980-1984 
Number of Animals Examined 
Years Total Positive Percent 
Positive 
1980 549 348 63 
1981 712 533 75 
1982 328 227 69 
1983 206 117 57 
1984 170 91 54 
5 year period 1965 1316 67 
Table 4. Positive rate for rabies in domestic animals in Iowa 
in the years 1980-1984 
Number of Animals Examined 
Years Total Positive Percent 
1980 2063 153 7.4 
1981 3121 306 10 
1982 2318 136 6 
1983 2110 76 3.6 
1984 1727 52 3 
5 year period 11339 723 6.4 
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Table 5. Positive rate for rabies in cattle in Iowa in the 
years 1980-1984 
Number of Animals Examined 
Years Total Positive Percent 
1980 454 66 14.5 
1981 609 140 23 
1982 420 77 18 
1983 361 34 9 
1984 275 23 8 
5 year period 2119 340 16 
Table 6 . Positive rate in 
years 1980-1984 
Iowa for rabies in dogs in the 
Number of Animals Examined 
Years Total Positive Percent 
1980 570 26 4.6 
1981 762 48 6.3 
1982 578 10 1.7 
1983 632 14 2.2 
1984 546 12 2.2 
5 year period 3088 110 3.6 
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Table 7. Positive rate in 
years 1980-1984 
Iowa for rabies in cats in the 
Number of Animals Tested 
Years Total Positive Percent 
1980 921 44 4.8 
1981 1547 87 5.6 
1982 1179 38 3.2 
1983 988 18 1.8 
1984 821 11 1.3 
5 year period 5456 198 3.6 
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Table 8. Number of cases of rabies reported monthly in skunks in Iowa 
in the years 1980-1984 
Months 1980 1981 1982 1983 1984 Total Percent 
Jan 13 24 16 12 4 69 5 
Feb 19 33 18 7 4 81 6 
Mar 18 59 21 13 13 124 9.4 
Apr 29 70 20 12 12 143 11 
May 30 49 20 18 8 125 9.5 
June 33 50 35 19 8 145 11 
July 43 52 21 8 15 139 10.6 
Aug 34 40 28 8 7 122 9.3 
Sep 29 62 10 2 4 107 8 
Oct 36 33 14 10 7 100 7.6 
Nov 30 26 10 8 5 79 6 
Dec 34 35 14 3 4 90 7 
Yearly 
totals 348 533 227 117 91 1316 
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returned to the February level in November and December (Figure 3). 
Discussion 
This study has pointed out the main species involved in the rabies 
cycle in Iowa. From the wild species, skunks are recognized as the 
dominant reservoir species with 93.3% of the cases in wild animals 
being reported in striped skunks. Other wildlife species which were 
reported as infected with rabies, including foxes, raccoons, and bats 
seemed to play a minor role. It is clear from the trends in number of 
cases in foxes and raccoons, especially during the peaks of 1964, 1972, 
and 1981, that the cases reported from these species represented a 
spill-over from the skunk population. When the number of rabies cases 
subsided below certain levels in the skunk population, the number of 
cases in raccoons and foxes decreased as well or even disappeared. 
This level may be slightly different between skunks and foxes, and 
between skunks and raccoons, as foxes are more susceptible than 
raccoons to rabies infection. The correlation is clear between the 
number recorded cases of rabies in skunks and in domestic animals, 
standing out clearly- between the number of cases in skunks and each in 
cattle, cats, horses and mules, sheep and goats, and dogs in the last 
episode of 1981. In Figure 2, the peaks in numbers of cases of skunk 
rabies are accompanied by increases in the numbers of rabies cases 
recorded in domestic animals. The living habits of skunks in areas 
adjacent to the farm animals brings this wild reservoir species of 
rabies recorded in close living association with farm animals. This is 
in agreement with previous studies (Smith et al., 1984) which showed that 
Figure 3. Percentage of total rabid skunks reported each month in the 
years 1980-1984 
% positive animais 
rabies isolates from different species in the midwest em states were of 
the skunk ecotype of rabies virus. Cases of rabies in bats, although 
few in number compared to skunk cases, did not correlate with the 
cyclic behavior or increase and decrease in the skunk cases of rabies. 
This presents the possibility that the bat ecotype(s) of rabies virus 
are also present in this state. The number of rabies cases in the 
foxes and raccoons as well as in the species of domestic animals seemed 
correlated with the cycles of rabies in skunks. 
The monthly positive rates which were presented in Table 8 and in 
Figure 3 have shown a monthly increase in the number of cases of rabies 
during February and March each year, followed by a more steady level 
during the summer months. This increase came after each over winter 
communal denning of skunks followed by the breeding season during 
February. The variable long incubation period which may be up to 120 
days or jsore, may be the cause of the continuous high number of cases 
during the spring and summer and final decline at the fall each year. 
This also would maintain a continuous source of exposure to other wild 
and to domestic animals during each spring and summer. 
This study has shown that the skunk is the main reservoir of the 
rabies virus in Iowa and the source for the annual economical losses 
due to rabies in domestic animals. Skunks also provide the constant 
source for direct or indirect exposure of people to rabies. 
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Sunmary 
During a three years study 1983-85, 475 raccoons were trapped in 
Guthrie County and their sex and weight were determined at the time 
of trapping. The age was determined for 401 (84%) raccoons by tooth 
sectioning. The proportion of the raccoons trapped each year were 15% 
in 1983, 39% in 1984, and 46% in 1985. Overall, 45% of the raccoons 
were captured during spring, 44% during sunmier and 11% during the fall 
season. In the spring trappings, 95% of the raccons were adults and 5% 
were juveniles; however, juveniles predominated in the sumner and fall 
with 60% and 77%, respectively. There were 56% male and 44% female 
raccoons in the collection. Serum samples were collected from all 
raccoons and titrated in four dilutions against rabies virus (CVS-11), 
using the rapid fluorescent focus inhibition test (RFFIT). Another 
group of 18 sera were collected from a closed population of confined 
raccoons (males only) at a licensed fur farm, and were titrated for the 
presence of antibodies against rabies virus as well. 
The seropositive rate in raccoons from Guthrie County was 18% for 
the total three year sample. In 1983, 34% of sera tested were 
positive, in 1984, 14% were positive, and in 1985, 16% were positive 
for rabies antibodies. Each year, the percentage of positive sera 
increased steadily from April through June and then decreased during 
July through September and Increased slightly again in October. This 
resulted in a positive rate of 27% in the spring, decreased to 10% in 
the summer and increased slightly to 12% in the fall. Both sexes had 
the same overall positive rate of 18%. However, differences were 
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detected between male and female positive rates related to seasons as 
well as to the ages and weights of the raccoons. A positive 
correlation between increasing positive rate, from 8 to 29% with 
increasing age and from 0 to 30% with increasing weight were detected. 
The juvenile raccoons showed an overall positive rate of 8% compared to 
24% in the adult raccoons. A seasonal difference between juvenile and 
adult raccoons was also detected. The 18 raccoons from the fur farm 
showed a positive correlation also between the positive rate and the 
age and weight. The positive rate in this group of captive raccoons 
was 22%. A further investigation to elucidate the nature of the 
infectious agent and its chain of transmission are suggested. 
Introduction 
Reported cases of rabies in raccoons in the U.S. increased from 99 
cases in 1965 to 1,906 cases in 1983. Reported occurrence of the 
disease in skunks varied from 319 cases in 1953 to 4,480 cases in 1981 
with a decline to 2,082 cases in 1984. However, occurrence of rabies 
in dogs declined during the same period from 5,688 cases in 1953 to 97 
cases in 1984 (CDC, 1985b, 1983; Pacer et al., 1985). This decrease in 
the number of cases of rabies in dogs was consistent in the western 
world (the U.S., Canada, and Europe) and followed implementation of dog 
vaccination (Acha and Arambulo, 1985; Fernandes and Arambulo, 1985; 
Beran 1981). The increase in cases of rabies reported in wild animals 
in the U.S. in 1983 accounted for 5,294 cases (90%) of the 5,880 total 
cases reported; skunks, raccoons, and bats constituted 96% of the 
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wildlife cases of rabies (CDC, 1985a). 
Rabies in raccoons in the U.S. was reported sporadically in 
California in 1936, and in Georgia in 1945 (Beran, 1981), and then in 
central Florida in. 1955 (Baer, 1985). From this focus in southeastern 
U.S., the disease extended northward and today dominates the number of 
cases reported in the eastern U.S. Reported cases of rabies in 
raccoons from the midatlantic and southeastern states accounted for 84% 
of the total reported cases of rabies in raccoon in the U.S. in 1983 
(CDC, 1985a; Pacer et al., 1985). A monoclonal antibody procedure was 
used in an epidemiological analysis of rabies virus isolates from these 
enzootic areas of the U.S. (Smith et al., 1984). The raccoon ecotype 
of rabies virus was responsible for rabies not only in the raccoons but 
also in other terrestrial species of wild and domestic animals in the 
midatlantic and southeastern U.S.; the skunk ecotype in the midwestern 
states, and the fox ecotype in the north eastern U.S. Bat isolates 
were diverse. They were different from one another, even within the 
same species and geographic area (Baer, 1985; Pacer et al, 1985; Smith 
et al., 1984). 
In the four midatlantic states (Maryland, Pennsylvania, Virginia, 
and West Virginia) and the District of Columbia, a 92% increase in 
cases of rabies in raccoons was reported from 1982 to 1983 (CDC, 1985a; 
Pacer et al., 1985). The positive rate in raccoons tested for rabies 
infection increased form 14.26% in 1982 to 18.56% in 1983 (CDC, 1983, 
1985a). Earlier serological investigations on raccoons in different 
parts of the U.S. were reviewed by McLean (1975) and the seropositive 
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findings were reported to be 0 to 3.5% in non-endemic areas, 0-6.5% 
adjacent to the endemic areas, 7.5-27.8% in areas of clinically 
inapparent epidemics, 3 to 12% in clinically epidemic areas and 11 to 
27% in immediate postepidemic areas. 
In Iowa, raccoons have not been considered as reservoir hosts of 
rabies. No raccoon ecotype of rabies virus has been detected in Iowa 
by monoclonal antibody investigation (Smith et al., 1984); only skunk 
and bat ecotypes have been reported to be endemic in Iowa (Smith et 
al., 1984; Beran, 1981). In the last three years (1983-1985), no cases 
of rabies in raccoons were reported in Iowa, and only 13 cases of 
rabies in this species were reported between January 1979 and December 
of 1982, an annual positive rate of only 1-2% (CDC, 1985a,b; 1983). 
This study was designed (1) to investigate the incidence of the 
disease in raccoons in Iowa, (2) to obtain epidemiological evidence 
whether raccoon ecotype of rabies virus may be present in Iowa, and (3) 
to assess the effect of different factors such as time, sex, age, and 
weight on the seropositive rate and immunity of the raccoon population. 
Materials and Methods 
Animal g 
Four-hundred and seventy-five raccoons were trapped at random 
locations in Guthrie County over a three-year period between 1983-1985 
in by personnel of the Department of Animal Ecology, Iowa State 
University, Ames, Iowa. Each trapping period was of 10 weeks duration 
between March 30 and October 10, with a recess during July, except in 
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1983 when only spring and early summer collections were made. Blood 
samples were collected from all animals and sexes and weights were 
recorded. Ages were determined for 401 (84%) of the raccoons by tooth 
extractions and sectioning. The sera were separated and stored at -20 
*C. At the time of performing the test, the sera were heat inactivated 
at 56* C for 30 minutes and Kaolin treated to adsorb non-specific 
inhibitors. Four primary dilutions were made from each serum (1:2, 
1:4, 1:8, and 1:16) to titrate for rabies neutralizing antibodies. 
Another 18 sera were collected from confined raccoons raised at a 
licensed fur farm in Iowa. These raccoons were raised completely iso­
lated from outside contact with other wild animals and had no history 
of rabies in previous generations. The age, sex, and weight of each 
raccoon was recorded and its sera was treated as the previous group. 
Virus «"H cell culture 
Challenge virus strain (CVS-11)^  of rabies virus was used. The 
optimal challenge dose was the highest dilution of virus that induced 
strong FA staining in 80-100% of the cells in a culture monolayer after 
48 hours incubation. This was determined to be 25,000 fluorescent 
forming units (FFU)/0.2 ml of the virus suspension. A cell line (BHK2^  
2 
clone was grown in culture in Glasgow minimum essential medium 
R^abies virus from CDC. Atlanta, Georgia. 
2 BHKg^  cells originated from CDC and were supplied to our 
laboratory by Dr. T. Bunn, National Veterinary Services Laboratories, 
Ames, Iowa 50013. 
106 
(G-MEM)^ , supplemented with 10% inactivated fetal calf serum (PCS) as 
growth medium (GM), and with 2% PCS as maintenance medium (MM). Sodium 
penicillin (100 U/ml) and streptomycin (100 yg/ml were added to both GM 
and MM. The virus and serum dilutions were made in MM. 
Virus neutralization tests 
The neutralizing antibody level in each serum was determined by 
the rapid fluorescent focus Inhibition test (RFFIT) (Smith et al., 
2 1973; Brown et al., 1984). Eight chamber Lab-Tek cell culture slides 
were used. A cell suspension containing 2 x 10^  cells/0.2 ml growth 
media was inoculated into each chamber and the slides were incubated at 
37" C in a humid chamber with 3-5% CO^ » After 24 hours, the inocula 
were prepared 1^  mixing 0.2 ml of the virus suspension with 0.2 ml of 
each test serum dilution. Known positive and negative sera were 
included as controls in each test. The inoculated cultures were 
incubated in a humid CO2 chamber for 1 hour at 37' C. The growth 
medium was removed from each slide and 0.3 ml of each virus-serum 
preparation was inoculated on the cell layer in each well. The slides 
were then returned to the humid CO^  incubator. One hour later, the 
inocula were removed and the cell layers washed once with MM and then 
covered with 0.3 ml of MM. Slides were then returned to the humid CO2 
incubator and maintained at 37° C for 48 hours. The inocula were then 
G^ibco Laboratories, 3175 Staley Road, Grand Island, New York 
14072. 
M^iles Scientific, Division of Miles Laboratories, Inc., 
Naperville, IL 60566. 
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removed and the cell monolayers fixed with acetone at -20' C for 10 
minutes, air-dried, and covered with a standard conjugate^  in a humid 
chamber at 37* C for 30 minute reaction times. The slides were then 
rinsed once with phosphate-buffered saline (PBS), then soaked in PBS 
for 10 mln, rinsed with distilled water and alr-drled. Slides were 
mounted in 50/50 (V/V) glycerine-saline solution, overlayed with 
coverslips and examined with a fluorescent microscope. 
The level of neutralization produced by any serum dilution was 
determined by examination of the entire field and comparison with the 
level of infection in virus controls. Each serum was tested at final 
dilutions of 1:4, 1:8, 1:16, and 1:32 to determine the titer of rabies 
neutralizing antibodies in eacn animal. À mouse neutralization test 
was performed on a randomly selected group of 10 raccoon sera and 
compared to REFIT. The results of both tests were comparable. 
Analysis of data 
Data were categorized in tables and graphs to study the effects of 
various factors involved, including time sequence of months, seasons, 
and years of collection and of sex, age, and weight of the animals on 
the rabies neutralizing antibody levels in the population. 
Correlation statistical tests were used to test the significance 
of differences in the prevalence and the levels of antibodies. 
A^nt Rabies Globulin, Equine, Fluorescein labeled. BBL 
Microbiology Systems, Becton, Dickinson and Co., Cockeysville, MD 
21030 
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Results 
Characteristics of the raccoon samples 
During the first year of collections, raccoon trapping was started 
on April 3, 1983 and continued until June 26, 1983; 70 sera were 
collected, constituting 15% of the total three year sample. In the 
second year, 1984, 184 raccoon sera were collected between April 3 and 
October 3. The 1984 collection constituted 39% of the total sample. 
In the third year of collection, 1985, trapping was conducted from 
March 23 until October 5. A total of 221 raccoon sera were collected, 
constituting 46% of the total. Table 1 shows the monthly and yearly 
collections, and Figure la shows the monthly percentage of sera 
collected in each year. On a cumulative basis, March and July had the 
lowest numbers of samples collected, constituting only 3% of the total. 
During April, May, and June, 49% of the samples were collected and 
during August, September, and October, 48% of the samples were 
obtained. See Figure Id. On a cumulative monthly basis, during the 
three-year period (Figure 2), adult raccoons dominated between March 
and the end of July, with only 5% (12/247) of the samples being from 
juveniles. Juveniles then dominated the collections during the last 
three months, constituting 72% (165/228) of the total sera collected 
during August, September, and October. On seasonal bases, 87% of the 
sera obtained in 1983 were collected in the spring and 13% in the 
summer (Table 2, Figure 3). The same table and figure show that in 
1984, 44% of the sera were collected in the spring, 48% in summer and 
8% In the fall. In 1985, 32% of the sera were collected In the spring. 
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Table 1. Number of raccoons trapped during each month during the three 
years of the study 
Years Cumulative Totals by Months 
1983 1984 1985 Total Percent 
March 00 00 03 03 0.6 
April 08 44 11 63 13. 
May 36 20 22 78 16.4 
June 26 23 47 96 20 
July 00 06 01 07 1.5 
August 00 34 25 59 12.4 
September 00 49 86 135 28.4 
October 00 08 26 34 7 
Total for 
Year 70 184 221 475 
Percent 15 38 46 
Figure 1. Percentages of sera collected during each month from 
total serum collections of the same year (a-c). 
Months of collection are abbreviated by their first 
letter. Percentages of total collection by months 
during the three years (1983-85) from the total serum 
collection (475 sera) are in (d), and percentages of 
collection during each year from total serum 
collection sera are in (e) 
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Figure 2. Percentages of juvenile and adult raccoons sampled 
each month during the three-year study, 1983-85. 
Months of collection are abbreviated by their first 
letter for March through October 
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Table 2. Number of raccoons trapped during each season during the 
years of the study 
Season Total for 
Year Spring Summer Fall the Year 
Mar. 23-June 20 June 21-Sept. 2 Sept. 23-Oct. 5 
1983 61 9 99 70 
1984 80 89 15 184 
1985 71 113 37 221 
Total for 
Season 212 211 52 475 
Percent 
for 
Season 45 44 11 
Figure 3. Percentages of the spring (Sp), Summer (Su) and fall 
(Fa) raccoon serum collections from each year's 
collection (A-C), and percentage of the cumulative 
(1983-85) collections for each season from the total 
sera collected (D) 
Figure 4. Percentages of male and female raccoons trapped 
during each year (A-C) and their percentage in the 
total population (D) 
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51% in the summer and 17% in the fall. Overall, 45% of the sera were 
collected in spring (95% adult, 5% juvenile), 44% in summer (40% adult 
and 60% juvenile) and 11% in the fall (23% adult and 77% juvenile). 
The male to female ratio of the animals trapped in each year of 
the study were 61% to 39% in 1983, 60% to 40% in 1984 and 52% to 48% in 
1985. The total sample had a sex ratio of 56% male and 44% female. 
Table 3 shows the number of raccoon in each sex category and Figure 4 
shows the percentage of each sex in each year's collection. The sex 
ratio by season of trapping was shown in Table 4. 
Âges of raccoons were determined by tooth sectioning of 401 (84%) 
raccoons. As shown in Table 5, 44% of the raccoons were less than one-
year old and were classed as juvenile. There are 24% in the one-year, 
22% in the two-year, and 10% in the equal to or more than three year 
old classes at the time of collection. The last category included all 
raccoons that were 3, 4, 5, or 6 years old at the time of trapping. 
Figure 5 shows the percentage of raccoons in the known age groups in 
the population. Table 6 shows the number of raccoons in each age group 
collected each season each study year plus the raccoons of unknown 
age group. 
Seven weight groups were used to categorize the raccoon samples. 
Table 7 shows the total number of raccoons in each weight group as well 
as their sex composition. Figure 6 shows the percentage of raccoons in 
each weight group from the total sample. There were 3% of the raccoons 
weighing ^  2000 gm, 10% between 2100 and 3000 gm, 19% between 3100 and 
4000 gm, 16% between 4100 and 5000 gm, 24% between 5100 and 6000 gm. 
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Table 3. Number of raccoons in both sex categories from each year 
of trapping during the three years of the study 
Year Male Female Total per Year Percent of Total 
1983 43 27 70 15 
1984 110 74 184 39 
1985 114 107 221 46 
Total/Sex 267 208 475 
Percent 
of Total 56 44 
Table 4. Number of raccoons in each sex category trapped during each 
season during the three years of the study 
Year Spring Summer Fall Total 
MF MF MF for Year 
1983 40 21 3 6 — — 70 
1984 60 20 42 47 8 7 184 
1985 39 32 61 52 14 23 221 
Total each 
sex for 
season 139 73 106 105 22 30 475 
Percent 66 34 50 50 42 58 
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Table 5. Number of raccoons trapped In each age category during the 
three years of the study 
Juvenile 
Year < 1 year 1 year 
1983 
1984 
1985 
Total, 
each 
age 
Percent 
0 
56 
121 
177 
44 
18 
49 
28 
95 
24 
Adults 
2 years 2 3 years 
18 
19 
51 
87 
22 
8 
12 
22 
42 
10 
Total/ Z of 
Year Total 
44 11 
136 34 
221 55 
401 
Table 6. Number of raccoons In each age category collected during each 
season of the three years study 
Age 
Sp 
1983 
Su Fa Sp 
1984 
Su Fa Sp 
1985 
Su Fa 
Cum* Season 
Sp Su Fa 
Total % 
Un 26 0 0 48 0 0 0 0 0 74 0 0 74 16 
< 1 0 0 0 0 46 10 10 81 30 10 127 40 177 37 
1 14 4 0 19 27 3 20 7 1 53 38 4 95 20 
2 14 4 0 10 9 0 27 18 5 51 31 5 87 18 
> 3 7 1 0 3 7 2 14 7 1 24 15 3 42 9 
Tot. 
Sea. 61 9 0 80 89 15 71 113 37 212 211 52 475 
% 87 13 0 44 48 8 32 51 17 45 44 11 
123 
Table 7. Number of raccoons In each sex and weight category from the 
raccoons trapped in the three-year study 
Sex 
Weight (gm) Male Female Total % of Total 
< 2000 10 5 15 3 
2100-3000 20 27 47 10 
3100-4000 44 48 92 10 
4100-5000 41 36 77 16 
5100-6000 58 57 115 24 
6100-7000 51 29 80 17 
> 7000 43 6 49 10 
267 208 475 
Figure 6. Percentage of raccoons distributed according to weight 
groups from the total sample (475 raccoons) 
Figure 7. Percentages of each sex in each weight group of the 
raccoons 
125 
C 
O 
5 30 
m 
"O 
c 
o 
m 
s Q. 
O Q. 
20 
10 
lO 
N 
V 
m 
# o 
CM CO 
VI I 
8 
1 
0 
1 
CN CO 
1 
u> 
to «D 
I I 
 ^U) 
Weight (xlOO gm) 
o 
00 
1 g 
I 
N. 
Al 
Maie 
Female 
CM «  ^ lO 
Weight (xlOO gm) 
126 
17% between 6100 and 7000 gm and 10% which were 2 7100 gm. The two 
sexes were similar in numbers in the weight groups between 2100 gm and 
6000 gm, however, beyond that weight the males predominanted 
constituting 64% of the raccoons in the 6100-7000 gm weight group and 
88% in the heaviest weight group 7100 gm). See Figure 7. 
The 18 raccoons sampled at the fur farm were represented by males 
only. Their age and weight distributions are presented in Figure 8. 
This group had 17% juveniles (< 1 year) and 83% adults of 2-6 years 
old. The two weight categories, included 33% ^  7000 gm and 67% 2 7100 
gm. 
Serological observations 
Criteria for classification as seropositive. As shown in Figure 
9, fluorescence was Inhibited to variable degrees by the field sera at 
the four concentrations tested. Graphic presentation of the degree of 
neutralization at each test dilution of the field sera was used to 
separate neutralization caused by specific antibodies from 
neutralization caused by non-specific factors, as shown in Figures 10 
and 11. At serum dilution 1:4, 14% of the sera showed 0% 
neutralization, 20% showed 25%, 26% showed 50%, 17% showed 75%, and 26% 
showed 100% neutralization (Figure 10). At 1:8, 25% showed 25%, 15% 
showed 50%, and 6% each showed 75% and 100% neutralization (Figure 11). 
At 1:32, 65% of the sera showed 0% neutralization, 20% showed 25%, 10% 
showed 50%, 3% showed 75%, and 2% showed 100% neutralization (Figure 
11). From these results any sera which showed fluorescent inhibition 
levels (FIL) of at least > 95% at 1:4 dilution, > 75% at 1:8, > 50% at 
Figure 8. Percentage of raccoons from fur farm in the (A) juvenile 
CJuv) and adult (Ad) age groups, and (B) weight groups 
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1:16, and > 20% at 1:32 final serum dilution were considered to be 
seropositive. Any sera that showed FIL of at least > 75% at 1:4, >50% 
at 1:8, and > 25%, at 1:16 were considered as producing partial 
neutralization (PN). 
1. Seropositive animals. In Guthrie County (GC), a total of 85 
raccoon sera met the criteria for classification as seropositive. This 
represents a PR of 18% in raccoons in GC. This rate varied among the 
years, months, seasons, sexes, ages, and weight groups. Twenty-eight 
percent of the positive sera were from the 1983, 31% from the 1984 and 
41% from the 1985 collections. However, the PR was higher in 1983 than 
in the consecutive two years, being 34% in 1983, 14% in 1984 and 16% in 
1985. See Table 8 and Figure 12a. A great variation was found in the 
PR among the months of collection. However, there is a general trend 
of increase in PR of the sera collected during April, May, and June of 
each year followed by a general decline in the PR in the following 
months As shown in Table 8 and in Figure 12b, the PR during April, May, 
and June 1983 was 0%, 28%, and 54%, respectively. In 1984, the PR was 
25% in April, 5% in May, 35% in June, 0% in July, 12% in August, 4% in 
September, and 0% in October. In 1985, the PR was 0% in March, 18% in 
April, 27% in May, 23% in June, 100% (1/1) in July, and 8% in August. 
On accumulative monthly basis during the three-year period, 
(Figure 12b) there was a gradual increase in the positive rate (PR) in 
the raccoons tested, from 15% in April to 20% in May to 39% in June, 
followed by a decline to 14% in July, to 7% in August to 12% in 
September, and to 6% in October. 
Figure 9. Characteristics of specific fluorescence at different levels 
of serum dilutions 
% of sera neutralizing at selected levels 
Figure 10. Classification of specific neutralization titers in raccoons 
at 1:4 and 1:8 serum dilutions 
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Figure 12. Percentages of positive sera detected from the total 
raccoon sera collection of (A) each year 1983-1985, (B) the 
• months of collection March through October (abbreviated by 
their first letter), (C) the season of collection (Spring -
Sp, Summer -Su, and Fall - Fa), and (D) the male (M) and 
female (F) sex groups 
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Table 8. Number of positive raccoon sera from each month 
collection during the three-year study 
1983 1984 1985 Total (M) Month 
Pos/Tot Pos/Tot Pos/Tot Pos/Tot PR 
March 0/0 0/0 0/3 0/3 0 
April 0/8 11/44 2/11 13/63 20.6 
May 10/36 1/20 6/22 17/78 22 
June 14/26 28/87 23/93 33/96 34.4 
July 0/6 1/1 1/7 14.3 
August 4/34 2/25 6/59 10 
September 2/49 8/86 10/135 7.4 
October 6/2 11/6 5/34 15 
Total/ 
year 24/70 26/184 35/221 85/475 
Year PR 34.3 14 16 18 
Table 9. Number of positive sera In each age category from the 
seasonal collection during the three-year study 
Age 1983 1984 1985 Cumulative Total 
Sp Su Fa Sp Su Fa Sp Su Fa Sp Su Fa Pos/Tot PR 
Un 2/26 11/48 13/74 13/74 18 
< 1 0/0 3/46 0/10 0/10 6/81 5/30 0/10 9/127 5/40 14/177 8 
1 5/12 2/4 4/19 3/27 1/3 5/20 1/7 0/1 14/53 6/38 1/4 21/95 22 
2 8/14 2/4 1/10 1/9 8/27 4/18 1/5 17/51 7/31 1/5 25/87 29 
> 3 5/7 0/1 1/3 1/7 0/2 5/14 0/7 0/1 11/24 1/15 0/3 12/42 29 
Total 
20/61 4/9 17/80 8/89 1/15 18/71 11/113 6/37 55/212 23/211 7/52 85/475 18 
PR 33 44 21 9 7 25 10 16 26 11 13.5 
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Table 10. Number of positive sera from each season collection during 
the three-year study 
Season 
Year Spring Summer Fall Total/year PR for Year 
1983 20/61 4/9 0/0 24/70 34 
1984 17/80 8/89 1/15 26/184 14 
1985 18/71 11/113 6/37 35/221 16 
Total/ 
Season 55/212 23/211 7/52 85/475 18 
PR for 
Season 26% 11% 13.5% 
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The official calendar daces of the seasons were used In 
classifying the PR in each season for each year of the study. Serum 
collections were halted from the middle of October each year until the 
end of March the following year, thus winter seasons were not covered 
in any of the three years and the PR during this season was not 
discerned. As shown in Table 9, sera were collected only during the 
spring and summer in 1983, yielding PRs of 33% and 44%, respectively. 
In 1984, the spring collection had a PR of 21%, the summer of 9% and 
the fall of 7%. In 1985, the seasonal PRs were 25% in spring, 10% in 
summer and 16% in the fall. The cumulative seasonal PRs were higher 
in the spring collections (26%) declined in the summer collections to 
11% and raised slightly in the fall collections to 13.5% (Table 10 and 
Figure 12c). The fall PR is only represented by collections during the 
first three weeks of the season and may not represent the complete 
picture for the rest of the season. 
There was no difference in the overall PR between the two sex 
categories in the total sample, both yielding the same 18% PR as the 
total population as shown in Figure 12c. However by seasons, the PR of 
the female raccoons was 30% in the spring, 9.5% in the summer, and 17% 
in the fall, and of the male, the raccoons was 24% in the spring, 12% 
in the summer and 9% in the fall, as shown in Figure 13 and Table 11. 
The overall PR of the adult raccoons was 24%, markedly higher than 
the PR of 8% recorded in the juvenile raccoons as shown in Table 12. 
Ninety-five percent of the sera collected during the spring were from 
adults, however, 60% of the summer and 77% of the fall sera collections 
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Table 11. Number of positive male and female raccoons in each season 
during the three-year study 
Season Spring Summer Fall Total 
Year M F MF MF Year 
1983 10 10 2 2 -- 24/70 
1984 15 2 3 5 0 1 26/184 
1985 8 10 8 3 2 4 35/221 
Total/ 
Season 33/139 22/73 13/106 10/105 2/22 5/30 85/475 
PR 24% 30% 12% 10% ' 9% 17% 
Figure 13. Percentages of positive sera detected from (A) total sera 
collected during the seasons, spring - Sp, summer - Su, and 
fall - Fa, of sera collection; and comparison (B and C) of 
each sex in the percentage of positive sera detected in 
males and females during the same seasons 
fi) 
0 
Positive, sera in % 
3 O O O O 
m ^ 
</) 
c 
3" 
T T T T 
33/139 
22/73 
13/106 
S 
-1 
- 1 I 1 1 
o « 22/73 
3" 
q 
0) 
c 110/105 
fi) 
(D ? |5/30 
§ 
Positive sera in % 
o â ë ë ê S 
1 —1 T 1 
« 55/212 
g 23/211 
2 7/52 
145 
were from juvenile. The overall seasonal PR in the total raccoon 
population was 27% in spring, 11% in summer and 13.5% in the fall as 
shown in Table 13 and Figure 14a. The seasonal adult PR was 27% in 
spring but decreased to 17% in summer and fall as shown in Figure 14c. 
The juvenile raccoons showed seasonal PRs from 0% in spring raising 
gradually to 7% in summer and 12.5% in the fall (Figure 14b). The PRs 
in the different age groups also varied between the two sexes as shown 
in Table 14 and Figure 15. In the juveniles, the PR was 9% for the 
male and 7% for the females. The PR in the male raccoons then showed a 
gradual increase to 17% in the one-year old, to 27% in the two-year old 
and to 24% in the older population of raccoons 3-years or older. 
Correspondingly, the female raccoons showed PRs of 30% in the one year 
•old, 31% in the two-year old and 32% in the older O 3-year old) age 
groups. See Table 14 and Figure 15c. 
A gradual increase in the PR with weight gain was very clear, as 
shown in Table 15 and Figure 16a. The PR rose from 0% in the ^  2000 
gm. to 8.5% in the 2100-3000 gm. to 10% in the 3100-4000 gm. to 12% in 
the 4100-5000 gm. to 25% in the 5100-6000, 25% in the 6100-7000 gm. and 
finally to 31% in the heavier weight raccoons of 2 7000 gm. Sex 
differences in PR were minor in the groups below 5000 gm. weight. 
However, differences in the PR between male and female raccoons in the 
weight groups above 5000 gm. were clear, with female raccoons showing 
markedly higher PRs. See Figures 16b and c. In the weight group > 
7000 gm. and in the age group 2 3 years, female raccoons showed PRs of 
32%. 
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Table 12. Number of positive raccoons in the juvenile and adult 
categories fom each season collection during the three-year 
study 
Juvenile 
Year Spring Summer Fall Total of Year PR for Year 
1983 00 00 00 00 00 
1984 00 4/46 0/10 3/56 5% 
1985 0/10 6/81 5/30 11/121 9% 
Total 0/10 9/127 5/40 14/177 S% 
PR for 
Season 0% 7% 13% 
Adult 
Year Spring Summer Fall Total for Year PR for Year 
1983 20/61 4/9 0/0 24/70 34% 
1984 17/80 5/43 1/5 23/128 18% 
1985 18/61 5/32 1/7 23/100 24% 
Total 55/202 14/84 2/12 71/298 24% 
PR for 
Season 27% 17% 17% 
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Table 13. Number of positive raccoons in each age group from the 
cumulative seasonal collections 
Season Total 
Spring Summer Fall Âge Group Percent 
Un 13/74 13/74 18 
< 1 0/10 9/127 5/40 14/177 8 
1 14/53 6/38 1/4 21/95 22 
2 17/51 7/31 1/5 25/87 29 
3 11/24 1/15 0/3 12/42 29 
Total 55/212 23/211 7/52 85/475 18 
Figure 14. Percentages of positive sera detected from (A) total sera 
collected during the seasons, spring - Sp, summer - Su, 
and fall - Fa, of sera collection, and comparison (B and C) 
in percentage of positive sera detected in two age 
categories during the same seasons 
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Four of the 18 sera from raccoons at the fur farm met the criteria 
for classification as positive, giving this group of raccoons a PR of 
22%. Those sera were collected at the same time, from only male 
raccoons and their number is small, thus they were described for age 
and weight only. The two age categories were juvenile and adult, with 
PRs of 0% and 27%, respectively, as shown in Table 16a. Two weight 
categories of 7000 gm. and 2 7100 gm. were used. The PR was 17% in 
the lower weight group and 25% in the higher weight group as shown in 
Table 16b. 
Discussion 
The findings in this study have indicated that 18% of the total 
sera collected from raccoons in GC have antibody level capable of 
neutralizing rabies virus by REFIT and are thus considered positive. 
In the meantime, during this three-year period, there were no recorded 
cases of rabies in raccoons in GC or In Iowa. 
In this study, classification of serum samples by years, seasons, 
sexes, ages, and weights has shown marked differences In PRs. In 
1983, when 15% of the sera were collected, the PR were 34%. This was 
the first year in the 1980s that no cases of rabies were recorded in 
raccoons in Iowa. Â trend of increasing PR toward the end of the 
spring and early summer in 1983 gave PRs of 33% that spring and 44% 
that summer. This high PR was followed in 1984 by a low overall PR of 
14%. The seasonal PR in 1984 showed a downward trend from 21% in 
spring to 9% in summer and to 7% in the fall. In 1985, the overall PR 
was 16% with a different seasonal trend from 25% in spring, down to 10% 
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Table 14. Number of positive male and female raccoons from the 
each age group for each sex 
total of 
Male Female Total Age 
Age Pos/Tot PR Pos/Tot PR Age PR 
< 1 year 8/89 9% 6/88 7% 14/177 8.0% 
1 year 10/58 17% 11/37 30% 21/95 22.0% 
2 years 13/48 27% 12/39 31% 25/87 29.0% 
2 years 4/17 24% 8/25 32% 12/42 29.0% 
Sex Total 
and PR 48/267 18% 37/208 18% 72/401 18% 
Table 15. Number of 
category 
positive and total raccoons in each weight 
Number of Animals 
Weight (gm) Positive Total PR 
< 2000 00 15 0% 
2100-3000 04 47 8.5% 
3100-4000 09 47 10.0% 
4100-5000 09 77 12.0% 
5100-6000 29 115 25.0% 
6100-7000 19 80 24.0% 
> 7100 15 49 30.6% 
Total 85 475 18.0% 
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Table 16. Number of positive, negative and total raccoons from a fur 
farm (A) age and (B) weight categories 
(A) Positive Negative Total 
Age No. % No. % No. Z 
Juveniles 
< 1 year 0 0 3 100 3 17 
Adult 
> 2 years 4 27 11 73 15 83 
Total 4 22 14 78 18 
(B) Positive Negative Total 
Weight No. % No. % No. % 
< 7000 1 17 5 83 6 33 
2 7100 3 25 9 75 12 67 
Total 4 22 14 78 18 
Figure 16. Percentages of positive sera detected from (A) 475 raccoon 
sera in different weight groups (1) ^ 4100-5000 gm, (2) 
4100-5000 gm, (3) 5100-6000 gm, (4) 6100-7000 gm, and (5) > 
7100 gm; and a comparison (B and C) of percentages of 
positive sera in the same weight groups for each sex 
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la the summer, and back up to 16% in the fall. 
The seasonal trends of 1984 and 1985 as well as the cumulative 
seasonal percentages for the three-year period have shown a general 
trend for PRs that starts high in spring and decreases in summer, 
possibly to rise again in the fall. The spring high PR was preceded by 
the breeding season as well as by over winter social gathering of 
raccoons in the den sites. The summer low PRs were preceded by spring 
mild weather that resulted in dispersion of the raccoons. Thus, spring 
PRs were considered to reflect the previous high overwinter contacts 
at den sites followed by the breeding season. These high population 
density and fighting occasions were considered favorable for the 
transmission of the infectious agent from infected to susceptible 
raccoons. 
Mild spring temperature result in the dispersion of raccoons from 
the family sites to variable distances away. This dispersion, 
especially of older males and of one-year old raccoons decreases 
contact among raccoons, interrupting the transmission of the infectious 
agent; this lends credence to the decrease in PR in summer and fall. 
The spring collection of sera constituted 45% of the total serum 
sample. Overall 65% of the positive sera were from spring collections, 
giving this season a 26% PR. Forty-four percent of the sera were 
collected in summer, with an 11% PR, and 11% were collected in the fall 
season, with a seasonal PR of 16%. 
By seasons, the PR in male raccoons decreased gradually from 24% 
in spring to 12% in summer and to 9% in the fall. The female PRs on 
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the other hand started higher in spring at 30%, decreased during summer 
to 10%, and increased again in the fall to 17%. This may have been 
related to the breeding season, during which male raccoons may contact 
several females. Then during gestation and care of newborn cubs, the 
movement and dispersion of females, are greatly curtailed and 
transmission opportunities would be reduced. The cubs from one female 
with positive sera were found to carry antibodies against rabies in 
their sera, indicating that maternal antibodies were transferred in 
this instance. 
The juvenile raccoons which were 3-11 months old showed PRs 
rising from 0% in spring to 7% in summer and up to 12.5% in the fall. 
This indicated continuous exposure of the juvenile raccoons to the 
antigen. 
PRs showed a positive correlation with advancing age (r=0.86). 
The PR of 8% in the juvenile group increased to 17% in the one-year age 
group, to 29% in the 2-year age group, and continued at this level in 
the raccoons 3 years of age or older. A sex difference within each age 
group was detected, the juveniles, the male PRs were slightly higher at 
9% than the female PRs at 7%. In the one-year age group, this trend 
was reversed and the female PRs jumped to 30%, while the male PRs 
increased gradually to 17%. The female PRs continued to increase after 
that to 31% at 2-years old and 24% in the older age group of 3 years. 
This positive correlation between age and PR indicated continuous 
contact with the antigen resulting in exposures which boosted titers. 
The female raccoons may have been the sources both of protection of the 
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cubs through transfer of maternal antibodies and of exposure of the 
cubs to the infectious agent as this passive inmtunity waned. 
The increase in PR was also found to be positively correlated with 
weight gain (rM).77). The PR increased from 0% in the ^  2000 gm. 
weight group to 8% in the 2100-3000 gm. group to 17% in the 3100-4000 
gm. group and continued up to 31% in the heavier weight raccoons. The 
male and female PRs are similar in the weight groups ^  5000 gm, but in 
heavier weight groups, female PRs become markedly higher than male PRs. 
This was considered more related to age than to other factors as in 
adult raccoons, the females were older than the males in the same 
weight groups. 
Raccoons at the fur farm were isolated from outside contact and 
were raised with no history of rabies vaccination, of contact with new 
additions of raccoons from other farms on or contact with wild raccoons 
or skunks. The 18 raccoons showed PRs of 0% in the juveniles, of 27% 
in the adults, 17% in ^  7000 gm of weight and of 25% in the 2 7100 gm 
of weight. These results have shown that the infectious agent did 
infect the confined raccoons that had no outside contacts. All the 
raccoons sampled at this farm were males, and the sera were collected 
in December, 1985 before the breeding season. Thus an overall PR of 
22% in this raccoon group does not represent an overwinter communal 
denning, or breeding season conflict. There was possible social 
conflict between residents in the same cages, but all of them were in 
total confinement and had no outside contact. 
The significance of these serological findings in the raccoons of 
160 
Guthrie County is not fully apparent. The initial recognition of a 
high prevalence of neutralizing antibodies against rabies virus was not 
expected. The sero-survey of raccoons in the county was initiated at 
the request of the Animal Ecology Department of Iowa State University 
to assay sera from apparently healthy animals for prevalence of 
antibodies against canine distemper, feline panleucopenia and porcine 
parvoviruses in raccoons. Rabies virus was added into the battery of 
tests and promptly became the most interesting portion of the 
seroprevalence survey. The principal leads were the findings of McLean 
and his coworkers of antibodies against rabies virus in the sera of 
raccoons within and adjacent to the area of endemic rabies in this 
species in Southeastern U.S., and in very low prevalence in nono-
endemic areas. When 24 of the 70 sera collected in 1983 were concluded 
to be seropositive against rabies virus, it was decided to expand these 
studies. 
A graphic presentation of percentages of neutralization of rabies 
virus at 2 fold final serum dilutions from 1:4-1:64 portrayed bymodal 
curves separating specific and possibly nonspecific neutralization. 
The point at which the curves crossed for each serum dilution was used 
as the minimum neutralization level for classifying sera as specifically 
positive. A small study on a subsample of five sera which neutralized 
rabies virus was carried out to determine whether neutralization was 
actually mediated by antibodies. Gamma globulin fractions extracted 
from each serum were reconstituted and tested for neutralizing 
activity. Neutralization titers of the reconstituted globulines were 
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identical to those of the original sera, demonstrating that the virus 
neutralizing activity in the sera was truly gamma globulin antibodies. 
Antibodies which neutralize rabies virus were considered to arise 
following either of two antigenic stimuli; i.e., either following 
nonfatal and probably clinically inapparent rabies Infection, or 
following stimulation by an antigen, probably infectious, which 
crossreacts with rabies viral antigens. The first investigation to 
resolve this dichotomy has been to carry out longitudinal studies on 
sera collected each year in Guthrie County from raccoons being trapped 
in ecological studies by the Animal Ecology Department. These sera 
have been categorized by month and year of collection and by age, sex 
and weight of the donor raccoons. The data have yielded certain, but 
not conclusive clues. 
Over three years of trapping raccoons, 1983-1985, 85 of 475 (18%) 
serum samples showed antibody titers. During the first year of the 
study, collections were made only from January-June. Comparing 
percentages of positive sera during those 4 months each year showed 
higher prevalence in 1985 (34%) than in either 1984 or 1985 (23% each). 
It is noted that 59% of the raccoons sampled in 1983 were alive in 
1981, the year of highest recorded occurrence of animal rabies in Iowa. 
Sera collected from March-October, 1984 and 1985 showed no differences 
In percent positive (14 and 16%, respectively). It appeared that 
sometime between 1981 and 1983, a higher prevalence of exposure to the 
agent had occurred. 
Prevalence of antibodies was highly age related. Seropositive 
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dams transferred passive protection to their offspring. By summer, 
these offspring were beginning active antibody production, which 
further increased in the fall, indicating an endemic presence and at 
least frequent contact with the antigen. In the overall population, 
antibody prevalence was always highest in spring but declined to lowest 
prevalence in summer as the proportion of juveniles in the population 
increased, only to increase in the fall as juveniles themselves 
developed antibodies. The serological data indicated that once formed, 
the neutralizing antibodies persisted, perhaps for the lifetime of the 
raccoon. 
Differences in antibody prevalence by sex was less definite, 
though it appeared that female raccoons in all age groups had somewhat 
higher antibody prevalence than males. Reasons for this were not 
immediately clear. Prevalence correlated positively with weight as 
would be expected because weight relates generally to age. Higher 
prevalence by weight groups for females over males would also have 
been expected, as in each weight group, females were older than males. 
No other epidemiological evidences have been discerned from the 
longitudinal serological studies on raccoons. Collections are 
continuing by the Animal Ecology Department, so the longitudinal study 
will be continued. In the past, rabies in animals in Iowa has shown a 
cyclical pattern with peaks in occurrences about every 7 years. It is 
desired to follow the seroprevalence of antibodies in raccoons which 
may occur at the next cyclical peak if such shall occur before the end 
of this decade. 
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Two small studies attempted in this laboratory have so far yielded 
only preliminary results and must be expanded in the future. An 
attempt was made to obtain and challenge with a standardized dose of 
rabies virus, raccoons with and without antibodies titers. 
Unfortunately all of five wild captured animals had titers. It was 
decided to proceed with a challenge dose previously demonstrated to be 
100% lethal to seronegative skunks. All the experimentally inoculatetd 
raccoons survived challenge and Interestingly showed Increase in 
neutralizing antibody titers. This study will be repeated on a larger 
scale. 
In the seasonal study, virus neturalization by raccoon sera 
Identified as positive by the REFIT test in cell culture, was also 
demonstrated in the mouse neutralization-test. However, in a 
preliminary study in which laboratory mice were initially injected 
intraparltonially with positive or negative raccoon sera followed six 
hours later by intramuscular challenge with rabies virus, the mice were 
not protected. The reasons for this may have been technical and the 
study will be repeated with a modified challenge procedure. 
These two studies will hopefully provide future evidence whether 
the antibodies occurring in raccoons may afford protection from rabies. 
If these titers are protective, it may only be at times of peak rabies 
incidence that levels of exposure become high enough to break through 
this resistance. If this may be the case, it would be expected that 
some of these raccoons would die of rabies while others would have 
their Inmune levels Increased. Some evidence for this latter booster 
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affect has been obtained. Hopefully the studies in mice may also 
provide evidence as to protective activity of these antibodies against 
rabies infection. 
At the present time, the epidemiological data have indicated that 
the antigen stimulating the antibody production is part of an 
infectious agent. Whether infected raccoons remain as carriers and 
shedders in the presence of antibody responses is unsure, though it 
appears that probably baby and then juvenile raccoons receive both 
maternal protection and then immunity stimulating exposures from their 
dams. At this time, it is unclear where in seropositive raccoons one 
might search for the infectious agent. Invasion of the central nervous 
system does not seem to be too likely a prospect as neuronal infections 
are not likely to be clinically inapparent. However, brain tissues of 
raccoons and other wild mammals diagnosed as rabid by fluorescent 
antibody tests at the Iowa Veterinary Diagnostic Laboratory are being 
retained in frozen storage for future experimental inoculation by 
several routes into seronegative raccoons. The fur farm at which 18 
adult raccoons were sampled did not prove to be a source of such 
raccoons, and at this time funds are not available for a wider search 
for such raccoons. If an infectious agent, probably a virus, could be 
isolated from raccoons which would in turn immunize but not kill 
seronegative raccoons inoculated with it, this would indeed be a 
fortuitous discovery. 
The agent might not be rabies virus. It might be another 
infectious agent, perhaps a rhabdovirus which shares one or more 
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aucleoprotelns or perhaps major glycoproteins with rabies virus. It is 
not impossible such a rhabdovirus could be arthropod borne and there 
are prototype arthropod-bome rhabdoviruses* Tick or mite vectors 
would have to be studied along with mosquitoes. If such a nonvirulent 
virus could be recovered, it could have potential wildlife vaccine 
application. Indeed, it may be serving to an extent in this way in 
Iowa at this time. 
The agent could be rabies virus. It could be a naturally 
attenuated strain which is propagated in raccoons and perhaps other 
wild animals in Iowa while skunk ecotypes virus is killing skunks and 
other animals. Such a strain of rabies virus would be most valuable 
to study in the laboratory. The agent could be virulent rabies virus 
being transmitted through generally nonfatal portals of entry, perhaps 
to baby raccoons protected from lethal infection by maternal 
antibodies. If because of host or immune related mechanisms, the virus 
is localized in lyn^ h nodes, it could induce immunity rather than 
neurological infection in most raccoons. Inoculation of the same virus 
parenterally by bites or at very high doses could overwhelm defense 
mechanisms and cause clinical rabies. 
The finding of antibodies in the sera of raccoons from the closed 
confined population at the fur farm indicated that the eliciting agent 
can be present with no cases of clinical rabies or possible exposure to 
clinically rabid animals. 
There is more to the epidemiology of rabies than we realize. 
Perhaps Louis Pasteur would still feel right at home reading what we 
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know today about the epidemiology of this disease. 
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Sunmary 
À cotai of 285 wild animals were trapped in Cerro Gordo County 
during the spring and summer of the years 1982-85. The sex and weight 
of each species involved were determined at the time of trapping. 
Also, a blood sample was collected from each animal. The total sample 
includes 175 (61%) skunks (Mephitis mephitis). 77 (272) raccoons 
(Procyon lotor) and 33 animals of three other species (12%). The sera 
from all the blood samples were separated and titrated for the presence 
of antibodies against rabies virus (CVS-11) with rapid fluorescent 
focus inhibition test (RFFIT). This study was mainly targeted to 
investigate epidemiology and transmission cycle of rabies in skunks and 
raccoons. 
In the skunk serum collection, the positive rate (PR) was 30% in 
1982, decreased to 10% in 1983, and increased again to 16% in 1984 and 
to 22% in 1985. The spring PR (20%) was lower than the summer PR 
(26%). The male skunks showed a PR of 17% which was lower than the 
female PR of 27%. The PR of skunks in lower weight groups was 26%. 
With increase in weight, the PR decreased to 21% in the middle weight 
and to 18.6% in upper weight group. The total skunk sample showed a PR 
of 22%. 
In the raccoon serum collection, the overall PR was 28.6% but the 
yearly PRs showed wide variations. By seasons, spring samples showed 
a PR of 26% which increased to 33% in the summer samples. Male 
raccoons showed a lower PR, 16% compared to the female PR of 52%. The 
PR in the raccoons increased with the increase in body weight from 16% 
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in the lower weight group to 30% in the middle weight group to 36% in 
the upper weight group. The female raccoons also showed a higher PR 
than the male raccoons in the same weight groups. 
A number of positive sera were also detected in the other species 
in this study. Â further investigation was suggested to elucidate the 
chain of transmission of rabies virus in these wild animals. 
Introduction 
Wildlife rabies is the main cycle of rabies in the U.S. and other 
western world countries (Femandes and Arambulo, 1985; Kaplan and 
Koprowski, 1980). Human beings as well as domestic animals are 
infected each year directly or indirectly with rabies transmitted to 
them with bites of wild animals, and significant losses of livestock 
and pet animals have been attributed to rabies (Kaplan, 1985; Beran, 
1981; Acha and Szyfres, 1980). In the last five years, 1980-84, the 
percentage of all animal cases of rabies which were reported in 
wildlife in the U.S. 85%, 85%, 88%, 87%, and 92%, respectively (CDC, 
1985a,b; 1983). Skunks, bats, raccoons, and foxes were the major 
wildlife hosts in these years (CDC, 1985b; Pacer et al., 1985). 
Domestic animals including dogs, cats, cattle, horses, mules, sheep, 
goats, and swine have been victims of the sylvatic rabies cycle in the 
U.S. Human beings are Indirect victims of dogs or cats Infected by 
rabid wild animals (Baer, 1985; Kaplan and Koprowskl, 1980). 
In Iowa, skunks constitute the main wildlife hosts for rabies. 
Other wild animals which contract rabies have been reported frequently, 
including bats, raccoons, and foxes among others, but those have been 
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of minor importance in the maintenance of rabies endemnicity in Iowa 
(Pacer et al., 1985; Smith et al., 1984; Beran, 1981). In Iowa during 
the five-year period, 1980-84, skunks constituted 96%, 93%, 94%, 96%, 
and 91%, respectively, of the total confirmed rabies cases in wild 
animals, and 65%, 60%, 60%, 60%, and 60%, respectively, of the total 
reported rabies cases in Iowa (CDC, 1985a,b; 1983). Skunk ecotype 
rabies virus has been identified as the principal strain of rabies 
virus in Iowa wild and domestic animals (Smith et al., 1984). 
In this study, the importance of wild animals for the maintenance 
of rabies in Iowa was investigated to determine the cycle of disease 
and mode of transmission between and within species. 
Materials and Methods 
An-fnial g 
A total of 285 animal sera were collected from wild animals 
trapped at random locations in Cerro Gordo County, Iowa, by the Iowa 
State Conservation Commission. The trapping period was for a variable 
length of time during each of four-years in this study. Generally 
trapping extended between 10 and 20 weeks, between March 30th and 
August 30th in the years 1982-1985. Five species of wild animals were 
among the animals trappe.d, including skunks, raccoons, woodchucks, 
opossums, and foxes. The sex and weight of each am'mal were determined 
at the time of blood collection. No age determination was attempted on 
any animal. The sera were separated and stored at -20 "C. At the time 
of performing the test, the sera were heat inactivated at 56° C for 30 
min and kaolin treated to adsorb non-specific inhibitors. Four 
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preliminary dilutions were made from each sera (1:2, 1:4, 1:8, and 
1:16} to titrate for the presence of neutralizing antibodies against 
rabies virus in those sera* 
Virus and cell culture 
Challenge virus strain (CVS-11)^  strain of rabies virus was used. 
The optimal challenge dose was the highest dilution of virus that gave 
strong fluorescent staining in 80-100% of the cells in the monolayer 
after 48 hr; which was determined to be 25,000 fluorescent forming unit 
2 (FFU)/0«2 ml of virus suspension. The cell line was and the 
3 growth medium is Glasgow minimum essential medium (G^ ŒM) supplemented 
with 10% inactivated fetal calf serum (PCS) in the growth medium (GM), 
and with 2% PCS in the maintenance medium (MM). Sodium penicillin C 
(100 U/ml) and streptomycin (100 p,g/ml) were added to both GM and MM. 
The virus and serum dilutions were made with MM. Known positive and 
negative sera and were included as controls in each test. 
The antibody levels were determined by rapid fluorescent focus 
inhibition test (RFFIT) (Smith et al., 1973; Brown et al., 1984). 
R^abies virus from CDC, Atlanta, Georgia. 
2 BHKg^  cells originated from CDC and were supplied to our 
laboratory by Dr. T. Bunn, National Veterinary Services Laboratories, 
Ames, Iowa 50013. 
3 Glbco Laboratories, 3175 Staley Road, Grand Island, New York 
14072. 
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Results 
AnHmal data 
h 
Between March 30, 1982 and August 29, 1985, 285 sera from wild 
animals in Cerro Gordo County were collected by the Iowa Conservation 
Commission. Table 1 shows the number and ratio of the species 
involved in each year of the study. Total populations in the study 
include 285 animals, 61% skunks, 27% raccoons, 6.3% woodchucks, 3.86% 
opossums, and 1.4% red foxes as shown in Figure 1. The ages of 
animals in this study was not determined and only their sexes and 
weights were recorded. 
1. Skunks. One hundred seventy-five skunk sera were collected, 
constituting 61% of the total population as shown in Table 1. Table 2 
shows the monthly and yearly collection data, with 38% of the sera 
being collected in 1982, 17% in 1983, 22% in 1984, and 23% in 1985. 
See Figure 2a. On a cumulative monthly basis as shown in Figure 2b, 5% 
of the sera were collected in March, 27% in April, 25% in May, 21% in 
June, 14% in July, and 7% in August. There were 51% male and 49% 
female skunks in the collection. See Table 3 and Figure 2d. Table 4 
shows the sex and seasonal distribution of the sera. Relatively 
comparable numbers of skunks of both sexes were capturedin each season. 
Spring collections constituted 67% and summer collections 33% of the 
total as shown in Figure 2c. There were no fall collections in any of 
the four study years; the sixes of the spring and summer collections 
during the four years are presented in Figure 3. Three weight groups 
were used as shown in Table 5 and Figure 2e for skunk data. 
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Table 1. Numbers of wild animals trapped from each species in the 
four-year study in Cerro Gordo County 
Species Year 
Year Skunks Raccoons Opossums Woodchucks Red Foxes Total % 
1982 66 26 0 17 0 109 
1983 30 16 1 1 4 52 
1984 38 13 1 0 0 52 
1985 41 22 9 0 0 72 
Total 
for 
Species 
175 77 11 18 4 285 
Percent 
for 
Species 
61 27 3.86 6.3 1.4 
Figure 1. Percentage of wild animal species from the total 
sample collected from Cerro Gordo County in: (A) each year 
(1982-85); (B) each species Included: skunks (Sku), 
raccoons (Rac), woodchucks (W.Ch.), oppossums (Opp), and red 
foxes (R.F.) 
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Table 2. Numbers of skunk trapped during each month during each of 
the four years of the study 
Months 1982 1983 1984 1985 Total Percent 
March 5 —• — 4 9 5 
April 18 14 7 9 48 27 
May 9 7 17 11 44 25 
June 24 9 3 1 37 21 
July 10 — 7 7 24 14 
August — — 4 9 13 7 
Total for 
Year 66 30 38 41 175 
Percent 
for Year 38 17 22 23 
Table 3. Numbers of male and female skunks trapped during each of 
the four years of the study 
Year Sex 
Sex 1982 1983 1984 1985 Total Percent 
Male 32 14 23 20 89 51 
Female 34 16 15 21 86 49 
Total for 
Year 66 30 38 41 175 
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Table 4. Number of male and female skunks Crapped during each season 
during each of Che four years of Che study 
Spring Summer Year 
Year M F M F Total PercenC 
1982 24 18 8 16 66 38 
1983 12 14 2 2 30 17 
1984 14 11 9 4 38 22 
1985 12 12 8 9 41 23 
Total 
Sex/ 62/117 55/117 27/58 31/58 175 
Season 
Percent 53 47 47 53 
Percent for 
Season 67 33 
Figure 2. Percentages of the total of 175 trapped skunks are 
skunks trapped during: (a) each year (1982-85), (b) the 
cumulative months (March through August abbreviated by 
the first letter) of the four years (1982-85) trappings, 
(c) the cummulative spring (Sp) and summer (Su) 
trappings, (d) the male (M) and female (F) categories, 
and (e) each weight group, from the total number (175) 
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2. Raccoons. Seventy-seven raccoon sera were collected in this 
study period, constituting 27% of the total sera collected as shown in 
Table 1. Table 6 shows the monthly and yearly collections. Figures 4a 
and 4b show the percentages of yearly and cumulative monthly 
collection. As shown in Table 7, 69% of the collections were from the 
spring and 31% were from the summer as shown in Figure 4c. There were 
no sera collected in any fall of the years in this study. The rates of 
the spring and summer collections are presented in Figure 5. Males 
constituted 72% of the spring collection, but both sexes were equal in 
the summer collection with 50% each. See Table 7. Male raccoons 
constituted 65% of the total raccoon sample with females constituting 
35%. See Figure 4d and Table 8. Table 9 shows the weight and sex 
distribution. Sixteen percent of the raccoons weighed less than 2000 
gm., with twice as many males as females in this weight group. Males 
and females were similar in numbers in the medium weight groups, but 
again male dominated the heavy weight group by 84%. 
3. Other animals. Three other species were also included in this 
study, constituting 12% of the total samples. The sera collected form 
those animal on a separate occasion and not on z. regular time. - Table 
10 shows the numbers, sexes, and times of collection of woodchucks, 
opossums, and foxes as well as their percentages of the total samples. 
The species percentages were shown in Figure lb. 
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Table 5. Numbers of male and female skunks in each weight group 
Sex Weight Group 
Weight (gm) M F Total Percent 
< 1500 25 28 53 30 
1500-2000 11 41 52 30 
> 2000 53 17 70 40 
Total 89 86 175 
Table 6. Numbers 
year of 
of raccoons trapped during each month during each 
the study 
Year Cumulative Months 
Month" 1982 1983 1984 1985 Total Percent 
March 1 0 0 3 4 5 
April 9 4 7 2 22 28.6 
May 2 1 4 11 18 23.4 
June 9 10 2 0 21 27 
July 3 1 0 6 10 13 
August 2 0 0 0 2 2 
Total for 
the year 26 16 13 22 77 
Percent for 
year 34 21 17 28 
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Table 7. Numbers of male and female raccoons trapped during each season 
season of the four years study 
Spring Summer Year 
Year M F M F Total Percent 
1982 10 7 2 7 26 34 
1983 6 2 6 2 16 21 
1984 9 3 1 - 13 17 
1985 13 3 3 3 22 28 
Total 
sex/ 
season 
38/53 15/53 12/24 12/24 77 
Percent 
sex/ 
season 
72 28 50 50 
Percent 
season 
for 
69 31 
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Table 8. Numbers of male and female raccoons trapped during each of 
the four years of the study 
Year Sex 
Sex 1982 1983 1984 1985 Total Percent 
Male 12 12 10 16 ' 50 65 
Female 14 4 3 6 27 35 
Total 
of 
Year 26 16 13 22 77 
Percent 
of year 34 21 17 28 
Table 9. Numbers of male and female raccoons in each weight group 
Sex Weight 
Weight (gm.) 
Class • 
M F Total Percent 
_< 2000 8 4 12 16.0 
2100-4000 4 3 7 9.0 
4100-6000 17 16 33 43.0 
2 6100 21 4 25 32.0 
Total 50 27 77 
Percent 65 35 
Figure 5. Percentages of raccoons trapped each spring (Sp) and 
summer (Su) season during the four years of the study, 
and percentages of the cumulative seasons of the four 
years from the total (77) 
191 
90-
80-
70-
c 60-
O 
9 
3 50-Q. 
1 40-
O 30-
20-
10-
OL 
. CM 
CO 
8 
8 : 
N 
<D 
8 
CO 
CM 
M CM 
Sp Su Sp Su Sp Su Sp Su 
1982 1983 1984 1985 
Raccoon population 
N 
N 
CO 
LA 
N 
N 
S 
Sp Su 
Cumulative 
seasons 
192 
Table 10. Numbers of males and females trapped among three wild 
animal species during each of the four years of the study 
Opossums Woodchucks Red Foxes Year 
Year M F M F MF Total Percent 
1982 0 0 5 12 0 0 17 51.5 
1983 1 0 0 1 3 1 6 18.2 
1984 1 0 0 0 0 0 1 3.0 
1985 3 6 0 0 0 0 9 27.3 
Total for 
sex 5 6 5 13 3 1 33 
Percent 
for sex 45 55 28 72 72 25 
193 
Serological observations 
The criteria for determining positive rates (PR) in serum sets 
have been described in Section II above. The number of sera from each 
species with their PRs varied among the species as well as within 
subgroups in the same species. 
1. Skunks. Thirty-eight skunk sera were positive giving this 
species a PR of 22%. Table 11 shows the monthly and yearly PRs. In 
1982, the PR was 30%, decreased to 10% in 1983 and increased gradually 
to 16% in 1984 and to 22% in 1985 as shown in Figure 6a. Figure 6b 
shows the PRs in cumulative months. Sixty percent (23/38) of the 
positive skunks were females and 40% (15/38) were males; the female and 
male PRs were 27% and 17%, respectively, as shown in Table 12 and 
Figure 6d. Â comparison between the male and female PRs on seasonal 
bases (Figure 7), and weight group bases (Figure 8), shows that the 
females consistently had higher PRs. The seasonal PRs were higher in 
summer with 26% positive than in spring with 20% positive, as shown in 
Table 13 and Figure 6c. The PRs in skunks by weight groups are 
presented in Table 14 and Figure 6e. 
2. Raccoons. Twenty-two raccoon sera collected in Cerro Gordo County 
were position, giving the raccoon sample an overall PR of 28.6%, but 
with a high level of variability among the months and years as shown in 
Table 15. The highest PR, in 1982 of 61% was followed by a PR of 0% in 
1983, of 15% in 1984 and of 18% in 1985. See Figure 8a. The monthly 
cumulative PRs are shown in Table 15 and Figure 8b. On a seasonal 
basis, the spring PR of 26% increased to 33% in the sera collected in 
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Table 11. Numbers of positive skunk sera detected by RFFIT from each 
month sera collections during each of the four years of the 
study 
Year Cumulative month 
Month 1982 1983 1984 1985 Total Percent 
March 2/5 0/0 0/0 2/4 4/9 44% 
April 4/18 0/14 2/7 1/9 7/48 15% 
May 1/9 2/7 4/17 0/11 7/44 16% 
June 9/24 1/9 0/3 1/1 11/37 30% 
July 4/10 0/0 0/7 3/7 7/24 29% 
August 0/0 0/0 0/4 2/9 2/13 15% 
Total for 
Year 20/66 3/30 6/38 9/41 38/175 22% 
PR for 
Year 30 10 16 22 
Figure 6. Percentages of positive skunk sera detected by RFFIT from the 
collections of (a) each year (1982-85), (b) the cumulative 
months (March through August abbreviated by the first letter) 
of the four years, (c) the cumulative spring (Sp) and summer 
(Su) seasons, (d) the total male and female skunks, and (e) 
totals in each weight class 
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Table 12. Numbers of positive sera from male and female skunks 
detected by RFFIT during the four years of the study 
Year Sex 
Sex 1982 1983 1984 1985 Total Percent 
Male 7/32 2/14 2/23 4/20 15/89 17 
Female 13/34 1/16 4/15 5/21 23/86 27 
Total for 
Year 20/66 3/30 6/38 9/41 38/175 22 
PR for 
Year 30 10 16 22 
Table 13. Numbers of positive sera from male and female skunks 
detected RFFIT from each spring and summer season 
collection during the four years of the study 
Spring Summer Year 
Year M F M F Total Percent 
1982 2/24 7/18 3/8 6/16 20/66 30 
1983 2/12 1/114 0/2 0/2 3/30 10 
1984 2/14 4/11 0/9 0/4 6/38 16 
1985 1/12 2/12 3/8 3/9 9/41 22 
Total 9/62 14/55 6/27 9/31 
PR for Sex 14.5 25 22 29 
PR for 
Season 20% 25% 
Figure 7. Percentages of positive sera from skunks detected by RFFIT from 
the total collections of (a) the spring (Sp) and summer (Su) 
seasons of the four years (1982-85), and for each sex (b and c) 
during the same seasons 
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Table 14. Numbers of positive sera detected by RFFIT from male and 
female skunks in each weight group 
Sex Weight 
Weight (gm) M F Total PR 
< 1500 5/25 9/28 14/53 26 
1500-2000 2/11 9/41 11/52 21 
2 2050 8/52 5/17 13/70 18.6 
Total for sex 15/89 23/86 38/175 21.7 
Sex PR 17 26.7 
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Table 15* Numbers of positive sera detected by RFFIT from raccoons 
from each month's collection during each of the four years 
of the study 
Year Cumulative month 
Month 1982 1983 1984 1985 Total Percent 
March 0/1 0/0 0/0 0/3 0/4 0 
April 7/9 0/4 2/8 1/2 10/22 45 
May 0/2 0/1 0/4 1/11 1/18 6 
June 7/9 0/10 0/2 0/0 7/21 33 
July 2/3 0/1 0/0 2/6 4/10 40 
August 0/2 0/0 0/0/ 0/0 0/2 0 
Total for 
Year 16/26 0/16 2/13 4/22 22/77 28.6 
PR for 
Year 61 0 15 18 
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summer. See Table 16 and Figure 8c. Female dominated in the number of 
positive sera compared to male with 14 positive sera from females and 8 
from males. The female raccoons also had a higher PR of 52% compared 
to 16% in the males. See Table 17 and Figure 8d. Comparisons between 
the PRs of the male and female raccoons on seasonal and weight group 
bases are presented in Figures 9 and 10, respectively. The PRs of the 
weight groups are presented in Table 18 and Figure 8e. 
3. Other wild animals. There were many sera from the species other 
than skunks and raccoons which were positive for rabies neutralizing 
antibodies, with marked differences in PRs among the different species 
as seen in Table 14. Opossums showed an overall PR of 18%, woodchucks 
39%, and red foxes of 0%. The small numbers from these species and the 
short periods during which they were trapped did not make it possible 
to monitor seasonal, weight, or sex differences in PRs. 
Discussion 
Five species of wild animals were included in the total collection 
from Cerro Gordo County. The sera from the five species provided 
evidence about the prevalence of antibodies neutralizing rabies virus 
in the sera of these wild animals. 
The skunk population, which constituted 61% of the total, showed a 
cumulative PR of 22%. With only two male and seven females collected, 
the PR for March was 44%. In April, with 48 sera, the PR declined to 
15%, with the exception of March, in which total serum collections were 
very small, the PR showed a gradual increase from April at 15% through 
June at 30%, and July at 29%, than a decrease in August back to 15%. 
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Table 16. Numbers of positive sera from male and female raccoons 
detected by RFFIT from each spring and summer collection 
during each of the four years of the study 
Season Spring Summer Year 
Yiear M F M F Total PR 
1982 5/10 5/7 0/2 6/7 16/26 61.5 
1983 0/6 0/2 0/6 0/2 0/16 0 
1984 1/9 1/3 0/1 — 2/13 15.4 
1985 2/13 0/3 0/3 2/3 4/22 18/2 
Total 9/38 6/15 0/12 8/12 22/77 28.6 
PR for 
Sex 21 40 0 67 
PR for 
Season 26 33 
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Table 17. Numbers of positive sera from male and female raccoons 
detected by RFFII from each of the four years of the study 
Year Sex 
Sex 1982 1983 1984 1985 Total Percent 
Male 5/12 0/12 1/10 2/16 8/50 16 
Female 11/14 0/4 1/3 2/6 14/27 52 
Total for 
Year 16/26 0/16 2/13 4/22 22/77 28.6 
PR for 
Year 61 0 15 18 
Figure 9. Percentages of positive sera detected by REFIT from total 
raccoon serum collections in: (a) each of the four years 
(1982-85); (b) the months (March through August abbreviated by 
the first letter) of the four years; (c) the spring (Sp) and 
summer (Su) seasons of the four years; (d) the male and female 
categories; and (e) the designated weight groups 
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Table 18. Numbers of positive sera from male and female raccoons 
detected by REFIT in each weight group 
Sex Weight 
Weight (gm) M F Total PR 
< 2000 0/8 2/4 2/12 17 
2100-4000 0/4 1/3 1/7 14 
4100-6000 2/17 8/16 10/33 30 
> 6000 6/21 3/4 9/25 36 
Total for 
Sex 8/50 14/27 22/77 28.6 
PR for sex 16 51.8 
Table 19. Numbers of positive sera from male and female animals of 
three wild animal species detected by RFFIT 
Sex Species 
Animal Species M F Total PR 
Opossums 1/5 1/6 2/11 18 
Woodchucks 2/5 5/13 7/18 39 
Red Foxes 0/3 . 0/1 0/4 0 
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This was also true when seasonal PRs were analyzed. The spring PR of 
20% increased to 26% in the summer. This gradual increase in PR toward 
the summer indicated that exposures probably increased during the 
breeding season in late February and March, at which time greater 
intraspecific contacts occurred. Females showed a higher PR at 27% 
positive than did males at 17% positive. On weight bases, juvenile 
skunks less than 1100 gm. had the higher PRs at 28%, while the lowest 
PRs were recorded in skunks 2050 gm. and heavier at 21.7%. In the 
medium weight group, female skunks dominated with PR of 25% compared to 
9% in the males. In the heavier weight group, males dominated the 
number of samples with 87% and the male PR also increased to 28% 
compared to 25% for the females. 
The number of raccoon sera collected in different months during 
the four years of this study was too small to support detailed 
comparisons in PRs by months. A seasonal examination of the PRs 
indicated that the PR in the spring samples of 26% increased to 33% in 
the summer samples. Females dominated in the number of samples, 
constituting 64% of the total, and also in PRs at 52% while male PRs 
were 16%. This seasonal increase in PR in the raccoon samples in the 
summer corresponds to the increase observed in skunk PRs. On the 
basis of the four weight groups, the PRs correlated positively (r = 
0.78) with increased body weight in the raccoons. The PRs increased 
from 17% in the lowest weight group 2000 gm.) to 36% in the heaviest 
weight group (>^ 6100 gm.), compared to the negative correlation (r = -
0.57) of PR with weight in the skunk samples. 
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Serum collections from wild animals in Cerro Gordo County were 
actually begun in 1982 as part of ecological studies by the Iowa 
Conservation Commission. Because raccoon sera collected in this study 
were from another part of Iowa and because skunks and a smaller number 
of other fur bearing animals were also being captured, serological 
studies on sera from these animals have been incorporated into 
comparative studies with those collected form raccoons in Guthrie 
County as detailed in Section II. 
Between 1982 and 1985, a total of 175 adult skunks were captured 
and bled in Cerro Gordo County during spring and sunmer each year. 
Neutralizing antibodies were found in these skunks at prevalences very 
comparable to those recorded in the raccoons trapped in Guthrie County, 
the overall prevalence being 22% serapositive. Since most skunks 
sampled in Cerro Gordo County were adults, most were alive at least the 
year before. The seroprevalence of antibodies by years was highest at 
30% in 1982 following the year of highest reported rabies in animals 
(principally skunks) in Iowa. 
By seasons, the prevalence of antibodies was higher in summer than 
in spring, juveniles not being tested. There seemed to be some 
evidence that prevalence of antibodies was higher in female than in 
male raccoons and in smaller rather than in larger and thus older 
skunks. .These sex and age findings may have been more apparent than 
real. Following the high antibody prevalence year, 1982, the 
prevalence dropped drastically in the following year. Apparently the 
skunks born in 1982 had a low occurrence of exposure and developed only 
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a low prevalence of antibodies (10%). Although the seroprevalence has 
been slowly rising since 1983, it appears that the high prevalence in 
adults in 1982 has not been maintained in the younger adults which have 
followed. 
Raccoons in Cerro Gordo County showed an even higher prevalence of 
antibodies in 1982 (62%) than was recorded in skunks in the county. 
Again, as was observed in the skunks, the seroprevalence crashed in 
1983 (to 0%) and has been slowly rising since. As was noted for 
skunks, only adult raccoons were collected in this study and 
seroprevalence generally rose from spring to summer each year. Unlike 
the findings in skunks, the seroprevalence generally increased with 
increasing weight and thus age. Seropositive females outnumbered 
seropositive males at a ratio of 3.2:1. Because the sample size of 
raccoons was only 77 in Cerro Gordo County, it was difficult to compare 
findings meaningfully with those from Guthrie County with a sample 
population 6.2 times larger. 
Among other animals sampled in Cerro Gordo County, rabies virus 
was neutralized by sera of 18% of 11 opossums, 38% of 18 woodchucks 
and none of 4 red foxes. It is interesting to note that included in 
these findings are opossums which are essentially refractory to field 
exposure to rabies, woodchucks which are the most frequently diagnosed 
as rabid of all rodents and foxes which are the most susceptible of all 
animals to rabies. 
The skunks collected in Cerro Gordo County(22% positive), the 
raccoons collected in Cerro Gordo County (29% positive) and the 
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raccoons collected in Guthrie County (18% positive) all showed 
serological evidence of infection with an agent that elicits 
antibodies which neutralize rabies virus. The findings of such 
antibodies in this second species (striped skunks) was pertinent. Few 
leads were found as bases for new epidemiological hypotheses except for 
the high seroprevalences in both skunks and raccoons which had been 
alive during the 1981 peak year in reported rabies in Iowa. It is 
pertinent to note the practical buildup which has been occurring in 
both skunks and raccoons in seroprevalence rats since the low 
prevalence recorded in 1983. It will be valuable to note whether the 
next peak in clinical cases in animals in Iowa will be accompanied or 
preceded by notable rises in prevalence of antibodies in skunks and 
possibly in raccoons, and thus possibly that the rise over the past 
three years after the 1983 crash predicts a forthcoming rise also in 
the incidence of clinical rabies. 
The serum samples collected from opossums, woodchucks, and foxes 
in Cerro Gordo County have so far been too low in number to provide 
instructive findings. It is pertinent, however, to note that 
neutralization of rabies virus by sera from opossums and woodchucks 
collected in Cerro Gordo County was recorded. Positive sera from these 
animals were not tested to determine whether the neutrallzating 
substances were antibodies. 
While the Cerro Gordo County study has provided evidence that the 
presence of neutralizing substances in sera of small ferrai mammals is 
more widespread than could be discussed from the single species sampled 
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in Guthrie County, it has not provided the basis for concluding whether 
the infecting agent (perhaps agents) is or is not rabies. The findings 
from samples collected in 1982 in Cerro Gordo County have indicated 
that during the 1982 peak in recorded animal rabies in Iowa, many 
skunks and raccoons in Iowa experienced nonlethal rabies virus 
infection, either stimulating primary Immunity or boosting heterologous 
titers* 
Much more elucidation of the epidemiology of rabies in wild 
animals in Iowa remains to be carried out. 
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Abstract 
Three chemotherapeutlc drugs were tested for activity to control 
and/or inhibit rabies virus (CVS) infection and/or replication in 
cell cultures. The rapid focus fluorescent inhibition test 
(KFTIT) was used to detect the level of viral infection of the cells. 
Against 10-20 TCID^q of CVS, Amantadine HCL (Am) at 0.03-0.06 mg/ml had 
more than 70% effectivity in inhibition of CVS when added within the 
first 8 hours post infection (PI); complete virus inhibition was 
attained when a concentration of 0.12-0.5 mg/ml was added. After 8-10 
hours. Am required progressively higher levels to produce inhibition. 
At 24 hours PI, only 10-20% inhibition was produced at 0.03-0.06 mg/ml, 
but more than 95% inhibition was maintained at 0.5-1.0 mg/ml. Rifampin 
(Rf) produced 70% inhibition at 0.03 mg/ml, more than 85% at 0.06 mg/ml 
and 95% to 100% at 0.12-0.5 mg/ml when used within the first 8 hours 
PI. After 8-10 hours PI, Rf showed similar activity to Am. Ribavirine 
(Rb) completely inhibited viral replication when used within 8 hours PI 
at concentrations of 0.03 mg/ml or higher. At lower concentrations of 
0.002, 0.004, 0.008, and 0.016 mg/ml, Rb produced inhibition levels of 
40%, 60%, 90%, and 95%, respectively when used within 4-8 hours PI. 
AM and Rf at 0.5-1.0 mg/ml showed inhibitory activity against cell 
division which was reversible when the drugs were removed. Rb did not 
show any cellular inhibition even when used at 4.0 mg/ml. No 
synergistic action existed between Am and Rb or Rf and Rb or Am and Rf. 
The three drugs were found in this study not to inhibit rabies 
virus adsorption or penetration. The mechanism of their action, as 
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evidenced from this study, is either inhibition of uncoatlng or of 
primary viral protein synthesis. The three drugs showed promising 
activity In cell culture for inhibiting rabies virus without 
irreversible damage to the host cells. An ^  vivo study is planned to 
evaluate their protective activities in laboratory animals 
experimentally inoculated with rabies virus. 
Introduction 
Rabies is a life-threatening zoonotic disease and an occupational 
health hazard (Paterson, 1986; Donham, 1985; Fischer-Hoch and Simpson, 
1985; Diesch et al., 1982; Martin et al., 1982; Beran, 1981). The 
post-exposure regimens of prophylactic treatment for rabies, using 
vaccines and hyperimmune sera or globulins have been effective in 
saving thousands of human lives throughout the world each year 
(Paterson, 1986; Postic and Wlktor, 1986b; Ajjan et al., 1985; Warrell 
et al., 1985; WHO, 1983; Beran, 1981). However, with this treatment 
many drawbacks have been reported, including both vaccine failures and 
mild to severe, even fatal side effects as well as medical difficulties 
in follow-up to complete vaccine regimens and medical costs In 
developing countries (Dreesen et al., 1986; Paterson, 1986; Ajjan et 
al., 1985; Fischer-Hoch and Simpson, 1985; Fomosi et al., 1985; 
Devriendt et al., 1982; Finlayson, 1982). The use of antiglobulins 
must be carefully balanced with administration of vaccines to provide 
immediate immune ptorection without masking the antigen and decreasing 
the value of the vactines, resulting in a low level of seroconversion 
(Dreesen et al., 1986; Fischer-Hoch and Simpson, 1985; Fornosl et al.. 
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1985; Dulbecco, 1980b; Doaham, 1985; Flnlayson, 1982; Dulbecco, 1980b). 
Rabies vims has shown minor antigenic variation (Warrell et al., 1985; 
Beran, 1981; Dulbecco, 1980a). Vaccines prepared of canine ecotype 
strains have shown less protective potency when the invading ecotypes 
of virus are heterologous, especially when of bat origin (Paterson, 
1986; Postic and Wiktor, 1986a; Fischer-Hoch and Simpson, 1985; Foronsi 
et al., 1985). 
Molecular biology has advanced in recent years in scientific 
approaches in the search for antiviral chemotherapeutic agents (AVCA). 
ÂVCÀ'S would have the advantages of immediate action required in 
treating people exposed to rabies. They could act protectively in the 
presence or absence of specific immunity (Braude, 1986; Gifford, 1982) 
and without interference with the development of the specific immunity 
and with hopefully with minimal side-effects (Webster et al., 1985; 
Canonico et al., 1984a,b; Voris et al., 1984; Jolley and Hinshaw, 
1980). If an AVCA may be targeted to selectively inhibit a viral gene 
expression and interfere with virus virulence or inhibit virus 
replication (Eisenstein and Engleberg, 1986; Benavente et al., 1984; 
Dulbecco, 1980b), it could hopefully have application in rabies, either 
in preventing development of the disease in exposed persons or animals 
or in treatment of the clnical disease. 
Amantadine hydrochloride activity against influenza viruses and 
other RNA viruses has been investigated and its therapeutic value well 
documented. It was licensed by FDA, in the U.S. and approved and 
recommended by WHO for use in respiratory viral illnesses (Douglas, Jr. 
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1986; Galbralth, 1985; WHO, 1985, 1983; Douglas Jr., 1984; Gifford, 
1982). It has been postulated that Am blocks uncoating of viruses by 
increasing the pH in lysosomes preventing the pH 5-mediated fusion with 
viral envelopes (Dulbecco, 1980b). Evidence has also been reported 
(Braude, 1986; Gifford, 1982) that has indicated that blockage occurs 
after uncoating, possibly inhibiting primary transcription of RNA. The 
recommended dose of Am is 2.5-4 mg/Kg (approximately 200-300 mg) daily. 
It may be accompanied with mild reversible dose-dependent side-effects 
such as nervousness, insomnia, depression, confusion, and drowsiness 
(Douglas Jr., 1986; Hayden et al., 1986; Galbraith, 1985; Voris et al., 
1984; Gifford, 1982). 
Ribavirin is a nucleoside analogue with wide spectrum ^  vitro and 
in vivo antiviral activity (Allen, 1980; Sidwell, 198). Rf competively 
inhibits IMP dehydrogenase as well as mRNA guanylyl transferase, the 
enzyme responsible for the addition of the 7-methyl guanocin cap to 5'-
terminus of viral mRNA (Braude, 1986; Hayden et al., 1986; Huggins et 
al., 1986). Infection with influenza virus, parainfluenza viruses, 
viral hepatitis viruses, herpesviruses Lassa Fever, and Machupo 
arenaviruses, the bunyavirus of Rift Valley fever, respiratory 
syncytial virus and hantaan virus are inhibited or controlled by Rb 
(Douglas, 1986; Huggins et al., 1986; Galbraith, 1985; Murphy and 
Webster, 1985; Webster et al., 1985; Hall, 1984; Knight, 1984). 
Treatment with Rb may be accompanied by reversible dose—related 
normochromic, normocytic anaemia; increased reticulocyte numbers and 
elevated serum bilirubin in 25% of the recipients following a daily 
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dosage of 15-60 mg/Kg, with possible teratogenic effects at higher 
doses being reported (Hayden et al., 1986; Huggins et al., 1986; 
Canonlco et al., 1984a,b; Hall, 1984; Gifford, 1982; Allen, 1980). 
Minimal side effects of ribavirin on the immune system and 
immunosuppression also been reported (Hayden et al., 1986; Jolley and 
Hlnshaw, 1980). 
Rlfamycin, from the ansamyclns family of antibiotics (Antosz, 
1982), has been reported to show antiviral activity (Antosz, 1982; 
Smith and Gallo, 1974) by inhibiting reverse transcriptase through 
enzyme binding. This binding to the B-unlt of KNA-polymerase results 
in the formation of complexes that inhibit the initiation step of SNA 
synthesis (Braude, 1986; Antosz, 1982). Inhibition of the assembly of 
poxvirus particles has also reported (Follett and Pennington, 1973). 
Rf may also induce hepatotoxlclty and immunosuppression by impairing 
nucleic acid synthesis (Braude, 1986; Carruthers, 1986; Antosz, 1982). 
Rabies is caused by a non-segmented single strand RNA virus, with 
negative polarity, carrying its own reverse transcriptase and 
replicating in the cytoplasm of Infected cells (Melnick, 1986; Postic 
and Wiktor, 1986a; Dulbecco, 1980a). The replication cycle is the same 
as in other rhabdoviruses, (Melnick, 1986; Delbecco, 1980) using its 
own reverse transcriptase to induce the formation of a positive copy 
(mRNA) that will be translated by cellular RNA polymerase to form the 
viral protein by the rlbosomes (Melnick, 1986; Postic and Wiktor, 1986a; 
Dulbecco, 1980a). 
This study was designed to evaluate the activity of these 
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chemotherapeutic agents against rabies virus in cell cultures as a very 
preliminary evaluation for possible use in the prophylactic treatment 
of persons exposed to rabies or in the therapy of patients with 
clinical rabies* 
Materials and Methods 
Virus, cells, and media 
Challenge virus strain CVS-11^ of rabies virus was used in this 
2 
study* The virus was propagated In cloan using Glasgow 
3 Minimum Essential Medium (G-MEM) enriched with 2% bovine serum albumin 
(BSA), 100 U/ml penicillin and 100 Ug/ml streptomycin. At 80% 
3 
confluence, monolayers of cells in 150 cm cell culture flasks 
were inoculated with 5 ml each of of virus tltering 10 TCID^q and 
incubated for 90 min at 37° C with 5% COg. The inoculum was removed 
after one hour, the cells were rinsed once with 10 ml of G-MEM, and 
then were covered with 50 ml G-MEM and incubated for 96 hours under the 
same conditions. The contents of the flasks were frozen and thawed 
twice and then centrifuged in conical centrifuge tubes at 650 x g for 
^Rabies virus, originating from CDC, and borrowed from Dr. P. 
Gough, Veterinary Medical Research Institute (VMRI), Ames, Iowa 50011. 
2 
clone S.^s cells originating from CDC and supplied to 
this laboratory by Dr. T. Bunn, National Veterinary Services 
Laboratories, Ames, Iowa 50013. 
3 
G-MEM; Gibco Laboratories, 3175 Staley Road, Grand Island, New 
York 14072 (Cat. No. 410-2200). 
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20 min to remove cellular materials* The supernatant fluids were 
dispensed in 0.4-1.0 ml aliquots in small vials and stored at -80* C. 
The virus titer of this stock preparation was examined and found to be 
1 X 107'48, 
Chemotherapeutic drugs 
Amantadine hydrochloride; Symmetrel® capsules contain 100 mg of Am 
as in a pasty thick white material. Rifamycin, rifampin, Rifadin® is 
an orange-red powder in capsules of 300 mg Rf each. Ribarin; Virazol® 
is a white powder. 
Stock solutions were prepared from each of these antiviral drugs 
at the time of each experiment, preparing 10 mg/ml solutions in 
distilled water. The working solutions of 2, 1, 0.5, 0.25, 0.125, 
0.062, 0.031, 0.015, and 0.007 mg/ml were then made from the stock 
solution using G-MEM^ as diluent. The final concentrations of these 
chemotherapeutics were the results of mixing equal quantities of the 
virus suspensions and the chemotherapeutic drug working solutions. 
Drug toxicity and applicability range 
The toxicity of each drug was evaluated in the laboratory on two 
bases; 
1. The cells doubling time; the time required for the cells to 
double in number compared to the control untreated cells 
at 24 and 48 hours. 
2. The microscopic morphological characteristics of the cells. 
At the time of each experiment the cell sheets were 50% confluent. 
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The cell monolayers were Inoculated with the test drug dilutions in 8 
well cell culture slides, using two wells per dilution. The control 
wells were inoculated with fresh media at the time of drug inoculation. 
The cells were studied under the microscope after 24 and 48 hours. 
After 48 hours post Inoculation (PI), the cell sheets were fixed with 
acetone and comparisons made between the virus infected drug treated 
and the uninfected untreated cell sheets. 
The drug applicability range was considered to be between its 
lowest viral inhibitory concentration and the highest concentration not 
toxic to the cell cultures. Two-fold serial dilutions were made below 
toxic concentration of each drug. These serial dilutions were tested 
against a 10 TCID^q of rabies virus. The lowest inhibitory 
concentration of each drug was the concentration at which at least a 
50% inhibition of the virus infection was detected. Drugs with a wide 
range of inhibitory concentrations below the toxic level were 
considered to be most promising for further study. 
Determination of the potential effectivity of the drugs 
Evidences of the potential effectivity were provided by the 
following: 
1. Pretreatment of cell cultures with different drug dilutions 
one hour before the time of virus inoculation. 
2. Mixing the virus 1:2 with the drug concentration and 
inoculating the cell monolayers with the mixture. 
3. Treatment of the cell cultures with the test drug concen­
trations at 1, 2, 4, 6, 8, 10, 12, 24, and 36 hours PI. 
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4. Stopping action of the test drugs at 3, 6, 12, 18, 24, and 36 
hours PI. 
Results 
Drug toad-city and potential effectlvlty 
i; Amantadine hydrochloride was toxic to cell cultures at 
concentration of U.5 mg/ml and 1.0 mg/ml. At these concentrations, 25% 
and 50% levels of toxicity were recorded. See Figure la. There was 5% 
toxicity to the cells at a concentration of 0.24 mg/ml, 2% toxicity at 
0.120 mg/ml, and 1% at 0.060 mg/ml Am. Am inhibited virus specific 
fluorescence by 60% at 0.03 mg/ml, 80% at 0.060 mg/ml, 90% at 0.120 
mg/ml, 98% at 0.24 mg/ml and 100% at 0.480 mg/ml concentration of Am. 
See Figure la. At concentrations lower than 0.03 mg/ml. Am showed 
inhibition levels of 25% at 0.016 mg/ml, 10% at 0.008 mg/ml, 5% at 
0.004 mg/ml and had no effective inhibitory action below this 
concentration. 
2. Rifampin was more toxic to cell cultures than Am. Rf had shown 
at 0.5 mg/ml and 1.0 mg/ml concentrations, toxicity levels to cell 
cultures of 50% and 75%, respectively. At 0.24 mg/ml Rf, there was 
still 20% toxicity and at lower concentrations, the levels of toxicity 
were 3% at 0.120 mg/ml and 1% at 0.060 mg/ml. See Figure lb. 
Inhibition of virus specific fluorescence was lower than for Am 
producing only 15% inhibition at a concentration of 0.030 mg/ml, 30% at 
0.060 mg/ml, 60% at 0.120 mg/ml, 95% at 0.24 mg/ml and 100% inhibition 
at 0.48 mg/ml, at which level the cell toxicity was 50%. Rf inhibition 
Figure 1. Levels of viral inhibition and cell culture toxicity. 
a) Amantadine HCL(_._) viral inhibition, ( . ) cell 
toxicity, b) Rifampin ( ) viral inhibition, ( . ) 
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of virus fluorescence was only 5% at 0.016 mg/ml, 1% at 0.008 mg/ml and 
there was no effective inhibition below this concentration. (See 
Figure 2a.) 
3. Ribavirin showed no toxicity to cell cultures at any level 
tested in this study. Rb was found to be more effective than either Am 
or Rf in inhibiting virus-specific fluorescence. In Figure 2, the 
three drugs were compared for their inhibitory activity at all the 
concentrations tested. Rb at concentrations of 0.002, 0.004, 0.008, 
and 0.016 mg/ml showed inhibitory activities of 40%, 60%, 90%, and 95%, 
respepctively, against rabies virus. A 100% inhibition was shown at 
0.030 mg/ml Rb, while at this same concentration only 60% inhibition 
was shown by Am, and 15% by Rf (Figure 2a). Figure 2b continues Figure 
2a with higher concentrations of the three drugs. 
Potential effectivity of the drugs 
The potentials for inhibitory effectivity against rabies 
infections was determined according to steps described In the methods 
section and presented In Figures 3—6. 
1. Amantadine HCL; six concentrations of Am were tested, from 
0.030 mg/ml through 1.0 mg/ml as shown in Figure 3. All the 
concentrations maintained the same levels of activity when added to 
cell cultures before, with or up to 8 hours PI. When Am was added 8 to 
10 hours PI, Am in all the concentrations other than 1 mg/ml showed 
proportional loss of activity. After 12 hours PI, Am showed an 
inhibitory activity of 30% at 0.030 mg/ml, 60% at 0.060 mg/ml, 80% at 
0.120 mg/ml, 95% of 0.24 mg/ml, 98% at 0.5 mg/ml and still 100% at 
Figure 2. Comparison of the activity of I, Rb, ribavirin-, II, Am, 
amantadine HCl; and III, Rf, rifampin in inhibiting rabies 
virus at all the concentration tested in (a) from 0.002 mg/ml 
to 0.060 mg/ml and in (b) from 0.060 mg/ml to 1.020 mg/ml 
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Figure 3. Effects of treatment with 6 concentrations of amantadine HCl 
on rabies virus in cell culture. The concentrations were: 
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rabies virus In cell culture. The concentrations were: 
0.03 mg/ml 
0.06 mg/ml 
— ' — 0.12 mg/ml 
0.24 mg/ml 
0.5 mg/ml 
1.0 mg/ml 
100 
90 
80 
c 70 
.2 
i 60 JC 
.E 50 
2 
'> 40 
o 
J 30 
o 
_J 20 
10 
0 
'-O. _ -
-o -
—  O — O "  
~~o 
I • ' ' • ' 
- 1 0  1 2  4  
• • • ' ' « ' ' ' ' ' ' 
I I I I I I I I I I I I I I I I I I I ? 
8 12 16 20 24 
Time of treatment (hours) 
Rifampin 
28 32 36 
5 
\C 
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rabies virus In cell culture. The concentrations were: 
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1 mg/ml. After 24 hours PI, Am Inhibitory activity was 10% at 0.030 
mg/ml, 20% at 0.060 mg/ml, 60% at 0.120 mg/ml, and 90% at 0.24 mg/lm. 
The same level of inhibitory activity was shown at 24 as at 12 hours PI 
at 0.5 mg/ml and 1.0 mg/ml, at 98% and 100%, respectively. Treatment 
initiated after 36 hours showed virus inhibitory levels of 5% at 0.030 
mg/ml, 10% at 0.060 mg/ml 20% at 0.120 mg/ml, 40% at 0.240 mg/ml, 60% 
at 0.50 mg/ml and 80% at 1.0 mg/ml. At 48 hours PI, inhibitory 
activity was greatly reduced, being negligible PI, thus the total 
period of treatment was different, and the slides (cell culture) 
treated after 36 hours PI, had a total of 12 hours of treatment. 
2. Rifampin; six concentrations of Rf were tested, from 0.030 
mg/ml through 1.0 mg/ml as shown in Figure 4. Rf has shown gradual 
loss of activity earlier when treatment initiated at 6 to 8 hours PI. 
Treatments initiated at 24 hours PI have shown 10% inhibitory activity 
to rabies virus at 0.030 mg/ml, 20% at 0.060 mg/ml, 40% at 0.120 mg/ml, 
70% at 0.24 mg/ml, 95% at 0.5 mg%, and 98% at 1.0 mg/ml. When the 
treatment initiated at 36 hours PI, the inhibition levels were 5% by 
0.030 mg/ml, 10% by 0.060 mg/ml, 20% by 0.120 mg/ml, 45% by 0.24 mg/ml, 
70% by 0.5 mg/ml, and 80% by 1.0 mg/ml concentration of Rf. 
3. Ribavirin; because no toxicity was detected before, eight 
concentrations of Rb were tested, from 0.030 mg/ml through 4.0 mg/ml as 
shown in Figure 5. All the concentrations from 0.030 mg/ml through 4.0 
mg/ml have shown identical level of inhibition up to the first 4 hours 
PI. Compared to the other two drugs. Am and Rf, all the concentrations 
of Rb from 0.030 mg/ml through 2 mg/ml started to lose their inhibitory 
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activity when treatments were initiated 6-8 hours PI. Treatment 
initiated after 10 hours had shown inhibitory levels of 90% to 98% 
between the lowest and highest concentrations. Treatment initiated 
after 24 hours have shown inhibitory levels of 15-20% on concentration 
of 0.030 mg/ml through 0*24 mg/ml, 25% by 0.5 mg/ml and 1.0 mg/ml, 45% 
by 2.0 mg/ml and 60% by 4.0 mg/ml. When the treatment initiated after 
36 hr, the inhibition levels were 10% by concentration between 0.030 
mg/ml and 0.5 mg/ml, 15% by 1.0 mg/ml, 20% by 2.0 mg/ml and 25% by 4.0 
mg/ml. 
In Figure 6, one concentration level of 0.240 mg/ml from each of 
the 3 drugs was chosen. Treatment was Initiated at the time of 
infection and the drug was maintained in the medium on the cell 
cultures for specific periods of time, 3, 6, 12, 18, 24, and 36 hours. 
The drug inocula were then removed and the cells were rinsed once with 
G-MEM, overlayed with fresh medium, and returned to the incubator to 
complete 48 hours from the time of Inoculation with rabies virus. 
Treatment for the first three hours showed mini mal inhibitory effects 
of 1% by Am and Rf, and 3% byRb. Treatment for the first 6 hours after 
infection showed a 10% inhibition in the infection level by Am, 5% by 
Rf and 15% by Rb. The continuous treatment for longer periods of 12, 
18, 24, and 36 hours PI demonstrated a gradual increase in the level of 
inhibition exerted by these drugs. Rb was most effective of the test 
drugs in controlling virus replication producing 100% inhibition of the 
virus when used for 36 hours. Only 90% inhibition was shown by Am and 
97% inhibition by Rf when they were maintained in the medium for a 
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continuous 36 hours. 
Discussion 
The three chemotherapeutic drugs used in this study were effective 
in inhibiting rabies virus replication in cell cultures. However, 
toxic effects were also detected in cell cultures treated with Am or 
Rf. The most effective concentration of Am were between 0.030 mg/ml 
and 0.240 mg/ml where the inhibition rates between 60% and 97%. In 
Figure 2, Am inhibition activity was decreased dramatically below 0.030 
mg/ml. The toxicity of Am was more pronounced when the concentration 
used was higher than 0.240 mg/ml. See Figure 1. The toxicity level 
was 25% when an Am concentration of 0.5 mg/ml was used. Am showed the 
same level of activity when used up to 8 hours PI. The use of Am 
before infecting the cell culture showed no inhibitory effects on the 
level of infection of the cells. Further, Am treatment during the first 
3 hours PI showed no inhibitory effects. These results indicated that 
Am did not interfere with virus attachment to cell walls or to viral 
penetration inside the cells. The action of Am is possibly during 
events after uncoating, namely inhibition of protein synthesis by viral 
transcriptase or cellular RNA polymerase. The treatment with Am at a 
later time, after 12 hours PI, required higher concentrations of the 
drug to be effective* Only 0.5 mg/ml and 1.0 mg/ml maintained more 
than 98% inhibition when used 12-24 hours PI. Still higher drug 
concentrations are required after 24 hours PI. This was possibly due 
to the fact that rabies virus has already replicated between 12 and 24 
hours PI at sufficient levels to overcome the concentration of Am in 
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the media. Treatment with Am for limited time pre- or post-inoculation 
did not inhibit the virus. See Figure 6. The removal of Am from the 
media at any time during the 48 hours Incubation period used in this 
study resulted in viral replication. This indicated that Am was not a 
virucidal drug but only produced virustatic action in the cell culture 
system. 
The effective inhibitory concentration of Rf appeared to be lower 
than that of Am; it was between 0.030 mg/ml and 0.120 mg/ml. Rf 
showed a toxicity level of 20% to cell cultures at a concentration of 
0.240 mg/ml, and of 50% at 0.50 mg/ml. The Rf inhibitory activity 
against rabies virus was 15% at 0.030 mg/ml and 30% at 0.060 mg/ml; 
thus the potential effectivity level was limited to only 0.120 mg/ml, a 
concentration which had an inhibitory effect of only 60%. Rf showed 
similar levels of activity when used before infection up to 6-8 hours 
PI. These results indicated that Rf did not interfere with attachment 
or penetration of the virus into the cells in culture. A possible 
mechanism of antiviral activity involved later events, probably during 
protein synthesis. Rf at concentration of 0.060 mg/ml and 0.120 mg/ml 
showed decreasing activity when used 2 to 8 hours PI. Only 
concentrations of 0.5 mg/ml and 1.0 mg/ml were effective at 95-97% 
levels when used 12-24 hours PI. Still higher drug concentrations were 
required to inhibit virus replication after 24 hours PI. Rf showed the 
same type of activity as Am when applied for only limited time. There 
was still a 3% level of infection in cell cultures treated with Rf for 
36 hours and fixed 12 hours later. This viral survival and delayed 
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replication Indicated that this drug was not virucidal but only 
virustatic. 
There was no toxicity detected with Rb at the concentrations used 
in this study. Rb at a concentration of 0.002 mg/ml showed 40% 
inhibition of rabies virus in the cell culture system. The inhibition 
level was 60% at 0.004 mg/ml, 90% at 0.008 mg/ml, 95% at 0.016 mg/ml, 
and 100% at 0.030 mg/ml. The potential effectlvity lelvel was 
considered to be between 0.008 mg/ml and 4.0 mg/ml. Thus, Rb showed a 
wider range of effectlvity than either Am or Rf against rabies virus in 
this study. The use of Rb before, with or up to 8 hours PI showed the 
same level of activity. These results have indicated that Rb did not 
interfere with virus attachment to the cell receptors or penetration 
through the cell walls. Rb showed reduced inhibitory activity when 
used after 8-12 hours PI at all test concentrations. These results 
have Indicated that Rb may be active only In one step in the virus 
replication cycle, either in the uncoating or the primary protein 
synthesis stages. Rb was more effective than Am or Rf when applied for 
only a limited time (Figure 6), and showed an effective 100% inhibition 
of rabies virus when used continuously for 36 hours PI in the medium. 
This may indicate that Rb had virucidal activity when used under 
conditions in this study. 
The results from this study show promise that these three drugs, 
especially Rb and Am may have application in protecting cells from 
Injury by rabies virus. Further studies are planned in laboratory 
animals experimentally inoculated with rabies virus. 
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GENERAL DISCUSSION 
The work described in the four papers presented in this 
dissertation deals with two important topics that are related to 
rabies. These two topics are epidemiology of rabies In wild animals, 
and the evaluation of the activity of three chemotherapeutic drugs 
against rabies virus in vitro. The importance of these research papers 
comes from their inmediate and future practical and theoretical 
applications. 
The immediate application in the epidemiological work comes from 
the observations collected and reported in the first three papers. 
These studies have provided new insights into the reservoir hosts and 
dynamics of cycles of the disease. In the first paper, the pattern of 
peaks in the reported cases of rabies in skunks in Iowa has been 
followed and compared to the same pattern in domestic animals. Rabies 
reported In raccoons and foxes In Iowa has shown Increases in 
occurrence correlated with increases in skunk rabies cases. The first 
paper also has shown that the reported cases of rabies in skunks have 
gradually increased each February, March, and April. The number of 
cases then has remained elevated through the end of the summer and then 
has decreased in September and October. This Information provides 
evidence that the peak of transmission each year probably occurs in 
January or February. The incubation period is usually 3-10 weeks, 
possibly up to 6 months. If In the future, an oral vaccine may have 
application as a control measure for rabies in Iowa, it should be 
disseminated in the late fall while skunks are still active and before 
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the major time of transmission. The raccoon population seems to play 
no role in the disease cycle in Iowa at this time. During the period 
of this study, no rabies cases in raccoons in Iowa were reported, and 
in the five-year period between 1979-83, the reported cases of rabies 
in raccoons were closely associated with the number of cases of rabies 
in skunks. It appears that there may be a threshold level in skunk 
cases beyond which spill-over to other species takes place, while below 
that level in skunks, rabies tends to disappear in these other wild 
species. This appears to be independent of the population density of 
raccoons and foxes in Iowa. It must be projected that if in the 
future, the raccoon ecotype of rabies may be introduced into Iowa, that 
it may become established in this species, with the result that dual 
epidemiological patterns would be maintained, one in skunks and one in 
raccoons. 
In Section II, longitudinal serological studies in raccoons from 
two sites in Iowa are detailed. The percentage of positive sera 
recovered each month increased from April through June and decreased 
during the summer, with a small rise again in early fall. Neutralizing 
antibodies against rabies virus were found to be widespread in the 
raccoon population and at sufficient titers to be considered positive 
by the criteria set for the study to separate out neutralization levels 
which could be nonspecific. Overall, 18% of the 465 raccoon sera were 
classified as positive for rabies virus neutralizing antibodies. The 
percentage of positive sera was highest (27%) in spring, decreased in 
summer to 10% and increased slightly in the early few weeks of the 
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fall. The spring collections were mainly from adult raccoons which had 
spent the winter together in communal dens and had gone through the 
breeding season of February. When the weather warms in the spring, 
adult male raccoons disperse leading to reduced population densities 
and possibly reducing occurrences of transmission. This may result in 
the decrease in the percentages of positive sera recorded in adult 
raccoons during^ the summer. However, the presence of infected dams has 
appeared to maintain transmission of the infectious agent to their 
offspring following decay of maternal antibodies below protective 
levels. The young raccoons which were bom each spring and which 
became juveniles in late summer and fall showed gradual increases in 
percentages of positive sera. Increasing age and weight was positively 
correlated with an increasing percentage of positive sera, indicating a 
continuous presence of the infectious agent. In the related study in 
which sera were collected from 18 raccoons in the closed confined 
population at a fur animal breeding farm, the positive rate of rabies 
neutralizing antibodies was 22%. This farm had no history of rabies in 
raccoons or other species, and had no records of vaccination against 
rabies. These raccoons had no direct contact with any free living wild 
mammals. Either the infectious agent eliciting the antibody responses 
recorded in these raccoons had Co be continually present in an endemic 
state in the population, or its entry from outside had to be by 
indirect means; i.e., through fecal, via air or carried by insects. 
None of these indirect means of introduction are very strong hypotheses 
for transmission of rabies virus. Both oral and aerosol exposures 
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would require large doses and rabies vlremias have been either 
nondetectable or of too low level to support arthropod transmission. 
In the third section, skunks and raccoons were studied in Cerro 
Gordo County. Skunks showed a positive rate of 30% in 1982 Immediately 
following the 1981 peak in rabies recorded in Iowa in skunks and other 
animals. This rate declined to 10% in 1983 and then increased 
gradually to 16% in 1984 and to 22% in 1985. In this study, the 
seropositive rates were lower in spring (20%) than in summer (26%), 
unlike the findings in raccoons in Guthrie County in which positive 
rates were higher in spring. This may be related to longer incubation 
periods described in skunks. As we had no collection of skunk sera 
during the fall, the overall annual positive rate could not be 
assessed. Male skunks showed a lower percentage of positive sera than 
female skunks, i.e., 17% in males and 26.7% in females. Further, in 
male skunks, the highest positive rates were recorded in animals of 
lower weight, with progressive decrease in heavier and thus older 
animals. In female skunks, positive rates were highest in the lightest 
and heaviest weight groups. It appeared that transmission cycles in 
skunks in Cerro Gordo County involved females and young more than adult 
males, with intertransmission being most frequent following loss of 
maternal antibody protection in the offspring. 
The raccoons collected in Cerro Gordo County showed somewhat 
similar seropositive patterns to the raccoons of Guthrie County. 
Seropostive rates overall were higher at 29% in Cerro Gordo than in 
Guthrie County at 18%. Positive rates increased with weight and thus 
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with age In both males and females. Positive rates increased in males 
from spring to summer, but the opposite trend was observed in females. 
In the fourth section, a separate area in rabies control has been 
investigated. Antiviral chemotherapeutic drugs have been inadequately 
studied against rabies virus infections. As a dangerous and life 
threatening disease, it is important that all possible methods of 
prophylactic treatment for persons exposed to rabies be investigated. 
The method which is in use now depends mainly on the use of rabies 
specific immunoglobulins along with a series of vaccine doses, 
depending on the type of vaccine used. This method has saved thousands 
of human lives each year and has been proven to be effective. However, 
many side effects have been reported, as well as vaccine failures, 
difficulties in follow up of patients, and burdensome costs in 
developing countries. The use of effective chemotherapeutic drugs as 
an adjunct or alternative to inmunoprophylaxis would have much medical 
application in the control of a dangerous pathogen like rabies virus. 
Three chemotherapeutic drugs were used in this study, including 
amantadine HCl, ribavirin, and rifampin. The activity of these drugs 
in rabies virus infected cell cultures was promising, and hopefully may 
serve as a basis for further studies in experimental animals. 
Amantadine HCl has shown 100% inhibition of rabies virus in the cell 
culture system, using drug concentrations below the toxic level. 
Ribavirin has shown a range of rabies virus inhibition even greater 
than amantadine HCl with no toxicity. Rifampin showed only limited 
rabies virus inhibition at concentrations below the cell culture. 
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These drugs were found to actively inhibit viral replication only if 
used within the first 8 to 12 hours after exposure. In this study, 
these drugs were chosen mainly because they were documented to inhibit 
protein synthesis or reverse transcriptase, applying knowledge of the 
molecular events in virus replication as well as the drug mechanisms of 
action. In living hosts, antiviral drugs would have the advantages of 
more Immediate action than can be obtained with vaccines and would 
hopefully be effective with all antigenic variants or ecotypes of 
rabies virus without the interference of immunity build up. Antiviral 
drugs could presumably be given with vaccines such as the human diploid 
cell vaccine, perhaps replacing the need for using immunoglobulins 
which may interfere with antibody production elicited by vaccination. 
The use of an effective antiviral drug which would inhibit viral 
replication instead of the use of immunoglobulins would have the 
advantage of not decreasing the value of vaccination. Further studies 
are needed on these and perhaps other antiviral drugs in vaccination in 
the prophylactic treatment of victims exposed to rabies. The 
possibility must not be excluded that someday antiviral drugs may also 
have therapeutic application in clinical rabies. 
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APPENDIX 1. GUIDE FOR POSTEXPOSURE TREATMENT 
The reconmendatloas given here are Intended only as a guide. It 
Is recognized that, in special situations, modifications of the 
procedures laid down may be warranted. Such special situations Include 
exposure of young children and other circumstances where a reliable 
history cannot be obtained, particularly in areas where rabies is known 
to be enzootic, even though the animal is considered to be healthy at 
the time of exposure. Such cases justify immediate treatment but of a 
modified nature, for example, local treatment of the wound, followed by 
administration of a single dose of serum (preferably human antirables 
immunoglobulin) and an initial course of vaccine; if the animal stays 
healthy for 5 days following exposure, no further vaccine need be 
given. Modification of the recommended procedures would also be 
indicated in a rabies-free area where animal bites are frequently 
encountered. In areas where rabies is epizootic, adequate laboratory 
and field experience indicating that there is no infection in the 
species involved may justify local health authorities is not 
recommending specific antirables treatment. 
Practice varies concerning the volume of vaccine per dose and the 
number of doses recommended in a given situation. Vaccines should be 
given according to the schedule and dose recommended by the 
manufacturer. 
Combined serum-vaccine treatment is considered by the Committee as 
the best specific systemic treatment available for the postexposure 
prophylaxis of rabies in man, although experience Indicates that 
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vaccine alone is sufficient for minor e^osures. Senim should be given 
in a single dose of 40 lU per kg of body weight for heterologous serum, 
and 20 lU per kg of body weight for human antirabies imnunoglobulin; 
the first dose of vaccine should be inoculated at the same time as the 
serum, but in a different part of the body. Sensitivity to 
heterologous serum must be determined before it is administered. The 
physician should be prepared to deal with anaphylactic shock reactions. 
Treatment should be started as early as possible after exposure, 
but in no case should it be denied to exposed persons whatever time 
interval has elapsed. 
In areas where antirabies serum is not available, full vaccine 
therapy should be administered. 
Local Treatment of Wounds Involving Possible Exposure 
to Rabies—Recommended in all Exposures 
(a) First-aid treatment 
Since elimination of rabies virus at the site of infection by 
chemical or physical means is the most effective mechanism of 
protection, immediate washing and flushing with soap^ and water, 
detergent, or water alone are imperative (this procedure is recommended 
for all bite wounds, including those unrelated to possible exposure to 
rabies). Then apply either alcohol (400-700 ml/litre), tincture or 
aqueous solution of iodine, or quaternary ammonium compounds 
^Where soap has been used to clean wounds, all remaining traces 
should be removed before application of quaternary ammonium compounds, 
because soap neutralizes the activity of such compounds. 
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(1 ml/litre).^ 
(b) Treatment by, or under direction of, a physician 
(1) Treat as In (a) above and then: 
(2) apply antirabies serum by careful instillation in the depth of 
the wound and by Infiltration around Che wound; 
(3) postpone suturing of the wound; if suturing is necessary, use 
antiserum locally as described above; 
(4) where Indicated, Institute antitetanus procedures and 
administer antibiotics and drugs to control Infections other than 
rabies. 
Specific Systemic Treatment 
Status of Biting Animal 
(irrespective of any earlier vaccination) 
Nature of At time During ^ext Recommended 
exposure of exposure 10 days treatment 
I. Contact, Healthy 
but no 
lesion; _ Healthy None 
indirect Suspected as rabid Rabid 
contact; 
no contact 
This observation period applies only to dogs and cats. Other 
domestic and wild animals suspected as rabid should be killed and 
examined using the fluorescent antibody technique. 
2 All unprovoked bites In endemic areas should be considered 
suspect unless proved negative by laboratory examination of the 
animal's brain. 
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II. Licks on Healthy 
the skin; 
scratches 
or abra­
sions; 
minor bites 
(on covered Suspected as rabid^ 
areas of arms, 
trunk, and 
legs) 
Healthy 
Rabid^ 
Healthy 
None 
Start vaccina^ 
tion schedule 
Start vaccina­
tion schedule; 
stop treatment 
if animal re­
mains healthy, 
for 5 days. ' 
Rabid Start vaccina­
tion schedule; 
upon positive 
diagnosis, 
complete the 
course of 
vaccine. 
Rabid; wild animal 
or animal unavailable 
for observation 
Give complete 
course of 
vaccine. 
III.Licks of 
mucosa; 
major 
bites 
(multiple 
or on 
face, 
head, 
finger, 
or neck) 
Suspect or confirmed ^ 
rabid domestic or wild 
animal, or animal unavailable 
for observation 
Serum + 
vaccine. Stop 
treatment only 
in the case 
of domestic 
animal unde^ 
observation 
which remains 
healthy for 5 
days. 
During the usual period of 10 days, begin treatment with vaccine 
at first sign of rabies in a dog or cat that has bitten someone. The 
symptomatic animal should be killed immediately and examined using the 
fluorescent antibody technique. 
Or if the animal^ s brain is found to be negative by ?A 
examination. 
^In general, exposure to rodents, rabbits, and hares seldom, if 
ever, requires specific antirabies treatment. 
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APPENDIX 2. COMPENDIUM OF ANIMAL RABIES VACCINES, 1986 PKEPASED BY: 
THE NATIONAL ASSOCIATION OF STATE PUBLIC HEALTH 
VETERINARIANS, INC. 
Reconmiendatioiis for Imnmlzation Procedures 
The purpose of these recomendatlons Is to provide information on 
rabies vaccines to practicing veterinarians, public health officials, 
and others concerned with rabies control. This document will serve as 
the basis for animal rabies vaccination programs throughout the United 
States. Its adoption will result in standardization of procedures 
among Jurisdictions, which is necessary for an effective national 
rabies-control program. These recommendations are reviewed and revised 
as necessary before the beginning of each calendar year. All animal 
rabies vaccines licensed by the U.S. Department of Agriculture (USDA) 
and marketed in the United States are listed in the next section. 
A. Vaccine Administration 
The Committee recommends that all animal rabies vaccines be 
restricted for use by or under the supervision of a veterinarian. 
B. Vaccine Selection 
The use of vaccines with 3-year duration of immunity is 
recommended, since their use constitutes the most effective method 
of increasing the proportion of immunized dogs and cats in 
comprehensive rabies-control programs. 
C. Route of Inoculation 
Unless otherwise specified by the product label or package insert. 
289 
all vaccines must be administered intramuscularly at one site in 
the thigh. 
Wildlife Vaccination 
Vaccination is not recommended, since no rabies vaccine is licensed 
for use in wild animals and since there is no evidence that any 
vaccine will protect wild animals against rabies. The Committee 
recommends that neither wild nor exotic animals be kept as pets and 
that wild animals not be crossbred to domestic dogs or cats. 
Offspring borne to wild animals crossbred to domestic dogs or cats 
will be considered as wild animals. 
Accidental Human Exposure to Vaccine 
Accidental human inoculation may occur during administration of 
animal rabies vaccine. Such exposure to Inactivated vaccines 
constitutes no known rabies hazard. No cases of rabies have 
resulted from needle or other exposure to a licensed, modified live 
virus vaccine in the United States. 
Identification of Vaccinated Dogs 
The Committee recommends that all agencies and veterinarian adopt 
the standart tag system. This will aid the administration of 
local, state, national, and international procedures. Dog license 
tags should not conflict in shape and color with rabies tags. It 
is recommended that anodized aluminum rabies tags not be less than 
0.064 inches In thickness. 
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1. Rabies Tags 
Calendar Year Color Shape 
1986 Orange Fireplug 
1987 Green Bell 
1988 Red Heart 
1989 Blue Rosette 
2. Rabies Certificate* All agencies and veterinarians should use 
form #50 Rabies Vaccination Certificate of the National 
Association of State Public Health Veterinarians, Inc. 
(NASFHV)f which can be obtained from vaccine manufacturers. 
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Vaccines Marketed in the United States and NASPHV Recommendations 
Vaccines Marketed in the United States and NÂSPHV Recommendations 
Product name Produced by Marketed by 
A. Modified live virus 
Endurall-R Norden 
License No. 189 Norden 
Neurogen-Tc Boehringer 
Ingelheim 
License No. 124 Bio-Ceutc 
B« Inactivated 
Trimune Fort Dodge 
License No. 112 Fort Dodge 
Ânnumune 
Biorab-1 
Fort Dodge 
License No. 112 
Douglas 
License No. 165-B 
Fort Dodge 
Sobering 
Veterinary 
TecbAmeric 
Biorab-3 Douglas 
License No. 165-B 
Sobering 
Veterinary 
TecbAmeric 
Rabume 3 Douglas 
License No. 165-B Beecbam 
1 Refers only to domestic species of this class of animals. 
All vaccines must be administered intramuscularly at one site in 
the thigh unless otherwise specified by the label. 
3 Three months of age (or older) and revaccinated 1 year later. 
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Âge at 
irloary 
use in" Dosage" vaccination" recommended 
For ^ 2 prim ^ Booster 
3 mos* & 
Dogs 1 ml 1 yr* later Triennially 
Cats 1 ml 3 mos. Annually 
3 mos* & 
Dogs 1 ml 1 yr. later Triennially 
3 mos* & 
Dogs 1 ml 1 yr* later Triennally 
3 mos* & 
Cats 1 ml 1 yr. later Triennially 
Dogs 1 ml 3 mos. Annually 
Cats 1 ml 3 mos. Annually 
Dogs 1 ml 3 mos. Annually 
Cats 1 ml 3 mos. Annually 
3 mos* & 
Dogs 1 ml 1 yr. later Triennially 
Cats 1 ml 3 mos. Annually 
3 mos. & 
Dogs 1 ml 1 yr. later Triennially 
Cats 1 ml 3 mos. Annually 
(continued) 
Product name Produced by Marketed by 
Dura-rab 1 
Rabclne 
Endurall-K 
Wildlife 
Vaccines, Inc. 
Kunz-tebblt 
License No. 277 
BeeCham 
License No. 225 
Norden 
License No. 189 
Wildlife 
Vaccines, Inc. 
Kunz-Tebbit 
Beecham 
Norden 
Rabguard-Tc 
Cytorab 
Trirab 
Rabvac 1 
Norden 
License No. 189 
Coopers Animal 
Health, Inc. 
License No. 107 
Coopers Animal 
Health, Inc. 
License No. 107 
Fromm 
License No. 195-A 
Norden 
Coopers 
Cooperse 
Durvet 
Fromm 
Rabvac 3 Fromm 
License No. 195-A Fromm 
Imrab 
Imrab-1 
Merieux 
License No. 298 
Merieux 
License No. 298 
Pitman-Moore 
Pitman-Moore 
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Âge at 
For . 2 primary _ Booster 
use in Dosage vaccination recommended 
Dogs 1 ml 3 mos. Annually 
Cats 1 ml 3 mos. Annually 
Dogs 1 ml 3 mos. Annually 
Cats 1 ml 3 mos. Annually 
Dogs 1 ml 3 mos. Annually 
Cats I ml 3 mos. Annually 
3 mos. & 
Dogs 1 ml 1 yr. later Triennially 
3 mos. & 
Cats 1 ml 1 yr. later Triennially 
Sheep 1 ml 3 mos. Annually 
Cattle 1 ml 3 mos. Annually 
Horses 1 ml 3 mos. Annually 
Dogs 1 ml 3 mos. Annually 
Cats 1 ml 3 mos. Annually 
3 mos. & 
Dogs 1 ml 1 yr. later Triennially 
Cats 1 ml 3 mos. Annually 
Dogs 1 ml 3 mos. Annually 
Cats 1 ml 3 mos. Annually 
3 mos. & 
Dogs 1 ml 1 yr. later Triennially 
3 mos. & 
Cats 1 ml 1 yr. later Triennially 
Dogs 1 ml 
Cats 1 ml 3 mos. & Triennially 
Sheep 1 ml 1 yr later 
Cattle 2 ml 3 mos. Annually 
Horses 2 ml 3 mos. Annually 
Dogs 1 ml 3 mos. Annually 
Cats 1 ml 3 mos. Annually 
(continued) 
Product name Produced by Marketed by 
C« Combination 
Eclipse 3 KP-R 
Eclipse 4 KP-R 
Cytorab RCP 
Fromm 
License No. 195-A 
Fromm 
License No. 195-Â 
Coopers Animal 
Health, Inc. 
License No. 107 
Fromm 
Fromm 
Cooeprs 
Fel—0—Vax 
PCT-R 
Fort Dodge 
License No. 112 Fort Dodge 
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Age at 
For , 2 primary _ Booster 
use in Dosage vaccination recommended 
Cats 1 ml 3 mos. Annually 
Cats 1 ml 3 mos* Annually 
Cats 1 ml 3 mos. Annually 
3 mos. & 
Cats 1 ml 1 yr. later Triannially 
